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ABSTRACT 
Total disc replacement (TDR) was clinically introduced as an alternative to 
spinal fusion to relieve back pain, maintain mobility of the spine and eliminate the 
adverse side effects of fusion. More recently, gamma-inert-sterilized ultra-high 
molecular weight polyethylene (UHMWPE) TDR cores were introduced to replace 
historical gamma-air-sterilized cores in an effort to reduce UHMWPE wear debris and 
inflammation. In this study, both implant and periprosthetic tissue retrievals from 
patients with gamma-inert-sterilized TDRs were evaluated for in vivo performance 
and biological responses, respectively. As pain was the primary revision reason for 
all patients, the contributions of implant-related damage and tissue responses to the 
development of pain were also a focus of this investigation. 
After analyzing implants and tissues for 11 TDR patients, detectable UHMWPE 
wear debris was identified with corresponding macrophage infiltration in six patients 
with associated implant damage. Neither damage nor TDR bearing design, fixed vs 
mobile, influenced the amount, size and shape characteristics of wear particles. 
However, comparisons to a retrieval study of historical devices indicated that the 
number of UHMWPE particles generated from gamma-inert-sterilized devices were 
decreased by 99% (p=0.003) and were 50% rounder (p=0.003), confirming the 
improved wear resistance of the newer devices. Accordingly, periprosthetic tissue 
reactions were also substantially reduced. 
Prospective immunohistochemical investigations for these devices showed, 
for the first time, that UHMWPE wear-debris induced tissue reactions in the human 
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lumbar spine can be linked to inflammation. First, inflammatory factors were 
elevated in TDR periprosthetic tissues (n=30) when compared to disc degenerative 
disease (DDD) patient tissues (n=3) from primary surgery and disc tissues (n=4) from 
normal autopsy patients with no history of lower back pain. The mean percent area 
of production for vascular endothelial growth factor (VEGF) (p=0.04), interleukin-
1beta (IL-1β), (p=0.01) and substance P (p=0.01) were significantly higher in TDR 
tissues when compared to tissues obtained from DDD patients. Although platelet 
derived growth factor-bb (PDGFbb) p=0.14), tumor necrosis factor-alpha (TNFα) 
(p=0.06) and nerve growth factor (NGF) (p=0.19) were also increased in the TDR 
patient tissues, these increases were not significant. Compared to normal disc tissues, 
the mean percent area for all six factors was statistically increased in TDR tissues (at 
least p<0.05). Interestingly, no statistical differences were observed between DDD 
and normal disc tissues. Next, our studies showed that TNFα, IL-1ß, VEGF, NGF and 
substance P strongly correlated with the number of wear particles and also the 
number of macrophages for the TDR patient group (at least p<0.05 for all). Finally, 
the pro-inflammatory/pain factors, TNFα and IL-1ß, and the vascularization factors, 
VEGF and PDGFbb, significantly correlated with the presence of the neural 
innervation and hypersensitization agents, NGF and substance P (p<0.01 for all). 
These findings suggest not only the presence of inflammatory reactions, but the 
presence of factors that can directly and indirectly contribute to the pain sensitivity.  
In addition to wear-debris and subsequent inflammation, increased 
vascularization was another key histomorphological change observed in the TDR 
tissues that may be involved in the pathogenesis of particle disease.  In brief, the 
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ingrowth of blood vessels may be providing a conduit for nociceptive innervation. 
Studying vascularity in revision tissues showed the total number of blood vessels was 
significantly associated with TNFα, IL-1ß, VEGF, PDGFbb, NGF and substance P (at 
least p<0.05 for all), suggesting an interrelation between vascular changes and 
inflammatory-mediated responses. Furthermore, analysis at the local level revealed 
the innervation/pain factors, NGF and substance P, were predominantly localized to 
vascular channels, suggestive of nerve ingrowth and potential neural-maladaptive 
plasticity at periprosthetic sites. Lastly, comparing blood vessel number with factor 
expression and macrophage number in individual images obtained from tissue 
sections with low and high vascularity suggested a temporal link between TNFα, 
macrophages and angiogenesis. Taken together, elucidating the pathogenesis of 
inflammatory particle disease will provide information needed to identify potential 
therapeutic targets and treatment strategies to mitigate pain. 
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CHAPTER 1 
Introduction & Background 
1.1 Low Back Pain & Surgical Fusion 
Low back pain is reported to be the leading cause of disability worldwide 
according to the 2010 Global Burden of Disease Study [48]. It is also the leading 
cause of activity limitation and work absence, resulting in a heavy economic burden 
on individuals, communities and governments [2, 74]. Degenerative disc disease 
(DDD) is one pathology known to result in chronic back pain due to the 
biomechanical instability caused by loss of disc height, disc dehydration and/or 
annular tears [18, 24, 82]. When conservative treatments such as pain medications 
and physical therapy fail, discectomy or surgical fusion are implemented to mitigate 
pain for patients with DDD. The number of spinal fusions performed each year is 
continually increasing [14], with an estimated 380,000 thoracolumbar fusions 
performed in 2013 according to the 2013 Spinal Surgery Update by the Millennium 
Research Group. However, the clinical success rate of lumbar fusion is variable 
ranging from 16-95%, as long-term results are poor due to increased risk of 
complications [7, 18, 80]. One noteworthy and common complication is adjacent 
segment disease (ASD) [23, 54].  ASD is the associated degeneration of adjacent 
intervertebral discs (IVDs) due to abnormal loading and increased mobility of IVDs 
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above or below the fused degenerated disc. Definitive treatment for this 
complication is a topic of continuing research, but disc replacement has been 
regarded as a potential solution [87]. 
1.2 Total Disc Replacement: An Alternative Treatment for DDD? 
Following the encouraging short term results of Fernstrom implantation of a 
steel ball in place of an IVD in the 1960s [15], total disc replacement (TDR) was 
conceived as an alternative to spinal fusion and its resulting complications. TDR 
involves the removal of a damaged or degenerating IVD and replacement with an 
artificial device. In theory, implantation of a mobile and potentially shock-absorbing 
component to replace a degenerating disc will not only restore disc height and 
alleviate pain, but also preserve spinal segmental motion and transmit/absorb load 
between vertebral bodies. In contrast to fusion, this preservation of mobility has 
been speculated to prevent ASD since excess strain at adjacent vertebral levels is 
theoretically diminished [18, 46]. In addition, other complications that may arise 
from fusion such as the morbidity associated with bone graft harvest, stiffening of 
the lumbar spine, sagittal balance misalignment, and nonunion are all avoided with 
disc arthroplasty [33, 47, 62]. 
 Several studies have demonstrated clinical success of disc arthroplasty in 
comparison to fusion for short and mid-term results [46, 82, 93]. Despite this 
evidence, fusion is still regarded as the “gold standard” for surgical treatment of 
DDD, and only 24,579 cervical and lumbar disc replacements were performed in 
2013 (Millennium Research Group). Roughly 10 years have passed since TDRs were 
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approved by the Food and Drug Administration (FDA) for use in the US, but the 
excitement surrounding TDR technology has been tempered due to limited long-
term data, which is needed to convince insurance companies to cover the increased 
cost of this surgery. Thus, it is crucial to pin-point any long-term pitfalls of motion 
preservation surgery and understand successful features as well as failure modes of 
both contemporary and emerging designs of artificial discs to further improve the 
technology.    
1.3 The Historical CHARITÉ Disc Design & Early Retrieval Studies of 
Wear Debris 
While Fernstrom’s steel spheres and many early artificial disc designs 
receded from clinical use soon after their introduction, the CHARITÉ artificial disc 
design has been used extensively since its development in the 1980s, with few 
changes to design and biomaterials over the past 2 decades [34]. The SB CHARITÉ 
III was the third iteration of the original device that became commercialized in 1987 
by Waldemar Link GmbH & Co. The lumbar TDR (L-TDR) design adapted 
biomaterials and design principles based on successful total joint replacement (TJR) 
designs. The original L-TDR incorporated two cobalt-chromium (CoCr) metallic 
endplates that were fixed to the superior/inferior vertebrae, and articulated against 
a mobile polymer core made of ultra-high molecular weight polyethylene 
(UHMWPE), which was gamma-air-sterilized. The design features were iconic for 
“historical” metal-on-polyethylene (MOP) L-TDRs. The clinical performance of this 
7 
 
disc design was reported to result in good to excellent clinical outcomes based on 
the alleviation pain and preservation of motion (Figure 1-1) [13, 39, 46, 66].  
 
Figure 1-1. (A) Anterioposterior and (B) lateral radiographs of a successfully 
implanted CHARITÉ TDR in the lumbosacral spine. 
While MOP designs have proven to be relatively successful in TJR, UHMWPE 
prosthetic wear debris generation is a clinically relevant complication that can 
ultimately result in osteolysis and aseptic loosening [28, 29]. Wear debris 
generation and osteolysis were initially thought to be negligible in anterior column 
of the lumbar spine due to the decreased sliding distance in MOP TDRs compared to 
total hip and total knee arthroplasty [40, 41]. However, retrieval studies of 
original/historical TDRs with gamma-air-sterilized UHMWPE cores demonstrated 
wear of the UHMWPE core, along with three ra[72]re cases of osteolysis in the 
lumbar spine [37, 78, 85]. Additionally, both submicron (0.05-2.0 µm) and large 
UHMWPE wear particles (> 2.05 µm) were present in periprosthetic tissues from 
historical TDRs, and these particles were associated with a chronic innate 
inflammatory response [57, 58]. TDR wear particles had a size range that was 
similar to that observed in revision tissues from total knee replacements (TKRs), 
however the majority were smaller than 6 µm as seen in revision tissues from total 
8 
 
hip replacements (THRs) [57]. Furthermore, the extent of impingement of the 
implant positively correlated with increased submicron wear debris and 
biological/inflammatory activity of these particles [4]. Collectively, these studies 
and others have established the clinically relevant complication of UHMWPE core 
wear for the historical TDRs [36, 38, 56, 83, 84], which served as an impetus for 
improving TDR bearing surface materials and designs. 
1.4 The Modern TDR: ProDisc-L & the new CHARITÉ 
The growing field of artificial disc replacement includes a broad range of 
designs and a heterogeneous assortment of biomaterials, but the most commonly 
employed L-TDRs have relied on developing better MOP devices [86]. Modern MOP 
devices, such as the ProDisc-L and CHARITÉ (re-modeled in 2004), incorporate 
conventional polyethylene cores which are fabricated with gamma-inert-sterilized 
UHMWPE GUR 1020 resin, designed to improve oxidation resistance and thus 
enhance the wear performance of the cores. While both devices were approved by 
the FDA and in clinical use for several years, the CHARITÉ was discontinued in 2011 
as their manufacturer, Synthes, was acquired by the ProDisc-L developer, DePuy. 
Today, the ProDisc-L remains as the only lumbar TDR in the present US market, 
however there is an extensive clinical history database for both devices as tens of 
thousands of people have received these devices. 
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Figure 1-2. (A) CHARITÉ mobile-bearing artificial disc; (B) ProDisc-L fixed-
bearing artificial disc. 
The biomaterials used in the fabrication of the ProDisc-L prosthesis are quite 
similar to the CHARITÉ, specifically a conventional UHMWPE core and two CoCr 
endplates, plasma-coated on the outside with titanium. However, unlike the mobile-
bearing CHARITÉ, the core of ProDisc-L is fixed via a locking mechanism into the 
inferior endplate, thus allowing relative motion only between the core and the 
superior endplate (Figure 1.2) [34]. To the author’s knowledge, no studies have 
evaluated implant wear or periprosthetic tissue reactions for contemporary MOP L-
TDRs. Additionally, it remains unclear whether TDR design will influence the 
generation of UHMWPE particles and the associated chronic inflammatory response.  
1.5 TDR Revision, Complications & Pain 
 TDR revision surgery can be a dangerous procedure due to the difficulty that 
is involved in retrieving the prosthesis that is adhered or in close proximity to great 
vessels and nerve plexus [82]. Nevertheless, revision cases are growing as TDRs are 
becoming more widely used. While TDR technology provides an alternative 
treatment approach to fusion, new operative techniques unfortunately mean new 
complications. However, many complications arising from TDRs that require 
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revision surgery result from iatrogenic causes such as inappropriate indications, 
poor implantation technique and malpositioning of the implant [5]. Implant 
subsidence into the vertebral body is a common problem that could potentially 
result from inadequate determination of preoperative bone quality as TDR 
contraindications include osteophenic/osteoporotic bones [26]. Other 
complications of poor implantation that result in revision surgeries include device 
migration, extrusion, or dislodgement that may ultimately result in spinal cord 
compression, causing nerve irritation or vascular impedance. A malpositioned 
prosthesis can cause foramenal narrowing and compromise the dorsal root ganglion 
or nerve root, thereby resulting in radiculopathy and excruciating pain. Adding to 
these complications, positional changes of the implant in vivo can also lead to wear 
debris generation from unintended contact between device components. 
 Pain is the primary reason for TDR revision, but iatrogenic damage is not 
always the cause. Periprosthetic wear debris generation in artificial disc 
replacement has recently emerged as a clinically relevant complication that may 
lead to a painful inflammatory response similar to what has been observed for some 
TJRs [20, 22]. Studies suggest there may be a functional link between the innate 
immune response, and neurological changes that ultimately result in the generation 
of peripheral pain [75, 94]. Specifically, activated macrophages have been reported 
to contribute to experimental pain states by releasing factors such as tumor necrosis 
factor-α (TNFα), interleukin-1β (IL-1β), IL-8, nerve growth factor (NGF), nitric oxide 
(NO) and prostanoids [43, 64, 76]. However, the role of wear-debris-induced 
inflammation and subsequent mediation of pain post-spinal arthroplasty remains 
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unknown. Thus, investigating wear debris and the resulting biological responses 
will be invaluable in understanding some of the underlying mechanisms of pain, 
which can then be targeted to preserve or extend the life-time of the implant. 
1.6 What We Know About Lumbar Pain from the Degenerative Disc 
 Much of what is known about the pathological states that can contribute to 
the mediation of pain in the lumbar spine is derived from the large body of research 
comparing the normal disc to degenerative states. The normal intervertebral disc is 
comprised of three regions that are morphologically distinct: the inner gelatinous 
nucleus pulposus (NP), the outer annulus fibrosis (AF) and cartilaginous endplates. 
While the adult human NP is completely avascular and aneural, a relatively low 
number of small blood vessels and nerve fibers are found in the very outer regions 
of the AF and endplates [11, 63, 67, 92]. The capillaries present in these regions 
provide nutrients to cells within the disc through diffusion-facilitated fluid transport 
that occurs from normal movements. During movement compressive loading causes 
water in the NP to extrude metabolic waste products from cells towards the blood 
vessels and the osmotic potential of the nucleus draws back nutrients into the inner 
disc. However, the distance between NP cells and the nearest blood vessel can be as 
much as 8 mm, resulting in a nutrient- and oxygen- poor environment [30, 81]; this 
hostile environment is reflected in significantly lower cell densities and metabolic 
activities than other cartilaginous tissues. The small existing body of NP cells 
regulate homeostatic turnover of the extracellular matrix and any imbalance in the 
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degradative/synthetic processes can contribute to loss of tissue integrity and 
degenerative conditions. 
Disc degeneration is characterized by not only the overall breakdown of the 
extracellular matrix, but also changes in resident cell number, phenotype and 
behavior. These changes can contribute to inflammatory-mediated discogenic pain 
(inflammatory changes in the disc that influence the nervous system by stimulation 
of nociceptors in the AF) and/or pain caused by the physical biomechanical 
instability of the spine leading to disc herniation and impingement of nerve roots [8, 
21, 91]. The loss of proteoglycans and overall breakdown of matrix is reflected in 
the poor reparative capacity of the disc. The breakdown of the matrix surrounding 
the cells ultimately results in inflammation, the replacement of NP with 
disorganized scar and granulated tissue [55]. The reparative effort of AF cells in 
response to matrix degeneration and tears/fissures also causes inflammation, 
scarring and promotes neovascularization [16, 17]. This process has been 
associated with an infiltration of inflammatory cells, as resident macrophages are 
not present [6, 17]. Koike and colleagues have found correlations that suggest 
progressive degeneration is accompanied by angiogenesis and that newly formed 
vessels play an important role as a passage for macrophages to enter the disc space 
[31]. Interestingly, an immunohistochemical study on human autopsy degenerative 
discs also showed the presence of CD68-positive (pan-macrophage marker) cells in 
the NP, and suggested these cells were transformed resident cells rather than 
invading monocytes [50]. While more substantiative evidence is necessary to 
determine whether the degenerative pathology enables a microenvironment 
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conducive to transdifferentiation of resident NP cells towards a macrophage-like 
phenotype, the presence of transformed cells or infiltrated inflammatory cells both 
have the potential to mediate pain.  
Inflammatory cells in the degenerated disc and AF secrete proinflammatory 
cytokines such as TNFα and IL-1ß that can directly and/or indirectly mediate pain 
sensitization [21, 53, 89, 91]. Both cytokines can directly exert algesic effects by 
binding to pain-associated receptors on the synapses of sensory neurons (which 
then respond by sending signals to the brain, initiating the perception of pain) [75, 
94]. These cytokines also have the potential to induce neural ingrowth into the disc 
and mediate hypersensitization by upregulating the expression of factors like NGF 
and substance P, both of which are also found to be upregulated or increased in the 
outer AF of degenerated disc [1, 21, 60]. Furthermore, TNFα and IL-1ß have been 
shown to induce blood vessel ingrowth by stimulating the release of factors like 
vascular endothelial growth factor (VEGF) [6, 79]. Activated fibroblasts and 
macrophages in close proximity to existing blood vessels can coordinate signals 
with endothelial cells (ECs) and other stromal cells to stimulate angiogenesis [10, 
27].    
Angiogenesis is a crucial component in the pain-associated pathogeneses of 
disc degeneration and herniation. An immunohistochemical study of 50 herniated 
discs showed 88% and 78% immunopositivity for the angiogenic growth factors, 
VEGF and platelet-derived growth factor (PDGFbb), respectively; both factors were 
predominantly observed in tissue capillaries, but also present in disc cells and 
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fibroblasts [77]. The presence of these factors in degenerated and herniated discs 
has been associated with neovascularization of the poorly vascular AF and avascular 
NP [6, 12]. This is a very noteworthy morphological change for two reasons. First, 
the newly formed blood vessels branch out to form a network of smaller vessels that 
provide a venue for monocyte infiltration into the disc tissue via post-capillary 
venules; this process can then induce further inflammation and vascularization in 
the disc space [31, 51]. Second, vascularization also contributes to pathological 
innervation into the disc space: blood vessels extend through the AF towards the 
degenerating NP and this process can be accompanied by ingrowing nerve fibers 
[16, 17]. On the basis that these nerve fibers originate from the dorsal root ganglia, 
they are nociceptive [3, 9, 19, 52]. Importantly, these nerve fibers can also become 
hypersensitized due the inflammatory conditions in the degenerated disc, thereby 
contributing to discogenic pain [19]. Gruber and colleagues (2012) proposed nerve 
ingrowth into the inner AF of degenerative discs encounter a proinflammatory 
cytokine-rich mileu that promotes hyperalgesia and exacerbates pain [21]. To 
complicate an already complex phenomenon in the degenerating disc, both ECs and 
nerve cells, in addition to inflammatory cells, produce proinflammatory cytokines, 
vascularization factors, neurotrophins or neuropeptides [51, 65, 70, 75, 91]. Taken 
together, inflammation and the vascularization/innervation process work in 
synergy to mediate discogenic pain. Although it is still not clear which comes first, 
both processes involve potential targets for therapeutic intervention to mitigate 
pain.  
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TDR is a surgical procedure that involves the removal of the degenerated disc 
in its entirety to alleviate back pain. Thus, in theory, the majority of the pathological 
disc is discarded, with the exception of outer-most portions of the AF. However, 
since the AF can be involved in the pathogenesis of discogenic pain, it raises the 
interesting question of how pain is developing in patients revised for TDRs. This 
present body of research aims to not only evaluate the wear performance of TDRs in 
patients that were originally indicated for DDD, but also study any overlaps in pain-
associated pathologies, since the primary reason for TDR revision surgery is pain.    
1.7 Overview of Thesis & Specific Aims 
This thesis presents extensive work reviewing artificial disc implant designs 
and biomaterials, followed by studying TDR retrievals, wear debris generation from 
these devices and the biological responses to the debris. The field of artificial disc 
replacement includes a broad range of designs as well as heterogeneous assortment 
of biomaterials for lumbar and cervical regions of the spine. Chapter 2 provides a 
systematic review evaluating the design and material factors that are associated 
with differences in clinical wear performance of lumbar and cerivical TDRs. The rest 
of the thesis details experimental research evaluating the wear performance and 
biocompatibility of lumbar TDRs comprised specifically of the 2-piece, metal-on-
polyethylene (MOP) design. Chapter 3 describes the retrieval analyses of 
contemporary MOP lumbar device components and periprosthetic tissue responses 
(see Aim I below). Chapter 4 investigates the immune responses to polyethylene 
wear particles and the involvement of inflammatory factors known to play both a 
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direct and indirect role in inflammatory-mediated pain (see Aim II below).  Chapter 5 
evaluates the relationship between inflammation, vascularization and innervation in 
the periprosthetic lumbar spine to elucidate the wear-debris-induced pathogenesis 
based on localized tissue/cellular responses (see Aim III below). Chapter 6 provides 
more information on the biological responses that led to the rare case of osteolysis 
noted in two TDR revision patients. Lastly, Chapter 7 summarizes the findings from 
the above body of research, along with implications of this work and future 
directions.  
1.7.1 Aim I: Retrieval Analyses of Contemporary MOP L-TDR Device 
Components & Periprosthetic Tissue Responses 
Modern L-TDR designs incorporate gamma-inert-sterilized or conventional 
ultra-high-molecular-weight polyethylene (UHMWPE) cores to improve wear 
resistance, minimize wear debris generation and reduce the risk of revision surgery 
[35]. Whether this contemporary material or the type of TDR design (mobile vs 
fixed) will influence UHMWPE wear debris and the subsequent tissue reactions in 
the spine remain unanswered questions. The hypothesis was that conventional 
UHMWPE cores used in contemporary TDR designs will decrease wear damage and 
periprosthetic tissue reactions compared to historical designs. The goals were to 
determine whether: (1) periprosthetic UHMWPE wear debris and biological tissue 
responses are present in tissues from revised contemporary MOP L-TDRs; (2) there is 
an influence of bearing design (i.e. fully mobile vs. fixed designs) on wear particle 
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number, size and shape; and (3) wear particles characteristics from contemporary 
MOP L-TDRs differ from historical MOP L-TDRs and conventional THRs. 
1.7.2 Aim II: Investigate the Immune Response to UHMWPE Wear Particles and 
the Involvement of Inflammatory Factors known to Play Both a Direct and 
Indirect Role in Inflammatory-mediated Pain 
Pain is the primary reason for revision of artificial discs. However, whether 
pain is mediated or exacerbated as a biological consequence of wear debris remains 
unclear. Hip and knee arthroplasty and in vitro studies have revealed that UHMWPE 
wear debris stimulate resident and recruited macrophages to secrete a number of 
inflammatory cytokines, chemokines, reactive oxygen species and reactive nitrogen 
species [25, 32, 44, 45, 59, 61, 68, 69, 71, 73, 88]. These factors are predominantly 
associated with the induction of bone resorption in TJAs, which can lead to the 
development of osteolysis and implant loosening [73]. However, their presence, 
quantity and role in the clinical failure of contemporary TDR designs have not been 
determined, where pain rather than osteolysis is the central reason for revision. 
Interestingly many of the aforementioned biological factors produced in response to 
wear debris in TJR have also been implicated in nociceptive pain mediation [90, 94]. 
Based on preliminary data from TDR wear debris and tissue analyses performed in 
Aim I, it was hypothesized that biological reactions to wear debris in the spine are 
unique, in that the production and interplay between key inflammatory mediators 
may be contributing to abnormal or enhanced pain sensitization. To test this 
hypothesis and better understand the biological responses in TDR patient tissues 
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with and without detectable wear debris, the second specific aim of this study was to 
analyze periprosthetic tissues from revised artificial discs using 
immunoshistochemistry to quantify the levels of select inflammatory factors that are 
known to play both direct and indirect roles in the mediation of pain. 
1.7.3 Aim III: Evaluate the Relationship between Inflammation, 
Vascularization and Innervation in the Periprosthetic Lumbar Spine to 
Elucidate the Wear-Debris-Induced Pathogenesis based on Localized 
Tissue/Cellular Responses 
As a part of Aim II, we reported an association for the angiogenic factor, 
VEGF with the neutrophin, NGF and the neuropeptide, Substance P. Associations for 
these factors have been previously reported, specifically at the sites of 
neovascularization, where infiltrating vessels are thought to physically provide a 
route for nerves to form and grow [6, 17, 42, 49]. Interestingly, inflammation and 
the production of the proinflammatory cytokines TNFα and IL-1ß were also 
associated with these neovascular changes. Taken together, these findings raise an 
important question: what is the significance of increased vascularization in TDR 
patient tissues and could the number of vessels independently serve as a pathogenic 
indicator and therapeutic target for pain-associated ‘particle disease’ in these 
individuals? To answer this question, macrophage, inflammatory factor and blood 
vessel and nerve cell contributions to the adverse reactions in TDR tissues needed 
to be systematically evaluated. We hypothesized that while inflammation is the 
driving force, increased vascularization may be a key histomorphological change 
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leading to nociception. Therefore, the final and prospective specific aim was to 
elucidate the wear-debris-induced inflammatory pathogenesis in TDR tissues based on 
vascular density and NGF and substance P production at the localized level. 
1.8 References 
1. Abe Y, Akeda K, An HS, Aoki Y, Pichika R, Muehleman C, Kimura T, Masuda K. 
Proinflammatory cytokines stimulate the expression of nerve growth factor 
by human intervertebral disc cells. Spine (Phila Pa 1976). 2007;32:635-642. 
2. Andersson GBJ. The Epidemiology of Spinal Disorders.  The Adult Spine: 
Principles and Practice. Philadelphia: Lippincott-Raven; 1997:93-141. 
3. Ashton IK, Roberts S, Jaffray DC, Polak JM, Eisenstein SM. Neuropeptides in 
the human intervertebral disc. Journal of orthopaedic research : official 
publication of the Orthopaedic Research Society. 1994;12:186-192. 
4. Baxter RM, Macdonald DW, Kurtz SM, Steinbeck MJ. Severe impingement of 
lumbar disc replacements increases the functional biological activity of 
polyethylene wear debris. The Journal of bone and joint surgery. American 
volume. 2013;95:e751-759. 
5. Bertagnoli R, Zigler J, Karg A, Voigt S. Complications and strategies for 
revision surgery in total disc replacement. The Orthopedic clinics of North 
America. 2005;36:389-395. 
6. Binch AL, Cole AA, Breakwell LM, Michael AL, Chiverton N, Cross AK, Le 
Maitre CL. Expression and regulation of neurotrophic and angiogenic factors 
during human intervertebral disc degeneration. Arthritis research & therapy. 
2014;16:416. 
7. Blumenthal S, McAfee PC, Guyer RD, Hochschuler SH, Geisler FH, Holt RT, 
Garcia R, Jr., Regan JJ, Ohnmeiss DD. A prospective, randomized, multicenter 
Food and Drug Administration investigational device exemptions study of 
lumbar total disc replacement with the CHARITE artificial disc versus lumbar 
fusion: part I: evaluation of clinical outcomes. Spine (Phila Pa 1976). 
2005;30:1565-1575; discussion E1387-1591. 
8. Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG. 
Classification of age-related changes in lumbar intervertebral discs: 2002 
Volvo Award in basic science. Spine (Phila Pa 1976). 2002;27:2631-2644. 
9. Brown MF, Hukkanen MV, McCarthy ID, Redfern DR, Batten JJ, Crock HV, 
Hughes SP, Polak JM. Sensory and sympathetic innervation of the vertebral 
endplate in patients with degenerative disc disease. The Journal of bone and 
joint surgery. British volume. 1997;79:147-153. 
10. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of 
angiogenesis. Nature. 2011;473:298-307. 
11. Choi YS. Pathophysiology of Degenerative Disc Disease. Asian Spine Journal. 
2009;3:39-44. 
20 
 
12. David G. Angiogenesis in the degeneration of the lumbar intervertebral disc. 
2010;3:154-161. 
13. David T. Long-term results of one-level lumbar arthroplasty: minimum 10-
year follow-up of the CHARITE artificial disc in 106 patients. Spine (Phila Pa 
1976). 2007;32:661-666. 
14. de Kleuver M, Oner FC, Jacobs WC. Total disc replacement for chronic low 
back pain: background and a systematic review of the literature. European 
spine journal : official publication of the European Spine Society, the European 
Spinal Deformity Society, and the European Section of the Cervical Spine 
Research Society. 2003;12:108-116. 
15. Fernstrom U. Arthroplasty with intercorporal endoprothesis in herniated 
disc and in painful disc. Acta chirurgica Scandinavica. Supplementum. 
1966;357:154-159. 
16. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MI. Nerve 
ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 
1997;350:178-181. 
17. Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross 
ER, O'Brien JP, Hoyland JA. Nerve growth factor expression and innervation 
of the painful intervertebral disc. The Journal of pathology. 2002;197:286-
292. 
18. Frelinghuysen P, Huang RC, Girardi FP, Cammisa FP, Jr. Lumbar total disc 
replacement part I: rationale, biomechanics, and implant types. The 
Orthopedic clinics of North America. 2005;36:293-299. 
19. Garcia-Cosamalon J, del Valle ME, Calavia MG, Garcia-Suarez O, Lopez-Muniz 
A, Otero J, Vega JA. Intervertebral disc, sensory nerves and neurotrophins: 
who is who in discogenic pain? Journal of anatomy. 2010;217:1-15. 
20. Grammatopoulos G, Pandit H, Kamali A, Maggiani F, Glyn-Jones S, Gill HS, 
Murray DW, Athanasou N. The correlation of wear with histological features 
after failed hip resurfacing arthroplasty. The Journal of bone and joint surgery. 
American volume. 2013;95:e81. 
21. Gruber HE, Hoelscher GL, Ingram JA, Hanley EN, Jr. Genome-wide analysis of 
pain-, nerve- and neurotrophin -related gene expression in the degenerating 
human annulus. Molecular pain. 2012;8:63. 
22. Hallab N, Cunningham B, Jacobs JJ. Spinal implant debris-induced osteolysis. 
Spine (Phila Pa 1976). 2003;28:S125-138. 
23. Hilibrand AS, Robbins M. Adjacent segment degeneration and adjacent 
segment disease: the consequences of spinal fusion? Spine J. 2004;4:190s-
194s. 
24. Hochschuler SH, Ohnmeiss DD, Guyer RD, Blumenthal SL. Artificial disc: 
preliminary results of a prospective study in the United States. European 
spine journal : official publication of the European Spine Society, the European 
Spinal Deformity Society, and the European Section of the Cervical Spine 
Research Society. 2002;11 Suppl 2:S106-110. 
25. Horowitz SM, Gonzales JB. Effects of polyethylene on macrophages. Journal of 
orthopaedic research : official publication of the Orthopaedic Research Society. 
1997;15:50-56. 
21 
 
26. Huang RC, Lim MR, Girardi FP, Cammisa FP, Jr. The prevalence of 
contraindications to total disc replacement in a cohort of lumbar surgical 
patients. Spine (Phila Pa 1976). 2004;29:2538-2541. 
27. Hughes CC. Endothelial-stromal interactions in angiogenesis. Current opinion 
in hematology. 2008;15:204-209. 
28. Ingham E, Fisher J. Biological reactions to wear debris in total joint 
replacement. Proceedings of the Institution of Mechanical Engineers. Part H, 
Journal of engineering in medicine. 2000;214:21-37. 
29. Ingham E, Fisher J. The role of macrophages in osteolysis of total joint 
replacement. Biomaterials. 2005;26:1271-1286. 
30. Katz MM, Hargens AR, Garfin SR. Intervertebral disc nutrition. Diffusion 
versus convection. Clinical orthopaedics and related research. 1986:243-245. 
31. Koike Y, Uzuki M, Kokubun S, Sawai T. Angiogenesis and inflammatory cell 
infiltration in lumbar disc herniation. Spine (Phila Pa 1976). 2003;28:1928-
1933. 
32. Koulouvaris P, Ly K, Ivashkiv LB, Bostrom MP, Nestor BJ, Sculco TP, Purdue 
PE. Expression profiling reveals alternative macrophage activation and 
impaired osteogenesis in periprosthetic osteolysis. Journal of orthopaedic 
research : official publication of the Orthopaedic Research Society. 
2008;26:106-116. 
33. Kumar MN, Baklanov A, Chopin D. Correlation between sagittal plane 
changes and adjacent segment degeneration following lumbar spine fusion. 
European spine journal : official publication of the European Spine Society, the 
European Spinal Deformity Society, and the European Section of the Cervical 
Spine Research Society. 2001;10:314-319. 
34. Kurtz SM. The UHMWPE Biomaterials Handbook. Burlington, MA: Academic 
Press; 2009. 
35. Kurtz SM, MacDonald D, Ianuzzi A, van Ooij A, Isaza J, Ross ER, Regan J. The 
natural history of polyethylene oxidation in total disc replacement. Spine 
(Phila Pa 1976). 2009;34:2369-2377. 
36. Kurtz SM, Patwardhan A, MacDonald D, Ciccarelli L, van Ooij A, Lorenz M, 
Zindrick M, O'Leary P, Isaza J, Ross R. What is the correlation of in vivo wear 
and damage patterns with in vitro TDR motion response? Spine. 
2008;33:481-489. 
37. Kurtz SM, Toth JM, Siskey R, Ciccarelli L, Macdonald D, Isaza J, Lanman T, 
Punt I, Steinbeck M, Goffin J, van Ooij A. The Latest Lessons Learned from 
Retrieval Analyses of Ultra-High Molecular Weight Polyethylene, Metal-on-
Metal, and Alternative Bearing Total Disc Replacements. Seminars in spine 
surgery. 2012;24:57-70. 
38. Kurtz SM, van Ooij A, Ross R, de Waal Malefijt J, Peloza J, Ciccarelli L, 
Villarraga ML. Polyethylene wear and rim fracture in total disc arthroplasty. 
Spine J. 2007;7:12-21. 
39. Lemaire JP, Carrier H, Sariali el H, Skalli W, Lavaste F. Clinical and 
radiological outcomes with the Charite artificial disc: a 10-year minimum 
follow-up. Journal of spinal disorders & techniques. 2005;18:353-359. 
22 
 
40. Link HD, Keller A. Biomechanics of Total Disc Replacement. In: Buttner-Janz 
K, Hochschuler SH, McAfee PC, ed. The Artificial Disc. Berlin: Springer Berlin 
Heidelberg; 2003:33-52. 
41. Link HD, McAfee PC, Pimenta L. Choosing a cervical disc replacement. Spine J. 
2004;4:294S-302S. 
42. Malinsky J. The ontogenetic development of nerve terminations in the 
intervertebral discs of man. (Histology of intervertebral discs, 11th 
communication). Acta anatomica. 1959;38:96-113. 
43. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic 
pain. Nature reviews. Neuroscience. 2005;6:521-532. 
44. Matthews JB, Besong AA, Green TR, Stone MH, Wroblewski BM, Fisher J, 
Ingham E. Evaluation of the response of primary human peripheral blood 
mononuclear phagocytes to challenge with in vitro generated clinically 
relevant UHMWPE particles of known size and dose. Journal of biomedical 
materials research. 2000;52:296-307. 
45. Matthews JB, Green TR, Stone MH, Wroblewski BM, Fisher J, Ingham E. 
Comparison of the response of primary human peripheral blood 
mononuclear phagocytes from different donors to challenge with model 
polyethylene particles of known size and dose. Biomaterials. 2000;21:2033-
2044. 
46. McAfee PC, Cunningham B, Holsapple G, Adams K, Blumenthal S, Guyer RD, 
Dmietriev A, Maxwell JH, Regan JJ, Isaza J. A prospective, randomized, 
multicenter Food and Drug Administration investigational device exemption 
study of lumbar total disc replacement with the CHARITE artificial disc 
versus lumbar fusion: part II: evaluation of radiographic outcomes and 
correlation of surgical technique accuracy with clinical outcomes. Spine 
(Phila Pa 1976). 2005;30:1576-1583; discussion E1388-1590. 
47. Moore KR, Pinto MR, Butler LM. Degenerative disc disease treated with 
combined anterior and posterior arthrodesis and posterior instrumentation. 
Spine (Phila Pa 1976). 2002;27:1680-1686. 
48. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, 
Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, 
Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, 
Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero 
LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, 
Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black 
JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, 
Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, 
Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, 
Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, 
Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, 
Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, 
Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, 
Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, 
Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, 
Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, 
23 
 
Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, 
Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, 
Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, 
Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, 
Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari 
F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, 
Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, 
Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill 
C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, 
James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan 
G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, 
Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, 
Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, 
Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, 
MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March 
L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, 
McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer 
M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, 
Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, 
Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, 
Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, 
Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon 
S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, 
Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, 
Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, 
Pope CA, 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah 
KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, 
Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room 
R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, 
Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, 
Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, 
Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, 
Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, 
Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, 
Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os 
J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall 
DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, 
Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, 
Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez 
AD, AlMazroa MA, Memish ZA. Disability-adjusted life years (DALYs) for 291 
diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the 
Global Burden of Disease Study 2010. Lancet. 2012;380:2197-2223. 
49. Nerlich AG, Schaaf R, Walchli B, Boos N. Temporo-spatial distribution of 
blood vessels in human lumbar intervertebral discs. European spine journal : 
official publication of the European Spine Society, the European Spinal 
24 
 
Deformity Society, and the European Section of the Cervical Spine Research 
Society. 2007;16:547-555. 
50. Nerlich AG, Weiler C, Zipperer J, Narozny M, Boos N. Immunolocalization of 
phagocytic cells in normal and degenerated intervertebral discs. Spine (Phila 
Pa 1976). 2002;27:2484-2490. 
51. Newman AC, Hughes CC. Macrophages and angiogenesis: a role for Wnt 
signaling. Vascular cell. 2012;4:13. 
52. Ohtori S, Takahashi K, Chiba T, Yamagata M, Sameda H, Moriya H. Substance 
P and calcitonin gene-related peptide immunoreactive sensory DRG neurons 
innervating the lumbar intervertebral discs in rats. Annals of anatomy = 
Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft. 
2002;184:235-240. 
53. Park JY, Kuh SU, Park HS, Kim KS. Comparative expression of matrix-
associated genes and inflammatory cytokines-associated genes according to 
disc degeneration: analysis of living human nucleus pulposus. Journal of 
spinal disorders & techniques. 2011;24:352-357. 
54. Park P, Garton HJ, Gala VC, Hoff JT, McGillicuddy JE. Adjacent segment disease 
after lumbar or lumbosacral fusion: review of the literature. Spine (Phila Pa 
1976). 2004;29:1938-1944. 
55. Peng B, Hao J, Hou S, Wu W, Jiang D, Fu X, Yang Y. Possible pathogenesis of 
painful intervertebral disc degeneration. Spine (Phila Pa 1976). 2006;31:560-
566. 
56. Punt I, Baxter R, van Ooij A, Willems P, van Rhijn L, Kurtz S, Steinbeck M. 
Submicron sized ultra-high molecular weight polyethylene wear particle 
analysis from revised SB Charite III total disc replacements. Acta 
biomaterialia. 2011;7:3404-3411. 
57. Punt IM, Austen S, Cleutjens JP, Kurtz SM, ten Broeke RH, van Rhijn LW, 
Willems PC, van Ooij A. Are periprosthetic tissue reactions observed after 
revision of total disc replacement comparable to the reactions observed after 
total hip or knee revision surgery? Spine (Phila Pa 1976). 2012;37:150-159. 
58. Punt IM, Cleutjens JP, de Bruin T, Willems PC, Kurtz SM, van Rhijn LW, 
Schurink GW, van Ooij A. Periprosthetic tissue reactions observed at revision 
of total intervertebral disc arthroplasty. Biomaterials. 2009;30:2079-2084. 
59. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and 
molecular biology of periprosthetic osteolysis. Clinical orthopaedics and 
related research. 2007;454:251-261. 
60. Purmessur D, Freemont AJ, Hoyland JA. Expression and regulation of 
neurotrophins in the nondegenerate and degenerate human intervertebral 
disc. Arthritis research & therapy. 2008;10:R99. 
61. Puskas BL, Menke NE, Huie P, Song Y, Ecklund K, Trindade MC, Smith RL, 
Goodman SB. Expression of nitric oxide, peroxynitrite, and apoptosis in loose 
total hip replacements. Journal of biomedical materials research. Part A. 
2003;66:541-549. 
62. Rao RD, David KS, Wang M. Biomechanical changes at adjacent segments 
following anterior lumbar interbody fusion using tapered cages. Spine (Phila 
Pa 1976). 2005;30:2772-2776. 
25 
 
63. Repanti M, Korovessis PG, Stamatakis MV, Spastris P, Kosti P. Evolution of 
disc degeneration in lumbar spine: a comparative histological study between 
herniated and postmortem retrieved disc specimens. Journal of spinal 
disorders. 1998;11:41-45. 
64. Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH, 
Cunha FQ. Involvement of resident macrophages and mast cells in the 
writhing nociceptive response induced by zymosan and acetic acid in mice. 
European journal of pharmacology. 2000;387:111-118. 
65. Risbud MV, Shapiro IM. Role of Cytokines in Intervertebral Disc 
Degeneration: Pain and Disc-content. Nature reviews. Rheumatology. 
2014;10:44-56. 
66. Ross R, Mirza AH, Norris HE, Khatri M. Survival and clinical outcome of SB 
Charite III disc replacement for back pain. The Journal of bone and joint 
surgery. British volume. 2007;89:785-789. 
67. Roughley PJ. Biology of intervertebral disc aging and degeneration: 
involvement of the extracellular matrix. Spine (Phila Pa 1976). 2004;29:2691-
2699. 
68. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT. Human monocyte 
response to particulate biomaterials generated in vivo and in vitro. Journal of 
orthopaedic research : official publication of the Orthopaedic Research Society. 
1995;13:792-801. 
69. Shanbhag AS, Kaufman AM, Hayata K, Rubash HE. Assessing osteolysis with 
use of high-throughput protein chips. The Journal of bone and joint surgery. 
American volume. 2007;89:1081-1089. 
70. Shubayev VI, Kato K, Myers RR. Cytokines in Pain. Boca Raton, FL: CRC 
Press/Taylor & Francis; 2010. 
71. Stea S, Visentin M, Donati ME, Granchi D, Ciapetti G, Sudanese A, Toni A. 
Nitric oxide synthase in tissues around failed hip prostheses. Biomaterials. 
2002;23:4833-4838. 
72. Steinbeck M, Veruva SY. Pathophysiologic Reactions to UHMWPE Wear 
Particles. In: Kurtz SM, ed. UHMWPE Biomaterials Handbook: Ultra High 
Molecular Weight Polyethylene in Total Joint Replacement and Medical 
Devices: William Andrew; 2015. 
73. Steinbeck MJ, Jablonowski LJ, Parvizi J, Freeman TA. The role of oxidative 
stress in aseptic loosening of total hip arthroplasties. The Journal of 
arthroplasty. 2014;29:843-849. 
74. Taimela S, Kujala UM, Salminen JJ, Viljanen T. The prevalence of low back 
pain among children and adolescents. A nationwide, cohort-based 
questionnaire survey in Finland. Spine (Phila Pa 1976). 1997;22:1132-1136. 
75. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of 
peripheral neuropathic pain: immune cells and molecules. Anesthesia and 
analgesia. 2007;105:838-847. 
76. Thomazzi SM, Ribeiro RA, Campos DI, Cunha FQ, Ferreira SH. Tumor necrosis 
factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of the 
supernatant of LPS-stimulated macrophages. Mediators of inflammation. 
1997;6:195-200. 
26 
 
77. Tolonen J, Gronblad M, Virri J, Seitsalo S, Rytomaa T, Karaharju EO. Platelet-
derived growth factor and vascular endothelial growth factor expression in 
disc herniation tissue: and immunohistochemical study. European spine 
journal : official publication of the European Spine Society, the European Spinal 
Deformity Society, and the European Section of the Cervical Spine Research 
Society. 1997;6:63-69. 
78. Tumialan LM, Gluf WM. Progressive vertebral body osteolysis after cervical 
disc arthroplasty. Spine (Phila Pa 1976). 2011;36:E973-978. 
79. Tunyogi-Csapo M, Koreny T, Vermes C, Galante JO, Jacobs JJ, Glant TT. Role of 
fibroblasts and fibroblast-derived growth factors in periprosthetic 
angiogenesis. Journal of orthopaedic research : official publication of the 
Orthopaedic Research Society. 2007;25:1378-1388. 
80. Turner JA, Ersek M, Herron L, Deyo R. Surgery for lumbar spinal stenosis. 
Attempted meta-analysis of the literature. Spine (Phila Pa 1976). 1992;17:1-
8. 
81. Urban JP, Holm S, Maroudas A, Nachemson A. Nutrition of the intervertebral 
disc: effect of fluid flow on solute transport. Clinical orthopaedics and related 
research. 1982:296-302. 
82. van den Eerenbeemt KD, Ostelo RW, van Royen BJ, Peul WC, van Tulder MW. 
Total disc replacement surgery for symptomatic degenerative lumbar disc 
disease: a systematic review of the literature. European spine journal : official 
publication of the European Spine Society, the European Spinal Deformity 
Society, and the European Section of the Cervical Spine Research Society. 
2010;19:1262-1280. 
83. van Ooij A, Kurtz SM, Stessels F, Noten H, van Rhijn L. Polyethylene wear 
debris and long-term clinical failure of the Charite disc prosthesis: a study of 
4 patients. Spine (Phila Pa 1976). 2007;32:223-229. 
84. van Ooij A, Oner FC, Verbout AJ. Complications of artificial disc replacement: 
a report of 27 patients with the SB Charite disc. Journal of spinal disorders & 
techniques. 2003;16:369-383. 
85. Veruva SY, Lanman TH, Hanzlik JA, Kurtz SM, Steinbeck MJ. Rare 
complications of osteolysis and periprosthetic tissue reactions after hybrid 
and non-hybrid total disc replacement. European spine journal : official 
publication of the European Spine Society, the European Spinal Deformity 
Society, and the European Section of the Cervical Spine Research Society. 2014. 
86. Veruva SY, Steinbeck MJ, Toth J, Alexander DD, Kurtz SM. Which design and 
biomaterial factors affect clinical wear performance of total disc 
replacements? A systematic review. Clinical orthopaedics and related 
research. 2014;472:3759-3769. 
87. Virk SS, Niedermeier S, Yu E, Khan SN. Adjacent segment disease. 
Orthopedics. 2014;37:547-555. 
88. Wang ML, Hauschka PV, Tuan RS, Steinbeck MJ. Exposure to particles 
stimulates superoxide production by human THP-1 macrophages and avian 
HD-11EM osteoclasts activated by tumor necrosis factor-alpha and PMA. The 
Journal of arthroplasty. 2002;17:335-346. 
27 
 
89. Weiler C, Nerlich AG, Bachmeier BE, Boos N. Expression and distribution of 
tumor necrosis factor alpha in human lumbar intervertebral discs: a study in 
surgical specimen and autopsy controls. Spine (Phila Pa 1976). 2005;30:44-
53; discussion 54. 
90. Winrow VR, Winyard PG, Morris CJ, Blake DR. Free radicals in inflammation: 
second messengers and mediators of tissue destruction. British medical 
bulletin. 1993;49:506-522. 
91. Wuertz K, Haglund L. Inflammatory Mediators in Intervertebral Disk 
Degeneration and Discogenic Pain. Global Spine Journal. 2013;3:175-184. 
92. Yasuma T, Arai K, Yamauchi Y. The histology of lumbar intervertebral disc 
herniation. The significance of small blood vessels in the extruded tissue. 
Spine (Phila Pa 1976). 1993;18:1761-1765. 
93. Zechmeister I, Winkler R, Mad P. Artificial total disc replacement versus 
fusion for the cervical spine: a systematic review. European spine journal : 
official publication of the European Spine Society, the European Spinal 
Deformity Society, and the European Section of the Cervical Spine Research 
Society. 2011;20:177-184. 
94. Zhang JM, An J. Cytokines, inflammation, and pain. International 
anesthesiology clinics. 2007;45:27-37. 
 
28 
 
†The content of this chapter was published in the journal of Clinical Orthopaedics 
and Related Research: Veruva, S.Y., Steinbeck, M.J., Toth, J., Alexander, D.D. and 
Kurtz, S.M. Which design and biomaterial factors affect clinical wear performance of 
total disc replacements? A systematic review. Clin Orthop Relat Res, 2014. 472(12): p. 
3759-69.  
CHAPTER 2 
A Systematic Review of Design & Biomaterial Factors Affecting the 
Clinical Wear Performance of Total Disc Replacements† 
2.1 Abstract 
Total disc replacement was clinically introduced to reduce pain and preserve 
segmental motion of the lumbar and cervical spine. Previous case studies have 
reported implant wear and adverse local tissue reactions around artificial 
prostheses, but it is unclear how design and biomaterials affect clinical outcomes. In 
this study, we asked which design and material factors are associated with 
differences in clinical wear performance (implant wear and periprosthetic tissue 
response) of (1) lumbar and (2) cervical total disc replacements?  
To research the literature for publications related to TDR implant wear and 
periprosthetic tissue response, we performed a systematic review using an 
advanced search in MEDLINE and Scopus electronic databases. Of the 340 
references identified, 33 were retrieved for full-text evaluation, from which 16 
papers met the inclusion criteria, which were semi-quantitative analysis of wear and 
adverse local tissue reactions along with a description of the implanted device. The 
16 papers included 12 on lumbar disc replacement and five on cervical disc 
replacement; one of the included studies reported on both lumbar and cervical disc 
replacement. An additional three papers were found by searching bibliographies of 
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the original articles, bringing the total to 19 papers (14 lumbar and 7 cervical 
studies). There were seven case reports, three case series, two case-control studies, 
and seven analytical studies. The Methodological Index for Non-randomized Studies 
(MINORS) Scale was used to score case series and case-control studies, which 
yielded mean scores of 10.3 of 16 and 17.5 of 24, respectively. In general, the case 
series (3) and case-control (2) studies were of good quality. In lumbar regions, 
metal-on-polymer devices with mobile-bearing designs consistently generated small 
and large polymeric wear debris, triggering periprosthetic tissue activation of 
macrophages and the formation of giant cells, respectively.  In the cervical regions, 
metal-on-polymer devices with fixed-bearing designs had similar outcomes. 
Information on lumbar fixed-bearing devices and cervical mobile-bearing devices 
was limited. All metal-on-metal constructs, of both lumbar and cervical constructs, 
tended to generate small metallic wear debris, which typically triggered an adaptive 
immune response of predominantly activated lymphocytes. There were no retrieval 
studies on one-piece prostheses. 
This review provides evidence that design and biomaterials affect the type of 
wear and inflammation. However, clinical study design, follow-up, and analytical 
techniques differ among investigations, preventing us from drawing firm 
conclusions about the relationship between implant design and wear performance 
for both cervical and lumbar total disc replacement. 
2.2 Introduction 
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Total disc replacement (TDR) was clinically introduced as an alternative to 
fusion to reduce pain and preserve segmental motion of the cervical and lumbar 
spine. TDR designs currently on the market may be classified as either fixed- or 
mobile-bearing analogous to total knee replacements. Of these designs, the most 
widely used in the market today include metallic endplates, which are fixed to the 
adjacent vertebral bodies and one or more articulations that involve either metal-
on-polymer or metal-on-metal bearing surfaces. The most commonly used lumbar 
disc replacements have relied on either cobalt-chromium (CoCr) alloy endplates 
articulating with a polymer core of ultrahigh-molecular-weight polyethylene 
(hereafter polyethylene) or metal-on-metal (MoM) bearings fabricated from CoCr 
alloys. In the cervical spine, a broader range of biomaterials have been used, 
including polyethylene, CoCr alloys, stainless steel, titanium (Ti) alloys, 
polyurethanes, polyetheretherketone, and Ti alloy-ceramic composites. In addition 
to the fixed- and mobile-bearing designs, a third “one-piece” classification of 
artificial disc design, in which an elastomeric polymer disc is fixed to metallic 
endplates, is currently undergoing clinical investigation. Thus, the field of artificial 
disc replacement includes a broad range of designs as well as heterogeneous 
assortment of biomaterials for lumbar (Table 2-1) and cervical regions of the spine 
(Table 2-2).  
Although the early developers of disc arthroplasty argued that the release of 
wear debris would not be a clinically relevant issue [1], case studies have emerged 
in the literature over the past decade that illustrate the potential for not only wear 
debris-induced osteolysis with metal-on-polymer (MoP) TDRs, but also adverse 
local tissue reactions for MoM TDRs [2]. Compared with THAs and TKAs, little is 
known about the clinical damage modes for TDRs because the surgery to remove a 
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malfunctioning artificial disc can be challenging, or even life-threatening, especially 
for the lumbar spine [3]. There has been one systematic review of complications in 
cervical disc arthroplasty [4] and previous (nonsystematic) surveys of retrieved 
total disc replacements [5, 6], but the authors are not aware of a previous systematic 
approach to examine the effects of design and material selection on wear, corrosion, 
and tissue response of revised TDRs.  Because the biomechanical requirements for 
TDRs differ for the cervical and lumbar spine and are reflected in both the TDR 
design and material selection, studies on TDRs for each region of the spine should 
be considered separately. 
We therefore performed a systematic review to evaluate which design and 
material factors are associated with differences in clinical wear performance 
(implant wear and periprosthetic tissue response) of (1) lumbar and (2) cervical 
total disc replacements.  
2.3 Search Strategy & Criteria 
This systematic review used guidelines from the Cochrane handbook during 
the development of the study protocol and report [7]. To address the research 
questions posed in this review, studies were identified by searching the MEDLINE 
and Scopus electronic databases. An advanced search was performed in MEDLINE 
through PubMed by querying spine and arthroplasty MeSH terms along with title, 
abstract, and text word fields in the database. The following precise syntax was used 
for the search: ((((((((corrosion[tw] OR wear[tw] OR deform*[tw] OR degra*[tw] 
OR fracture[tw]))) OR (((adverse[tw] AND effects[tw]))))) AND ((((((spin
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Table 2-1. Summary of contemporary lumbar total disc replacements 
Device Manufacturer Classification Biomaterials Bearing design 
IDE trial status 
(www.clincialtrials.gov) Current regulatory status  
CHARITÉ DePuy Synthes Spine, Raynham, MA MoP CoCr-UHMWPE Mobile Completed 
FDA-approved but withdrawn from 
US/OUS market after DePuy Synthes 
merger, 2012 
ProDisc-L DePuy Synthes Spine, West Chester, PA MoP CoCr-UHMWPE Fixed Completed FDA-approved, available US/OUS 
Activ-L Aesculap AG, Tuttlingen, Germany MoP CoCr-UHMWPE Mobile Active; not recruiting Available OUS 
Mobidisc LDR Spine, Troyes, France MoP CoCr-UHMWPE Mobile Terminated Withdrawn 
Maverick Medtronic, Memphis, TN MOM CoCr-CoCr Fixed Completed Available OUS 
Kineflex Spinal Motion Inc, Mountainview, CA MoP CoCr-CoCr Mobile Terminated Withdrawn 
Flexicore Stryker Spine, Allendale, NJ MoP CoCr-CoCr Constrained Not registered Withdrawn 
Baguera L Spineart, Geneva, Switzerland MoP 
Diamolith-coated 
Ti-UHMWPE Fixed Not registered Available OUS 
CAdisc-L Ranier Technology, Cambridge, UK 1P 
1-piece 
polyurethane One-piece Completed Available OUS 
Freedom AxioMed, Garfield, OH 1P 
Ti plates and 
elastomer core One-piece Recruiting Available OUS 
eDisc Integra Spine, Vista, CA 1P 
Ti plates and 
elastomer core One-piece Not registered Available OUS 
Physio-L Nexgen Spine, Whippany, NJ 1P 
Ti plates and 
elastomer core One-piece Not registered Available OUS 
M6-L 
Spinal Kinetics 
Sunnyvale, CA 1P 
Ti plates and 
polyurethane-
UHMWPE fiber 
core One-piece Withdrawn NA 
IDE = Investigational Device Exemption; MoP = metal-on-polyethylene; 1P = one-piece; CoCr = cobalt-chromium; Ti = titanium; OUS = outside United States; NA 
= not available. 
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Table 2-2. Summary of contemporary cervical total disc replacements 
Device Manufacturer Classification Biomaterials 
Bearing 
design IDE trial status  Current regulatory status  
Prestige ST Medtronic, Memphis, TN MoM Stainless steel-stainless steel Fixed Completed FDA-approved, available US/OUS 
Bryan Medtronic, Memphis, TN MoP Ti-PCU Mobile Completed FDA-approved, available US/OUS 
Prodisc-C DePuy Synthes Spine, West Chester, PA MoP CoCr-UHMWPE Fixed Completed FDA-approved, available US/OUS 
PCM Nu Vasive, San Diego, CA MoP CoCr-UHMWPE Fixed Completed FDA-approved, available US/OUS 
Mobi-C LDR Spine, Troyes, France MoP CoCr-UHMWPE Mobile Completed FDA-approved, available US/OUS 
SECURE-C Globus Medical, Audubon, PA MoP CoCr-UHMWPE Mobile Active; not recruiting FDA-approved, available US/OUS 
Activ C Aesculap AG, Tuttlingen, Germany MoP CoCr-UHMWPE Mobile Unknown Available OUS 
Kineflex/C Spinal Motion Inc, Mountainview, CA MoM CoCr-CoCr Mobile Terminated Withdrawn 
CerviCore Stryker Spine, Allendale, NJ MoM CoCr-CoCr Constrained Not registered Withdrawn 
DISCOVER DePuy Synthes Spine, West Chester, PA MoP Ti-UHMWPE Fixed Active; not recruiting Available OUS 
Baguera C Spineart, Geneva, Switzerland MoP Diamolith-coated Ti-UHMWPE Fixed Not registered Available OUS 
Prestige LP Medtronic, Memphis, TN CoC Ti-ceramic composite Fixed Active; not recruiting Available OUS 
NUNEC 
Pioneer Surgical Technology, Marquette, 
MI 
PoP PEEK-PEEK Fixed Recruiting Available OUS 
Freedom AxioMed, Garfield, OH 1P Ti plates and polymer core One-piece Recruiting Available OUS 
NeoDisc Nu Vasive, San Diego, CA 1P Silicone elastomer and textile One-piece Completed Available OUS 
CAdisc-C Ranier Technology, Cambridge, UK 1P 1-piece polyurethane One-piece Not registered Available OUS 
Discocerv Alphatec Spine Inc, Carlsbad, CA CoC Ceramic-ceramic Fixed Terminated Available OUS 
ALTIA Amedica, Salt Lake City, UT CoC 
Ceramic-ceramic  
(silicon nitride) 
Fixed Not registered Available OUS 
CerPass Nu Vasive, San Diego, CA CoM Ceramic-ceramic Fixed Terminated NA 
M6-C 
Spinal Kinetics 
Sunnyvale, CA 
1P Ti plates & PCU-UHMWPE fiber core One-piece Withdrawn NA 
IDE = Investigational Device Exemption; MoM = metal-on-metal; MoP = metal-on-polymer; CoC = ceramic-on-ceramic; PoP = polymer-on-polymer; 1P = one-
piece; CoM = ceramic-on-metal; Ti = titanium; PCU = poly(carbonate urethane); CoCr = cobalt-chromium; PEEK = polyether ether ketone; OUS = outside United 
States; NA = not available.   
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e[mh]) OR ((Spinal[tw] OR disc[tw] OR disk[tw]))) AND ((((((artificial[tw] AND 
prosthe*[tw]))) OR (((disc[tw] AND arthroplast*[tw]) OR (Disc[tw] AND implant) 
OR (Disc[tw] AND replace*) OR (Disc[tw] AND prosthe*)))) OR posterior 
fusion[tw]) OR (stabilization[tw]) ))) AND ((peek[tw] OR polyethylene[tw] OR 
polycarbonate urethane[tw] OR cobalt chromium[tw] OR prodisc[tw] OR 
freedom[tw] OR charite[tw] OR maverick[tw] OR kineflex[tw] OR activ[tw] OR 
mobidisc[tw] OR flexicore[tw] OR xl[tw] OR bryan[tw] OR prestige[tw] OR 
cadisc[tw] OR nubac[tw] OR secure[tw] OR discover[tw] OR nunec[tw] OR pcm[tw] 
OR dynesys[tw]))))))) NOT (finite element[tiab] OR biomechanical analysis[tiab] OR 
biomech*[ti] OR model[tiab] OR MRI[tiab] OR clinical outcome*[ti] OR 
ossification[ti]) AND "humans"[mh] AND ("2000/01/01"[pdat] : 
"2013/12/31"[pdat]) AND "English"[la]. The search was streamlined to specifically 
identify reports of wear, corrosion, and periprosthetic tissue response after spinal 
arthroplasty. Terms in the latter portion of the code were chosen based on the 
brand names of motion preservation devices currently in active use or under 
investigation. Lastly, the search code excluded papers centrally themed around 
finite element analysis, biomechanical modeling, or strict clinical outcomes. PubMed 
filters further restricted results to human studies and reports published in English. 
Using the aforementioned criteria, 160 articles were obtained from MEDLINE 
published between January 1, 2001, and April 30, 2014. The same search strategy 
and filters were used for the Scopus database, yielding 180 articles, many of which 
overlapped the search results from MEDLINE. The following precise syntax was 
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used in Scopus: (((((TITLE-ABS-KEY(corrosion) OR TITLE-ABS-KEY(wear) OR 
TITLE-ABS-KEY(deform*) OR TITLE-ABS-KEY(degra*) OR TITLE-ABS-
KEY(fracture))) OR (((TITLE-ABS-KEY(adverse) AND TITLE-ABS-KEY(effects))))) 
AND ((((((TITLE-ABS-KEY(spine) OR TITLE-ABS-KEY(spinal) OR TITLE-ABS-
KEY(disc) OR TITLE-ABS-KEY(disk))) AND ((((((TITLE-ABS-KEY(artificial) AND 
TITLE-ABS-KEY(prosthe*))) OR (((TITLE-ABS-KEY(disc) AND TITLE-ABS-
KEY(arthroplast*) OR (TITLE-ABS-KEY(disc) AND TITLE-ABS-KEY(implant)) OR 
(TITLE-ABS-KEY(disc) AND TITLE-ABS-KEY(replace*)) OR (TITLE-ABS-KEY(disc) 
AND TITLE-ABS-KEY(prosthe*))))) OR TITLE-ABS-KEY(fusion)) OR (TITLE-ABS-
KEY(stabilization))))) AND ((TITLE-ABS-KEY(peek) OR TITLE-ABS-
KEY(polyethylene) OR TITLE-ABS-KEY(polycarbonate urethane) OR TITLE-ABS-
KEY(cobalt chromium) OR TITLE-ABS-KEY(prodisc) OR TITLE-ABS-KEY(freedom) 
OR TITLE-ABS-KEY(charite) OR TITLE-ABS-KEY(maverick) OR TITLE-ABS-
KEY(kineflex) OR TITLE-ABS-KEY(activ) OR TITLE-ABS-KEY(mobidisc) OR TITLE-
ABS-KEY(flexicore) OR TITLE-ABS-KEY(xl) OR TITLE-ABS-KEY(bryan) OR TITLE-
ABS-KEY(prestige) OR TITLE-ABS-KEY(cadisc) OR TITLE-ABS-KEY(nubac) OR 
TITLE-ABS-KEY(secure) OR TITLE-ABS-KEY(discover) OR TITLE-ABS-KEY(nunec) 
OR TITLE-ABS-KEY(pcm) OR TITLE-ABS-KEY(dynesys)))))))) AND NOT (TITLE-
ABS-KEY(finite element) OR TITLE-ABS-KEY(biomechanical analysis) OR TITLE-
ABS-KEY(biomech*) OR TITLE-ABS-KEY(model) OR TITLE-ABS-KEY(mri) OR 
TITLE-ABS-KEY(clinical outcome*) OR TITLE-ABS-KEY(ossification))) AND 
(PUBYEAR > 1999 AND PUBYEAR < 2015) AND (LIMIT-TO(LANGUAGE,"English")). 
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Of the 340 papers obtained using the search strategies, duplicates were 
removed and studies were then screened and assessed for eligibility to be included 
in the systematic review (Figure 2-1). Screening of titles and abstracts revealed 55 
articles with potential relevance for this review. Next, in vitro studies and review 
articles were excluded, narrowing the number of eligible papers for inclusion to 33. 
An additional three studies were located by searching bibliographies of key articles 
and identifying full-text articles by hand search. Further full-text assessment for 
eligibility led to the exclusion of papers without any semiquantitative analyses of 
wear, corrosion, osteolysis, or adverse local tissue reactions; this left 19 articles 
meeting the inclusion criteria, of which 14 were lumbar and seven were cervical 
TDR studies (with one overlapping study). The majority of clinical research was 
low-level evidence [8] and included a total of seven Level V case reports, three Level 
IV case series, and two Level III case-control studies. Case series and case-control 
studies, in general, were good-quality studies with mean scores of 10.3 of 16.0 and 
17.5 of 24.0, respectively, on the Methodological Index for Non-randomized Studies 
(MINORS) Scale [9]. The main limitations to these studies included the lack of 
unbiased assessments, sufficiently long follow-up implantation times, and 
prospective calculations of study size. We did not grade study quality for the seven 
analytical reports because a suitable tool for this purpose is not available.   
Each study was reviewed in detail by three authors (SYV, MJS, SMK). Data 
were extracted using a standardized form, which included study design, number of 
patients, patient demographic information, implant type, design, biomaterials, and 
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Figure 2-1. A flow diagram demonstrates the systematic review protocol. 
outcome measures for device damage, wear, corrosion, metal ion levels, histology, 
and osteolysis. Some overlapping studies involving the same patients were included        
if the authors reported on larger patient pools in prospective retrieval studies or if 
authors evaluated varying durations of follow-up in clinical metal-ion investigations. 
For the systematic review, we summarized the authors’ assessments of the 
removed artificial disc wear, corrosion, and/or periprosthetic tissue responses. We 
then classified these damage factors as absent or present in the patient cohorts to 
evaluate the impact of implant design and biomaterials on wear and corrosion 
performance. Given the methodological and analytical heterogeneity (ie, between-
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study variation) between the studies included in this systematic review, the 
retrospective nature of the clinical series, and the absence of control groups in many 
of the studies, we were unable to combine data across studies to perform a 
quantitative meta-analysis. Instead we sought to examine each study to obtain the 
desired information concerning clinical performance outcomes based on implant 
design, wear performance, and local tissue reactions in light of each study’s 
strengths and limitations. 
2.4 Results 
2.4.1 Lumbar Total Disc Replacement 
In MoP studies, the mobile-bearing designs, CHARITÉ (Depuy Synthes Spine, 
Raynham, MA, USA), Activ-L (Aesculap AG, Tuttlingen, Germany), and Mobidisc 
(LDR Spine, Troyes, France), demonstrated evidence of polyethylene surface 
damage, polyethylene wear debris, and innate periprosthetic inflammation; fixed-
bearing ProDisc-L (DePuy Synthes Spine, West Chester, PA, USA) devices evidenced 
a high frequency of endplate impingement and metal wear debris (Table 2-3). A 
total of 49 mobile-bearing MoP retrievals with gamma-air-sterilized polyethylene 
were evaluated in two studies (48 from one report and one from a case study) [10, 
11]. Impingement, typically between the polyethylene core and the metallic 
endplate, was observed in 34 of 49 (69%) of the retrievals in those two studies. Two 
separate studies analyzed periprosthetic tissues from 22 of the 48 retrievals and 
reported polyethylene wear and inflammation in 16 of 22 (73%) patients [12]. A 
direct association was observed for severe or moderate impingement, wear debris, 
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and inflammation for 11 of the 34 impinged devices [13]. Despite the high incidence 
of polyethylene wear, osteolysis was only reported in one of 48 (2.1%) implants 
[10].  For mobile-bearing designs with conventional or gamma-inert-sterilized 
cores, a single report on three retrievals found wear particle generation was two 
orders less when compared to gamma-air-sterilized cores [14]. Nevertheless, 
impingement, wear debris, and innate inflammation were observed in all three 
retrievals. For fixed-bearing designs, one study reported burnishing in 11 of 19 
(58%) and another reported the same wear mechanism in one of one retrieval [15, 
16]. In a separate case report for a prosthesis removed as a result of migration, the 
presence of metallic debris was observed on the polyethylene core [17].  
In MoM studies, both mobile-bearing Kineflex (Spinal Motion Inc, 
Mountainview, CA, USA) and fixed-bearing Maverick (Medtronic, Memphis, TN, USA) 
devices generated metallic debris accompanied by a mixed innate and adaptive 
immune response. Based on a case report of two mobile-bearing retrievals, implant 
damage in one was negligible and unreported in the second; however, tissues from 
both devices contained metallic debris [18]. Similarly, fixed-bearing implant 
analysis of tissues from two separate case studies [18, 19] reported metallic debris. 
Furthermore, all tissue retrievals showed mixed inflammation. Two independent 
studies looking at systemic metal ions found elevated serum Co and Cr ion levels 
postoperatively between 0.25 and 49.4 years [20, 21].  
2.4.2 Cervical Total Disc Replacement 
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In MoP studies, there were no reports on mobile-bearing designs; the fixed-
bearing designs, ProDisc-C (DePuy Synthes Spine, West Chester, PA, USA) and Bryan 
Cervical Disc (Medtronic, Memphis, TN, USA), showed a high frequency of endplate 
impingement with polymeric wear debris and mixed inflammation (Table 2-4). As 
observed in lumbar fixed-bearing designs, burnishing was consistent with metallic 
endplate impingement in 24 of 30 (80%) retrievals [22]. A separate case report 
notedone rare incidence of osteolysis [23]. In another study, impingement was 
observed in nine of 30 (30%) retrievals [5]. Tissues obtained from 15 of these 30 
devices showed polymeric debris. Similarly, a separate case study reported 
polymeric debris [24]. Metallic debris was infrequent to negligible in all but one of 
the cases [25]. An innate immune response was predominant in all tissues,  although 
a few isolated regions of lymphocytic infiltration were noted [5]. In MoM studies, 
impingement was observed in one case study of a mobile-bearing Kineflex/C (Spinal 
Motion Inc, Mountainview, CA, USA) device; fixed-bearing Prestige Cervical Disc 
(Medtronic, Memphis, TN, USA) devices evidenced impingement, metallic debris, 
and mixed inflammation.  
A case study on one mobile-bearing device reported no evidence of metal 
particles in tissues, but visual evidence of metallosis within the joint tissue was 
pronounced [18]. In devices with fixed-bearing designs, impingement was evident in 
11 of 16 (68.8%) retrievals, typically in anterior regions [5]. In addition, screw hole 
fretting and fretting adjacent to bone screws were detected. Metallosis was 
observed in all 15 (100%) patients with tissue retrievals and metallic debris within 
the tissue was noted, but in both cases its distribution was not uniform and was 
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described as focal. A separate study with an unreported bearing design also 
reported the presence of metallic debris in tissue retrievals [26]. Mixed 
inflammation was observed in all tissues for both mobile- and fixed-bearing designs. 
2.5 Discussion 
Although benefits of treating degenerative disc conditions with TDR include 
preservation of motion and limiting stress at adjacent vertebra, potential 
complications associated with wear debris remain a concern. The aim of this study 
was to systematically review reports of wear, corrosion, and subsequent biological 
responses for lumbar and cervical TDR. Additionally, we sought to determine 
whether design and material issues were associated with the wear and corrosion 
behavior of these motion-preserving spinal devices. After analyzing reports from 14 
lumbar and seven cervical studies (in 19 papers), we found that wear-associated 
complications may be specific to the biomaterial used for TDR in both regions of the 
spine. Specifically, MoP devices typically produced polymeric wear debris, which 
was usually accompanied by an innate inflammatory response. On the other hand, 
MoM constructs tended to generate small metallic wear debris and metal ions, 
which activated an adaptive immune mechanism leading to adverse local tissue 
reactions in some patients.   
As of the time of this writing, for the one lumbar and five cervical disc 
artificial disc designs that have been approved by the FDA, only one is a MoM 
cervical device fabricated from stainless steel (Table 2). MoM prostheses have been 
under heavy scrutiny by researchers/regulators given the high-profile concern of 
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previous recall and warnings of THA devices with Co-based alloy MoM bearings 
[27]. Metallosis and subsequent soft tissue reactions and pseudotumors have been 
reported in patients with CoCr MoM articulations, in which some cases showed 
aseptic lymphocyte-dominated vasculitis-associated lesion response associated with 
normal implant wear rates [2, 18]. Metal hypersensitivity is also an issue with CoCr 
designs [26], although the relationship between delayed hypersensitivity and 
metallic debris remains unclear. Adverse host responses may also be triggered by 
metal tribochemical reactions in vivo, but to our knowledge, there have been no 
direct and standardized measurements of implant corrosion in TDRs. Although 
fretting and corrosion products were observed in some cervical MoM TDRs [5, 24], 
the extent of corrosive removal of metal in these devices remains unclear. Serum 
assays after lumbar TDR have revealed an elevation in Co and Cr ions, thereby 
inferring corrosion, but it was later concluded that these levels were similar to those 
observed for successful MoM THAs [20, 21, 28]. Despite these biomaterial issues, 
using MoM designs has its benefits, for example, these devices are theoretically 
designed to achieve lower volumetric wear (mainly as a result of lower friction) in 
comparison to traditional MoP designs, which potentially would reduce local 
inflammation and osteolysis. Also, it is worth noting that adverse local tissue 
reactions have been reported with all implant designs; thus, the small number of 
case reports for MoM studies exhibit important risks/complications of the 
technology. Further long-term follow-up studies are necessary to better understand 
the impact of such designs/materials on long-term wear rates.  
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Table 2-3. Summary of findings from 14 published studies of retrieved implants, tissues, & fluids from lumbar total disc 
replacements 
Classification Bearing 
design 
Device Study Mean 
implant
ation 
time 
(years) 
Impingement 
 
Periprosthetic 
debris 
Inflammation Osteolysis Systemic 
metal ions  
measured 
(# of 
patients) 
      Polymeric Metallic Innate Adaptive   
MoP Mobile CHARITÉ David, 2005 [9] 9.5 0/1  NR NR NR NR    0/1    NR 
MoP Fixed ProDisc-L Stieber and Donald, 2006 [37] 0.1 NR  NR 1/1 NR NR    NR    NR 
MoP Mobile CHARITÉ van Ooij et al, 2007 [40] 9.4 5/5  5/5 0/5 Y N    1/5    NR 
MoP Mobile CHARITÉ Kurtz et al, 2009 [21] 8.50 34/48*  NR NR NR NR   1/48*    NR 
MoP Fixed ProDisc-L Choma et al, 2009 [5] 1.2 1/1  1/1 0/1 N N    NR    NR 
MoP Mobile Activ-L; 
Mobidisc 
Austen et al, 2012 [2] 1.9 3/3  3/3 0/3 Y N    NR    NR 
MoP Mobile CHARITÉ Punt et al, 2012 [34] 10.0 NR  21/22 0/22 Y N    NR    NR 
MoP Fixed ProDisc-L Lebl et al, 2012 [26] 1.1 11/19  NR NR NR NR    NR    NR 
MoP Mobile CHARITÉ Baxter et  al, 2013 [3] 9.7 NR  11/11 0/11 Y N    NR    NR 
MoM Fixed Maverick Francois et al, 2007 [12] 1.2 NR  NA 1/1 Y Y    NR    NR 
MoM Fixed Maverick Zeh et al, 2009 [42]† 3.1 NR  NA NA NA NA    NA   15/15 
MoM Mobile Kineflex Guyer et al, 2011 [17] 1.7 NR  NA 2/2 Y Y    NR    NR 
MoM Fixed Maverick Guyer et al, 2011 [17] 3.1 NR  NA 1/1 Y Y    NR    NR 
MoM Fixed Maverick Kurtz et al, 2012 [24] 1.3 2/7  NA 1/1 Y Y    NR    NR 
MoM Fixed Maverick Gornet et al, 2013 [16]† 3 NR  NR NR NR NR    NR   24/24 
*This cohort includes retrievals from study performed by van Ooij et al [40]; †these are metal ion clinical studies, not retrieval studies; MoP = metal-on-
polyethylene; MoM = metal-on-metal; NR = not reported; Y = yes; N = no; NA = not applicable. 
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Table 2-4. Summary of findings from eight published studies of retrieved implants and tissues from 
cervical total disc replacements 
Classification Bearing 
design 
Device Study Mean 
implantation 
time (years) 
Impingement Periprosthetic 
debris 
Inflammation Osteolysis 
      Polymeric Metallic Innate Adaptive  
MoP Fixed Bryan Anderson 
et al, 2004 
[1] 
1.0 NR 2/2 0/2 Y N NR 
MoP Fixed ProDisc-C Tumailan 
and Gluf, 
2011 [38] 
1.3 NR NR NR NR NR 1/1 
MoP Fixed Bryan Fan et al, 
2012 [11] 
8.0 NR 1/1 1/1 NR NR NR 
MoP  Fixed Bryan Kurtz et al, 
2012 [24] 
3.2 9/30 15/15 ~0/15 Y Y NR 
MoP Fixed ProDisc-C Lebl et  al, 
2012 [27] 
1.0 24/30 NR NR NR NR NR 
MoM Fixed Prestige Anderson 
et al, 2004 
[1] 
2.4 0/2 NA 2/2 Y Y NR 
MoM Mobile Kineflex/C Cavanaugh 
et al, 2009 
[4] 
~0.6 NR NA 1/1 Y Y NR 
MoM Mobile Kineflex/C Guyer et al, 
2011 [17] 
1.2 1/1 NA 0/1 Y Y NR 
MoM Fixed Prestige Kurtz et al, 
2012 [24] 
2.0 11/16 NA 15/15 Y Y NR 
       MoP = metal-on-polyethylene; MoM = metal-on-metal; NR = not reported; Y = yes; N = no; NA = not applicable. 
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Unlike MoM devices, the central concern with the use of MoP devices is the 
generation of polymeric wear debris from bearing surfaces and the subsequent 
innate inflammatory response. Recent studies on MoP TDRs have revealed that 
tissue responses resulting from wear-related damage are indeed comparable to 
responses seen in total joint arthroplasties (TJAs) [12]. However, for THAs, 
polyethylene wear activates an innate inflammatory response that is associated 
with osteolysis and aseptic loosening, which is a fundamental cause of clinical 
failure [29, 30]. Vertebral osteolysis, on the other hand, appears to be a rare 
phenomenon in the spine and has only been reported in one patient with lumbar 
mobile-bearing TDR and one patient with cervical fixed-bearing TDR in the retrieval 
studies [23, 31] included in this review. Explanations for the relatively low 
frequency of osteolysis may include the low ranges of motion in the anterior column 
of the lumbar spine and an absence of resident macrophages and synovium 
compared with the hip and knee [1]. Furthermore, the reduced particle 
concentration/number, degree of inflammation and/or cytokine levels may be too 
low to directly cause osteolysis [14]. Reduced cytokine levels and/or local cellular 
responses to these factors is of particular interest since similar cytokines which 
include tumor necrosis factor-α, interleukin-1, and interleukin-6 are released by 
macrophages and giant cells in both tissue types; however, osteoclastogenesis is 
observed in THAs and neuroinflammatory pain in TDRs [32, 33]. For these reasons, 
the presence of wear remains a critical concern in the spine. 
 This review consisted primarily of papers reporting on wear performance of 
MoP retrievals with fixed- or mobile-bearing designs; collectively, these reports 
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indicated that wear damage mechanisms may be linked to the bearing design. 
Mobile-bearing retrievals tended to have characteristic multidirectional scratches 
with adhesive/abrasive wear mechanisms at the dome (much like THAs) and 
microadhesive/microabrasive wear mechanisms at the rim (much like TKAs) [34]. 
Although several fixed-bearing retrievals also had signs of scratches in the dome 
regions, a large percentage had characteristic metallic and endplate burnishing 
typically in the posterior region associated with impingement [15]. Also, fatigue-
related rim damage and radial crack formation were only reported in gamma-air-
sterilized cores of historical mobile-bearing retrievals, attributable to oxidative 
degradation [10, 11]. This was not evident in gamma-inert sterilized fixed-bearing 
designs and it is possible that the fixture of the core in designs may contribute to 
these wear mechanisms. The increased mobility and abnormalities in ROMs in 
mobile-bearing designs can influence the number and type of wear debris 
generation. Although flexion/extension ROM was restored to physiological ranges 
by both designs [35-37], mobile-bearing devices provide higher degrees of freedom 
(i.e., CHARITÉ; 5 DOF) compared with fixed bearings (i.e., ProDisc-L; 3 DOF).  The 
long-term consequences of the differing kinematics on wear debris generation and 
subsequent inflammation remain unclear. 
 For the papers identified by the systematic search, there were no studies of wear 
for one-piece spine retrievals, thereby highlighting a need for research on nonball-
and-socket type designs to evaluate their effectiveness and resistance to 
wear/corrosion. Ball-and-socket articulating bearings were originally modeled from 
total joint arthroplasties, which raises the question whether they replicate the 
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biomechanics of the intervertebral disc. Ball-and-socket designs are typically rigid 
in the axial direction and are not designed to resist moments in bending or rotation 
forces like the natural and deformable spinal disc, which may lead to altered ROM, 
segmental lordosis, or overloading of facet joints [38-41]. One-piece designs 
typically incorporate compliant elastomer biomaterials to mimic the physiological 
six degrees of freedom [42, 43]. Although the first one-piece model, known as the 
Acroflex (DePuy-AcroMed, Inc., Raynham, MA) discs, was abandoned as a result of 
failure of elastic rubber [44], newer designs have developed to improve the 
technology, including solving the issue of bonding elastic components to titanium 
endplates. Long-term follow-up studies are required to better understand the wear 
performance for these devices. 
In summary, current TDRs have been developed using total joint arthroplasty 
models and thus comparable biomaterial issues have been observed. MoP devices 
raise a concern for the production of polymeric wear debris that initiates innate 
inflammation. MoM devices present the risk of generating small metallic debris, 
metal ion release, adaptive host responses, metal hypersensitive reactions, and 
pseudotumor formation. Increases in systemic metal ion levels have also been 
detected, raising the likelihood of responses in other tissues. Design factors such as 
mobile- and fixed-bearing or one-piece constructs may also influence wear 
performance of TDRs, but more research is necessary to better understand which 
models truly mimic the natural motions of the spine while minimizing wear. 
Additional analytical studies with standardized cohort and case-control based 
observations would augment the existing body of literature and facilitate a more 
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formal quantitative assessment of TDR material and design. In addition, future 
studies need to address how design and wear of the various biomaterials impact 
neuroinflammation in the spine, considering pain is the primary reason for revision 
of both lumbar and cervical TDRs.  
2.6 Study Limitations 
Limitations of this review included the number limited number of studies 
and the mixed quality of the research, of which only a small number of case-control 
studies scored well on the MINORS quality scale. Furthermore, in the application of 
our inclusion and exclusion criteria, studies that did not report at least 
semiquantitative measures of wear were excluded, thus potentially eliminating 
studies with some important clinical information and patient outcomes in response 
to the use of certain implant designs/biomaterials. It is also important to note that 
all the studies that were included involved cases in which the primary revision 
reason was pain rather than an association with wear, and tissue evaluations of 
wear debris and inflammatory responses were limited. Nevertheless, these criteria 
were necessary to report common endpoints and measurable findings that could be 
summarized and evaluated. Finally, variability in the reporting of wear and related 
damage mechanisms made it difficult to synthesize results as did the inclusion of 
data from case reports, which lack a representative comparison group. Standardized 
test methods for retrieval analysis of TDRs have only recently been developed [5]; 
thus, older studies included in this review typically relied on visual characterization 
of wear.  
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CHAPTER 3 
Retrieval Analyses of Contemporary Lumbar TDRs & 
Periprosthetic Tissue Responses† 
3.1 Abstract 
Lumbar total disc replacement (L-TDR) is a procedure used to relieve lower 
back pain and maintain mobility. Contemporary metal-on-polyethylene (MoP) L-
TDRs were developed to address wear performance concerns about historical 
designs, but wear debris generation and periprosthetic tissue reactions for these 
newer implants have not been determined. The purpose of this study was to 
determine (1) whether periprosthetic ultrahigh-molecular-weight polyethylene 
(UHMWPE) wear debris and biological responses were present in tissues from 
revised contemporary MoP L-TDRs that contain conventional cores fabricated from 
γ-inert-sterilized UHMWPE; (2) how fixed- versus mobile-bearing design affected 
UHMWPE wear particle number, shape, and size; and (3) how these wear particle 
characteristics compare with historical MoP L-TDRs that contain cores fabricated 
from γ-air-sterilized UHMWPE. We evaluated implant retrievals and periprosthetic 
tissues from 11 patients who received eight fixed-bearing ProDisc-L and four 
mobile-bearing CHARITÉ contemporary L-TDRs with a mean implantation time of 
4.1 and 2.7 years, respectively. Implants were first examined for wear and surface 
damage. Histologic analysis of tissues was then performed to assess biological 
responses and polarized light microscopy was used to quantify number and 
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size/shape characteristics of UHMWPE wear particles. Comparisons were made to 
previously reported particle data for historical L-TDRs. All fixed-bearing (100%) 
and two of four mobile-bearing (50%) implant component retrievals indicated wear 
damage. Five of seven (71%) fixed-bearing and one of four mobile-bearing L-TDR 
patient tissues contained at least 4 particles/mm2 wear with associated macrophage 
infiltration. Tissues with wear debris were highly vascularized, whereas those 
without debris were more necrotic. Given the samples available, the tissue around 
mobile-bearing L-TDR was observed to contain 87% more, 11% rounder, and 11% 
less-elongated wear debris compared to tissues around fixed-bearing devices; 
however, there were no significant differences. Compared to historical L-TDRs, 
UHMWPE particle number and circularity for contemporary L-TDRs were 99% less 
(p = 0.003) and 50% rounder (p = 0.003). In this study, short-term results suggest 
there was no significant influence of fixed- or mobile-bearing design on wear 
particle characteristics of contemporary L-TDRs, but conventional UHMWPE has 
notably improved the wear resistance of these devices compared to historical 
UHMWPE.      
3.2 Introduction 
Lumbar total disc replacement (L-TDR) is an established alternative to spinal 
fusion for degenerative disc disease and its associated lower back and leg pain. With 
the goal to preserve natural segmental motion in the spine, commonly used implant 
designs incorporate cobalt-chromium (CoCr) metallic endplates, which are fixed to 
the adjacent vertebral bodies, articulating against a polymer core made of ultrahigh-
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molecular-weight polyethylene (UHMWPE). As a result of the decreased sliding 
distance in metal-on-polyethylene (MoP) L-TDRs compared with THA and TKA, 
wear and osteolysis of L-TDRs were originally thought to be negligible in the 
anterior column of the lumbar spine [24, 25]. However, studies of historical L-TDRs 
with γ-air-sterilized UHMWPE cores have demonstrated wear of the UHMWPE core 
along with rare cases of osteolysis in the lumbar spine [21, 44]. Additionally, both 
submicron (0.05-2 µm) and large UHMWPE wear particles ( 2 µm) were present in 
periprosthetic tissues from historical TDRs [33, 34]. The presence of wear debris 
was associated with an innate inflammatory response and in one case contributed to 
osteolysis. The particle shapes were comparable to those observed in revision 
tissues from THA and generally round to oval in morphology, whereas the TKA 
particles were more needle-shaped [33]. The mean particle numbers were similar 
and ranged from 0 to 1002 particles/mm2 [33]. Additionally, the extent of 
impingement of the implant positively correlated with increased submicron wear 
debris and thus, biological activity of the particles [5]. Collectively, these studies and 
others have established the clinically relevant complication of UHMWPE core wear 
for historical L-TDRs [20, 22, 32, 42, 43] and served as an impetus for improving 
bearing surface materials and designs. 
 Contemporary L-TDR designs incorporate γ-inert-sterilized (conventional) 
UHMWPE cores and air-impermeable packaging to improve oxidation resistance 
and thus enhance the wear performance of the cores [19, 45]. The ProDisc-L (DePuy 
Synthes Spine, West Chester, PA, USA) and CHARITÉ (originally Waldemar Link, 
Hamburg, Germany, later fabricated by DePuy Spine, Raynham, MA, USA, and 
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currently discontinued) are two established contemporary designs. The 
biomaterials used in the fabrication of the ProDisc-L prosthesis are quite similar to 
theCHARITÉ as they both consist of two CoCr alloy endplates articulating against a 
conventional UHMWPE core component. Although the materials used in these L-
TDRs are similar, there are differences in the design of these implants. Unlike the 
mobile-bearing design of the CHARITÉ, the core of ProDisc-L is fixed through a 
locking mechanism into the inferior endplate, thus allowing relative motion only 
between the core and the superior endplate [18]. Other contemporary L-TDRs 
designs currently in clinical use are the Mobidisc (LDR Spine, Troyes, France) and 
Activ-L (Aesculap AG, Tuttlingen, Germany), which use similar biomaterials in 
fabrication but differ specifically from the CHARITÉ in the amount of constraint 
presented by the bearing. To our knowledge, only one case report has evaluated 
retrievals of Mobidisc and Activ-L from two patients [2], and there is still limited 
understanding of implant wear or periprosthetic tissue reactions for contemporary 
MoP L-TDRs. Additionally, it remains unclear whether the L-TDR design will 
influence the generation of UHMWPE particles and their associated biologic 
response.  
 In this study, we analyzed retrievals of two contemporary designs of fixed-
bearing and mobile-bearing L-TDRs to evaluate γ-inert-sterilized UHMWPE 
performance in vivo and to compare design differences. We asked: (1) are 
periprosthetic UHMWPE wear debris and associated biological responses present in 
tissues from revised contemporary MoP L-TDRs that contain cores fabricated from 
γ-inert sterilized UHMWPE; (2) what is the influence of bearing design (i.e., fully 
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mobile versus fixed designs) on wear particle number, size, and shape; and (3) how 
do the dectectable wear UHMWPE particles from contemporary MoP L-TDRs 
compare with historical MoP L-TDRs that contain cores fabricated from γ-air-
sterilized UHMWPE? 
3.3 Materials & Methods 
3.3.1 Tissue Collection & Patient Clinical Information  
 
Figure 3-1. Tissues are harvested from annular regions during L-TDR revision 
surgery. 
 Spine tissues from regions adjacent to the implanted device were obtained at the 
time of revision surgery (Figure 3-1). Tissues, along with their respective devices, 
were collected as part of a public, multicenter retrieval research program initiated 
in 2004 [17, 22]. Contemporary TDRs were classified as modern device designs 
incorporating components made of γ-inert-sterilized UHMWPE GUR 1020 resin; this 
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study investigated tissue retrievals from around two contemporary lumbar designs: 
the fixed-bearing ProDisc-L and mobile-bearing CHARITÉ. The fixed-bearing L-TDR 
cohort included seven patients and eight implants (implantation time, 1-6 years; 
mean, 4.1 years), whereas the mobile-bearing cohort included four patients and four 
implants (implantation time, 2-3 years; mean, 2.7 years).  All were primarily revised 
for persistent back and/or leg pain and, for two of the patients, osteolysis was 
observed (Table 3-1). Implant subsidence or migration was a complication noted in 
three patients with fixed-bearing and one patient with mobile-bearing L-TDRs 
(Figure 3-2). Primary surgical tissues were obtained from other L-TDR patients and 
served as controls. Quantitative findings on particle number and were compared to 
our previous findings for 16 patient tissue responses from revised historical TDRs, 
SB CHARITÉ III, in which the core was either γ-air-sterilized UHMWPE GUR 412 
resin or γ-inert-sterilized UHMWPE GUR 1020 resin with polymer barrier packing 
that allowed exposure to air [32]. 
 
Figure 3-2. Sagittal CT scan illustrating implant subsidence at the L4 level on 
the right side of the vertebra from a fixed-bearing L-TDR patient (BHSP023). 
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Table 3-1. Clinical information of MoP L-TDR retrievals 
Patient ID Device Bearing 
design 
Patient 
sex 
Age at 
implantation 
(years) 
Primary diagnosis Level Year of 
index 
surgery 
Year of 
removal 
surgery 
Implantation 
time (years) 
Revision reason(s) Complications Osteolysis 
BHSP 022 ProDisc-L Fixed Male 41 Herniated disc; 
lumbar pain/ 
radiculopathy 
L4-L5 2007 2012 5.0 Right L4-L5 arthropathy; 
facet pain; progressive 
degeneration; 
radiculopathy 
 Yes 
BHSP 023 ProDisc-L Fixed Male 56 Herniated disc; 
lumbar pain/ 
radiculopathy 
L4-L5 2009 2012 3.0 Increasing pain in the back, 
lower back and left quad 
Subsidence Yes 
BHSP 025a 
BHSP 025b 
ProDisc-L 
ProDisc-L 
Fixed 
Fixed 
Male 49 Disc degeneration; 
discogenic back 
pain 
L4-L5; 
L5-S1 
2009 2013 4.0 Severe pain Posterior 
migration; 
compressing nerve 
roots 
No 
BHSP 026 ProDisc-L Fixed Female N/A N/A L5-S1 N/A 2012 N/A Persistent pain  No 
BHSP 027 ProDisc-L Fixed Female 33 Herniated disc 
w/degeneration; 
back pain 
L4-L5 2008 2013 5.0 Lumbar pain; radiculopathy  No 
BHSP 0032 ProDisc-L Fixed Male 46 N/A L5-S1 2008 2014 6.0 Severe lower back pain; L4-
L5 disc injury; 
radiculopathy 
Subsidence; upper 
level degeneration 
No 
PDL 004 ProDisc-L Fixed Female 27 Unremitting lower 
back pain 
L5-S1 2008 2009 1.3 Pain; ventral encroachment 
into spinal canal 
Partial dissociation No 
BRSP 003 CHARITÉ Mobile Male 28 Disc degeneration L4-L5 2006 2008 1.5 Discogenic pain  No 
BRSP 004 CHARITÉ Mobile Female 22 Disc degeneration L5-S1 2004 2008 3.3 Discogenic pain  No 
BRSP 006 CHARITÉ Mobile N/A N/A Disc degeneration L4-L5 2005 2008 2.7 Painful instrumentation Subsidence; 
scarring in disc 
space 
No 
BRSP 007 CHARITÉ Mobile N/A N/A Painful retained 
hardware 
L5-S1 2005 2008 3.3 Pain Periprosthetic 
scarring 
No 
MoP = metal-on-polyethylene; L-TDR = lumbar total disc replacement; N/A = not available
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3.3.2 Implant Retrieval Analysis  
         All implants were cleaned with 10% bleach and examined under a 
stereomicroscope equipped with a digital camera (Leica DFC490, Wetzlar, 
Germany) to assess surface damage and gross fracture. All components were 
inspected to identify surface damage mechanisms (plastic deformation, scratching, 
burnishing, pitting, and embedded debris). Select implant components with 
macroscopic surface damage were further analyzed using scanning electron 
microscopy (SEM; Supra 50 VP, Zeiss Peabody, Massachusetts) to identify specific 
wearing patterns and distinguish any iatrogenic damage introduced by the surgeon 
during the retrieval process. Lastly, Energy-dispersive X-ray spectroscopy (EDS) 
was utilized to detect and identify any abnormal surface deposits on implant 
components, whereas x-ray fluorescence (XRF) was used to conduct elemental 
analysis on the interior of the metallic endplates to ensure they met the American 
Society for Testing and Materials (ASTM) weight standards. 
3.3.3 Tissue Preparation and Histological Analysis  
         Tissues collected from revision and primary surgeries were fixed in either 
formalin or Universal Molecular Fixative (UMFIX; Sakura Finetek USA, Inc, Torrance, 
CA, USA). One to two 4-mm punches from each tissue, considering variations in 
color, texture, and size of specimen, were embedded in paraffin blocks, and 6-µm 
serial sections were mounted onto ProbeOnPlus (Fischer Scientific Co, Pittsburgh, 
PA, USA) slides. Slides were dewaxed, rehydrated, and stained with hematoxylin, 
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and eosin (H&E) (ThermoFisher Scientific, Waltham, MA) to visualize the nucleic 
acids, extracellular matrix and other proteins in the tissue sections. The alcian blue 
stain (Electron Microscopy Sciences, Hatfield, PA) was also used in conjunction with 
H/E to detect cartilaginous regions. Subsequently, Wright-Giemsa (Electron 
Microscopy Sciences, Hatfield, PA) and Prussian blue (Electron Microscopy Sciences, 
Hatfield, PA) stains were used for further in-depth histological evaluation when 
inflammation was present to facilitate the differentiation of leukocytes and identify 
hemosiderin deposits, respectively. Transmitted and polarized light images were 
captured using an Olympus BX50 microscope (Olympus, Melville, NY, USA) 
equipped with a stepper motor-controlled stage, an elliptically polarized light 
imaging system, and a Jenoptik ProgRes Speed XT Core5 camera (Jenoptik, Jena, 
Germany). A 36-image (200X magnification) composite, that spanned the entire 
tissue section, was created for each section under transmitted light to grade tissue 
reactions by at least two individuals (SYV, MJS) using a scoring system scaled from 0 
to 3 (Table 3-2). The scoring criteria were based on the Oxford method that is 
presently used for grading total joint arthroplasty tissues for macrophage and 
lymphocyte inflammation, aseptic lymphocyte-dominated vasculitis associated 
lesion (ALVAL), and necrosis [8, 31], but modified to exclude ALVAL responses to 
metal wear debris and include hemosiderin deposition and vascularization, which 
are more predominant in spine tissue. This criteria allowed us to make semi-
quantitative comparisons to previous research using similar grading scales for 
periprosthetic inflammatory responses.  
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Table 3-2. Modified Oxford scoring criteria for grading biological responses in 
periprosthetic tissues of L-TDRs 
Score Necrosis Hemosiderin 
Innate 
Inflammation 
Vascularization 
  
Tissue 
Percent 
Area 
Tissue 
Percent Area 
Number 
of Cells 
Tissue 
Percent 
Area 
Number of  
Blood 
Vessels 
Tissue 
Percent 
Area 
0+ 0 0 0 0 0 0 
1+ 
Scattered 
or Isolated < 10 1-9 < 10 < 10 < 10 
2+ < 25 10-50 10-50 10-50 10-50 10-25 
3+ > 25 > 50 > 50 > 50 > 50 > 25 
3.3.4 Wear Particle Characterization 
For UHMWPE particle analysis, a 36-image (200X magnification) composite was 
created from each tissue section under polarized light that corresponded to the 
transmitted light tissue composites. Our polarized light microscopy enabled us to 
detect particles as small as 0.34 µm. In each individual image, UHMWPE wear 
particle number, size, and shape were determined by first using a customized image 
threshold operation programmed in MATLAB® (MathWorks Inc, Natick, MA, USA) 
followed by counting/measuring particles using NIH ImageJ (National Institutes of 
Health, Bethesda, MD, USA) (Figure 3-3). In brief, polarized light images were split 
into three eight-bit channels (red, green, and blue). Signal from blue channels were 
converted into masks based on a threshold value relative to the average signal 
intensity of  each  image.  All  images  were  visually  reviewed  to  ensure  that  false- 
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Figure 3-3. Representative images of L-TDR periprosthetic tissues with wear 
particles under polarized light (left) followed by thresholding for UHMWPE 
particles in MATLAB (right). 
positive signals from birefringent collagen or dust did not contribute to particle 
counts. The resulting particle number was then converted to number/mm2 area of 
tissue using a measured conversion factor of 3.887 µm/pixel. Initial validation of 
this technique was performed using an environmental scanning electron 
microscope (ESEM) to study histomorphologic changes and wear debris in 
periprosthetic tissues of THAs [3]. Particle size and shape were characterized by 
calculating the equivalent circular diameter (ECD) (Equation 3-1), aspect ratio 
(Equation 3-2) and perimeter-based-circularity (Equation 3-3); the use of these 
measurements for particle analysis was validated in an earlier study by Baxter et al 
[4] and compared to ASTM guidelines for particle characterization [1].  
𝐸𝐶𝐷 = √4 𝑥 𝐴(𝑝)/𝜋 
Equation 3-1. Equivalent circular diameter (ECD) (μm), where A(p) is the area 
of the particle, represents the diameter of a circle that occupies the same two 
dimensional surface area as the particle. ECD provides a standardized 
measure of particle size [30]. 
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𝐴𝑅 =
𝐿(𝑝)
𝑊(𝑝)
 
Equation 3-2. Aspect ratio (AR) (unitless), where L(p) is the particle length 
and W(p) is the particle breadth, represents the proportional relationship 
between  length and breadth. AR provides a standardized measure to classify 
the general form of particles (e.g. equant, acicular or fibrous) [30]. 
𝐶 =
4 𝑥 𝜋 𝑥 𝐴(𝑝)
𝑃2
 
Equation 3-3. Circularity (C) (unitless), where A(p) is the area of the particle 
and P is the perimeter, represents the degree (from 0 to 1) to which the 
particle is similar to a circle based on the smoothness of the perimeter. C 
provides a measure for both particle form and roughness [30]. 
3.3.5 Statistical Analysis  
 Descriptive statistics were used for evaluating wear debris-induced tissue 
responses, which were semi-quantitatively compared based on histology/tissue 
scores. When quantifying UHMWPE particle numbers, the total number of particles 
in all tissue sections for each patient was normalized to total tissue sectional area, 
minimizing the effect of region-specific heterogeneity of particle distribution 
(Figure 3-4). Size and shape measurements of particles were averaged for each 
patient when dectectable wear debris was present. To statistically compare 
UHMWPE particle number, ECD, perimeter, circularity, and aspect ratio between the 
two different bearing designs, the Mann-Whitney U-test was employed using IBM 
SPSS Statistics V22 software package (IBM Corporation, Armonk, NY, USA). 
Significance was based on p < 0.05. Because we were unable to detect statistical 
differences in particle measurements between the two bearing designs, fixed- and 
mobile-bearing patients were combined into a single contemporary L-TDR cohort 
before comparing it with the historical L-TDR cohort. To compare these two groups, 
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the Mann-Whitney U-test was used to test differences in UHMWPE particle number, 
circularity, and aspect ratio. Particle size measurements of ECD (mean, 2.71μm ± 
4.29) and perimeter (mean, 11.07μm ± 27.54) were not statistically analyzed 
because particles larger than 2 µm were not evaluated in the historical L-TDR 
cohort.  
  
Figure 3-4. Patient tissues with detectable wear debris had a heterogeneous 
distribution of particles as illustrated by significant debris in the lateral tissue 
from patient BHSP027 (left, 200X), but no debris in other regions of same 
tissue (right). 
3.4 Results 
3.4.1 Device Retrieval Analysis for Contemporary L-TDRs 
 The eight fixed-bearing L-TDRs (implantation time, 1-6 years; mean, 4.1 years) 
exhibited minor to moderate signs of implant damage after discounting iatrogenic 
markings that were induced inadvertently by the surgeon. All eight cores from the 
seven patients (100%) showed evidence of burnishing and mild abrasive scratching 
on the bearing surfaces (Figure 3-5). In addition, impingement was noted in two of 
eight implants (25%) from two different patients with malpositioning, and the 
respective components evidenced plastic deformation (Figure 3-5). Microscopic 
scratches of fan-shaped pattern were found on  the interior  of these  metallic  plates 
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Figure 3-5. Representative fixed-bearing L-TDR retrieval components (top). 
All fixed-bearing UHMWPE cores showed evidence of burnishing (green 
arrow) and mild abrasive scratching (blue arrow). Impingement was noted in 
two patients and the respective components evidenced plastic deformation 
(red arrow). 
and a glossy appearance on the polyethylene core, respectively. SEM images of the 
impinged regions showed a polished appearance in comparison to the as-
manufactured texture seen in non-impinged regions of the metallic plate (Figure 3-
6). The unidirectional and circumferential wear patterns seen on the endplates 
suggest the wear may have occurred during axial rotation and/or lateral bending of 
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Figure 3-6. Representative fixed-bearing retrieval with impinged regions on 
both endplates (black arrows). SEM images showed the impinged region on 
the metallic plate (lower right) had a smooth surface compared to the 
unimpinged region (upper right). 
the articulating surfaces. Lastly, all fixed-bearing retrievals showed no indications of 
fatigue wear or fracture of the polyethylene core. No abnormal surface deposits 
were observed by SEM/EDS analysis. XRF scans showed the metallic surface-
constituents on the interior of the endplates consistently matched CoCr ratios seen 
in ASTM F-75 cobalt alloy standards, and the exterior of plates consisted of weight 
compositions seen in commercially pure titanium.  
 The four mobile-bearing L-TDRs (implantation time, 2-3 years; mean, 2.7 years) 
exhibited minor signs of implant damage after discounting iatrogenic markings. Two 
of four mobile bearing cores showed signs of burnishing, pitting and mild scratching 
(Figure 3-7). Minor unidirectional scratches were present on the endplates from all 
patients.  There were no obvious signs of impingement on the metallic endplates. 
Analysis using SEM and EDS revealed no abnormal surface deposits on the metallic 
endplates. As expected, XRF scans consistently detected cobalt-chromium ratios 
matching ASTM F-75 cobalt alloy weight-standards in the interior of the endplates.   
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Figure 3-7. Representative mobile-bearing L-TDR retrieval components (top). 
Two of four patients with mobile-bearing UHMWPE cores showed evidence of 
burnishing, pitting (green arrow). Minor unidirectional scratches were noted 
on endplates from all patients (red arrow). 
3.4.2 UHMWPE Wear Debris from Contemporary L-TDRs & Biological Tissue 
Responses  
 Periprosthetic UHMWPE wear debris with corresponding macrophage 
infiltration was observed in five of seven patients with a fixed-bearing L-TDR and 
one of four patients with a mobile-bearing L-TDR. Generally, detectable wear debris 
was associated with low to moderate biological tissue responses as compared to 
tissues (controls) from L-TDR patients undergoing primary surgery (Figure 3-8). 
For the fixed-bearing L-TDR revisions, tissues from three of seven (43%) patients 
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Figure 3-8. Transmitted light images (left) and polarized microscopy (middle) of tissue sections revealed the 
presence of UHMWPE wear and corresponding macrophage infiltration; particles were characterized using a 
MATLAB threshold (right). 
69 
 
 
Table 3-3. Histologic evaluation and mean scores of retrieved tissues with wear debris 
Patient ID 
Implant 
bearing 
design 
Tissue 
samples 
with wear 
debris 
UHMWPE wear 
debris 
(particles/mm2) 
Metal 
wear 
debris 
Inflammation 
(macrophages) 
Type of inflammatory 
cells 
Necrosis Hemosiderin Vascularization 
BHSP 022 Fixed 2/4 4.27 No 0.5 Macrophages 1.0 0.5 0 
BHSP 023 Fixed 6/14 4.78 Yes 1.7 
Predominantly 
macrophages with 
lymphocytes and plasma 
cells 
0.9 1.2 1.3 
BHSP 025a Fixed 2/6 21.82 Yes 2.0 
Predominantly 
macrophages with 
lymphocytes and plasma 
cells 
1.5 2.0 2 
BHSP 025b Fixed 6/12 1.74 Yes 1.8 
Predominantly 
macrophages with 
lymphocytes and plasma 
cells 
0.0 1.7 2.5 
BHSP 027 Fixed 3/6 29.12 No 1.7 Macrophages 0.5 0.0 1.5 
BHSP 0032 Fixed 1/1 15.03 Yes 1.5 
Predominantly 
macrophages with 
lymphocytes 
1.0 0.0 2.5 
PDL 004 Fixed 1/3 20.91 No 0.0 None 1.0 0.0 0 
BRSP 003 Mobile 1/4 107.33 No 3.0 Macrophages 1.0 0.0 1 
Inflammation, necrosis, hemosiderin, and vascularization scores on a 0-3 scale. 
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Figure 3-9. Wright Giemsa and Prussian blue stains were used to identify inflammatory cells and hemosiderin 
deposits, respectively. Both fixed-bearing (left) and mobile-bearing (middle) tissues showed inflammatory 
infiltrates, but hemosiderin deposits were also found in fixed-bearing cohorts. There was no inflammation or 
hemosiderin present in control tissue (right) obtained from primary surgery (Original magnification x 400; 
inset, x 1000).
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contained at least 15 UHMWPE particles/mm2 with an associated macrophage 
infiltration score > 1.5 (Table 3-3).  Tissues from the two other patients (29%) 
contained < 5 UHMWPE particles/mm2 and a variable macrophage infiltration (0.5 
and 2). Tissues with UHMWPE wear debris from patients BHSP 023 and BHSP 025, 
who had their implants revised for malpositioning and device impingement, also 
had some isolated regions containing metal wear debris, lymphocytes, plasma cells, 
and hemosiderin that occupied > 10% of the total tissue area (Figure 3-9). Another 
tissue with UHWMPE wear debris from patient BHSP 0032 also contained metal 
particles and lymphocytes but no hemosiderin deposits. Patient PDL 004 had one 
tissue sample with an isolated area containing 21 UHMWPE particles/mm2 but no 
detectable inflammation. For the mobile-bearing L-TDR cohort, tissue that 
contained detectable UHMWPE wear debris (> 0.34 μm) was found in only one of 
four patients. None of the tissues associated with the mobile-bearing devices 
contained metallic debris, and none of the implants exhibited rim impingement.  A 
tissue sample from patient BRSP 003 contained 107 UHMWPE wear particles/mm2 
and it had a high macrophage infiltration score (3.0). For the fixed-bearing cohort, 
tissues with wear debris were consistently more vascularized with mean scores as 
high as 3 (range, 0-3), whereas necrotic/acellular regions were scarce (Figure 3-10). 
In contrast, the majority of tissue samples around the devices that did not contain 
detectable wear debris had low vascularity and more prominent regions of necrosis 
(mean necrosis score, 2) (Table 3-4).  Tissues around mobile-bearing devices, with 
or without detectable wear, were moderately vascularized with isolated necrotic 
regions. 
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Figure 3-10. Representative fixed-bearing L-TDR tissue images showed 
increased vascularization (top left) in tissues with wear debris and regions of 
necrosis (bottom left) in tissues without wear debris. Mobile-bearing L-TDR 
tissues had lower vascularization (top right) in tissues with wear debris and a 
mix of moderate vascularization and isolated necrosis (bottom right) in 
tissues without wear debris (Original magnification, x 400). 
3.4.3 Wear Particle Number, Size & Shape for Contemporary L-TDRs 
 In general, L-TDRs patient tissues collectively had limited wear debris and the 
majority were small (< 10 µm) with low aspect ratio and high circularity (Figures 3-
11, 3-12, 3-13). For the mobile-bearing L-TDR patient tissue with UHMWPE wear 
debris, particle  number  was  increased  by  87%  compared to  fixed-bearing  
patient tissues, and the particles were 11% rounder and 11% less elongated (Table 
3-5), but, with the number of samples available, these differences were not 
significant.  Qualitative  observations  revealed   the  area   percentage or   amount of  
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Table 3-4. Histologic evaluation & mean scores of retrieved tissues without 
wear 
Patient ID 
Implant 
bearing 
design 
Tissue samples 
without wear debris 
Necrosis Hemosiderin Vascularization 
BHSP 022 Fixed 2/4 0.5 0.5 0.0 
BHSP 023 Fixed 8/14 1.2 0.8 0.8 
BHSP 025a Fixed 4/6 2.0 0.0 0.0 
BHSP 025b Fixed 6/12 1.0 1.0 1.2 
BHSP 026 Fixed 4/4 0.8 0.8 1.0 
BHSP 027 Fixed 3/6 1.5 0.0 0.0 
PDL 004 Fixed 2/3 1.0 0.0 0.0 
BRSP 003 Mobile 3/4 0.7 0.0 1.0 
BRSP 004 Mobile 4/4 0.5 0.0 1.5 
BRSP 006 Mobile 6/6 0.7 0.0 1.3 
BRSP 007 Mobile 2/2 0.0 0.0 0.0 
Note: Necrosis, hemosiderin, and vascularization scores on a 0-3 scale. 
tissue occupied by particles from the mobile-bearing device was more extensive 
than the particles from fixed-bearing devices with the exception of tissues from 
patient BHSP 022, which contained large (> 10 µm) particles (highest ECD and 
perimeter values). Nonetheless, the overall distribution of particle sizes was similar 
for both cohorts. The majority of the particles were between 1 and 10 µm (75% and 
83% for the fixed- bearing and mobile-bearing L-TDR cohorts, respectively). 
Submicron particles (< 1 μm) represented 20% of the particles from fixed-bearing 
devices and 16% from the mobile-bearing device. Large particles (> 10 μm) were 
rarely observed and represented less than 2% of the particles in both cohorts. 
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Table 3-5. UHMWPE particle number and characteristics from tissues with wear debris 
*Percent area of particles is the ratio of the total area of all particles to the total area of tissue; † mean ± SD. 
Table 3-6. Comparing UHMWPE particle number and characteristics in patients with wear debris 
Comparison Fixed-Bearing L-TDR Mobile-Bearing L-TDR 
Contemporary L-TDR 
(Fixed and Mobile ) 
Historical Mobile-Bearing L-TDR* 
(Punt et al., 2011) [30] 
UHMWPE core γ-inert-sterilized γ-inert-sterilized γ-inert-sterilized γ-air-sterilized 
Patients with 
wear debris (number) 
6 of 7 1 of 4 7 of 11  5 of 5 
Particle number** 
(particles/g x 107; mean  ± SD) 
1.16 ± 3.09 8.99 2.14 ± 2.90†  162.10 ± 27.10 
Circularity (mean  ± SD) 0.78 ± 0.20 0.86 ± 0.15 0.80 ± 0.19† 0.40 ± 0.20 
Aspect ratio (mean  ± SD) 1.88 ± 0.76 1.70 ± 0.53 1.84 ± 0.71 2.00 ± 0.10 
*Particle measurements were generated using ESEM and a cutoff of 2 µm so size characteristics were not comparable; **Measurements from 
contemporary L-TDR cohorts were converted from particles/mm2 for comparison purposes; L-TDR = lumbar total disc replacement; SD = 
standard deviation; N/A = not available; ESEM = environmental scanning electron microscope. †Significant differences between combined 
contemporary L-TDRs and historical L-TDRs (p < 0.01) 
Patient ID 
Implant 
bearing 
design 
Tissue 
samples 
with wear 
debris 
< 0.1-1µm 
(particles/
mm2) 
1-10 µm 
(particles/
mm2) 
> 10 µm 
(particles/
mm2) 
All sizes 
(particles/
mm2) 
Percent 
area of 
particles* 
Equivalent 
circular 
diameter 
(µm) 
Perimeter 
(µm) 
Circularity Aspect ratio 
BHSP 022 Fixed 2/4 0.52 3.14 0.61 4.27 0.12% 6.64 ± 10.78 28.05 ± 47.09 0.74 ± 0.20 1.76 ± 0.54 
BHSP 023 Fixed 6/14 1.15 3.13 0.51 4.78 0.05% 2.68 ± 5.63 13.43 ± 39.45 0.67 ± 0.25 2.02 ± 0.99 
BHSP 025a Fixed 2/6 4.69 16.70 0.44 21.82 0.03% 2.90 ± 3.12 11.95 ± 19.13 0.76 ± 0.19 1.93 ± 0.74 
BHSP 025b Fixed 6/12 0.15 1.52 0.06 1.74 0.02% 2.60 ± 2.71 10.31 ± 15.69 0.80 ± 0.18 1.85 ± 0.67 
BHSP 027 Fixed 3/6 6.78 21.79 0.55 29.12 0.07% 2.86 ± 5.24 11.82 ± 38.18 0.80 ± 0.18 1.90 ± 0.77 
BHSP 0032 Fixed 1/1 2.55 10.57 1.28 15.03 0.06% 3.78 ± 4.65 8.43 ± 11.45 0.77 ± 0.20 1.87 ± 0.82 
PDL 004 Fixed 1/3 4.55 15.91 0.45 20.91 0.02% 2.28 ± 2.40 8.44 ± 11.43 0.86 ± 0.17 1.56 ± 0.44 
BRSP 003 Mobile 1/4 17.68 89.12 0.54 107.33 0.11% 2.23 ± 2.85 8.16 ± 14.11 0.86 ± 0.14 1.70 ± 0.53 
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3.4.4 Comparison of Wear Particle Characteristics to MoP Historical L-TDRs 
 Compared to five historical L-TDR patients identified in a previous study [32], 
UHMWPE particle number and circularity in the seven contemporary L-TDR patient 
tissues were significantly different, but aspect ratio was not (Table 3-6). Specifically, 
the number of particles per gram of tissue was 99% less (p = 0.003) and their shape 
was 50% rounder (p = 0.003) in contemporary L-TDR cohorts, which included both 
fixed- and mobile-bearing designs. Qualitative observations of particle size revealed 
that tissues from contemporary L-TDR patients contained more submicron and 
small (< 10 µm) wear debris and less associated inflammation in comparison to the 
historical L-TDR cohort. 
3.5 Discussion 
 L-TDR was developed as an alternative to spinal fusion for the treatment of 
degenerative disc disease in the lumbar spine, and is a device that preserves or 
restores segmental function and motion. However, historical generations of L-TDR 
devices with γ-air-sterilized UHMWPE cores raised concerns regarding wear debris 
generation and subsequent immunological responses that may adversely affect 
clinical outcomes. Today, modern L-TDR designs incorporate purely γ-inert-
sterilized UHMWPE cores to improve wear resistance and minimize wear debris 
generation in an effort to reduce the risk of revision surgery. The aims of this study 
were to evaluate wear debris and biological responses in tissues from revised 
contemporary MoP L-TDRs and determine the influence of bearing design on wear 
particle number, size, and shape. Furthermore, we wanted to know how UHMWPE 
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wear particle densities and characteristics compared with previous historical MoP 
L-TDRs.  After analyzing retrieved tissues around eight fixed- and four mobile-
bearing L-TDRs from 11 patients revised primarily for pain, we found measurable 
UHMWPE wear debris with corresponding macrophage infiltration in five patients 
that had fixed-bearing L-TDRs and one patient that had a mobile-bearing L-TDR. The 
frequency, amount, and shape of wear debris suggested the bearing design of 
contemporary devices did not influence wear particle characteristics. Furthermore, 
particle comparisons with a retrieval study of historical devices suggested that γ-
inert-sterilized UHMWPE has improved wear resistance and as a result reduced 
wear-induced periprosthetic tissue reactions.  
 Not all periprosthetic tissue from the two contemporary MoP L-TDRs examined 
in this study contained detectable UHMWPE wear debris (> 0.34 μm); this was true 
for tissues from all patients and different tissues from the same patient. However, 
those tissues that contained UHMWPE wear debris generally had an associated 
macrophage inflammation. This type of co-localization of wear debris and 
macrophages is an established phenomenon in total joint arthroplasty and more 
recently noted in historical L-TDRs [34]. One noteworthy difference observed for 
the contemporary L-TDRs was a decrease in particles > 10 um and as a result; unlike 
historical L-TDRs, giant cells were not observed in these tissues. Periprosthetic 
UHMWPE particles from both contemporary L-TDR cohorts resulted primarily in a 
macrophage response, except for three patients with metallic wear debris from 
fixed-bearing devices where an associated lymphocytic response was observed. 
These patient tissues also had higher macrophage infiltration scores. The presence 
78 
 
 
of metallic debris may be attributed to the unintended wear mechanism of 
impingement between the metallic endplates arising from malpositioning and/or 
subsidence, which was noted in more than 50% of contemporary fixed-bearing 
device retrievals in a separate retrieval study [23]. Interestingly, considerable 
amounts of hemosiderin were present in many of these tissues, indicative of 
phagocytosis of erythrocytes and degradation of hemoglobin by macrophages [16, 
39]. The exact contribution of hemosiderin to revision remains unclear; however, a 
previous study has associated the deposition with the accumulation of activated 
macrophages that are positive for osteoclastic cell markers [28]. Although the 
amount of UHMWPE wear debris in the spine may not be severe enough to directly 
contribute to osteolysis [21], vertebral osteolysis was noted as a clinical 
complication in two patients with fixed-bearing L-TDRs, both of whom had tissues 
containing hemosiderin. The effect of hemosiderin in these tissues on UHMWPE 
wear-induced inflammation requires further investigation. Other biological tissue 
responses noted around the fixed-bearing devices included increased 
vascularization in tissues with wear and necrosis in tissues without wear. In 
contrast, tissues around mobile-bearing L-TDRs, with and without detectable wear 
debris, had low to moderate vascularization and necrosis. The presence of these 
reactions in both cohorts is noteworthy because these reactions have been 
implicated in the development of pain. Specifically, increased vascularization and 
sensory nerve growth are closely linked processes [6, 27]; and tissue necrosis or cell 
death results in the release of proinflammatory cytokines and other factors that 
initiate persistent pain by directly activating nociceptive sensory neurons [7, 47]. 
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Both reactions can lead to maladaptive plasticity and neural disease states, which 
raises the question whether these tissue responses contributed to neuropathic pain 
in both fixed- and mobile-bearing L-TDR patients.  
 While the observations and data did not explain why wear debris in patients 
lead to vascularization in some tissues and necrosis in others, we believe the 
amount of wear debris and the stage of inflammation contributed to pathological 
modes observed at fixation. It is important to note that nanometre-sized wear 
debris may still be present in tissues that were indicated for no debris due to our 
detection limitations (>0.34 µm) [36]; and also that particles can be cleared by the 
lymphatic system when the tissue matrix degenerates [10]. Furthermore, apparition 
of the inflammatory modes of vascularization and necrosis can depend on the 
nature and extent of the injury (e.g. wear-debris amount and length of exposure), 
along with the locale and cell types present in the region [41]. For example, tissue 
sections that were excised from deeper discal regions with severe wear-induced 
hypoxic conditions may reflect inflammation that led to ischemic necrosis; 
contrarily, inflammation and wear-induced hypoxia in outer layers of the disc with 
access to ingrowing blood vessels may lead to vascularization and more 
inflammation [14, 38, 41]. Nonetheless, with enough time, it is thought that all wear-
induced tissue responses eventually lead to necrosis as inflammatory cells are 
unable to digest or enzymatically degrade UHMWPE wear particles [40].  
 UHMWPE wear debris in tissues around fixed-bearing devices qualitatively 
appeared smaller, less concentrated, and less round than debris in tissues around 
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the one mobile-bearing retrieval; however, no statistical difference was observed. 
Austen et al. recently reported a case study of two patients revised for a different set 
of fixed- and mobile-bearing contemporary L-TDRs, and observed larger UHMWPE 
particles in tissues from the patient with the mobile-bearing design [2]. 
Interestingly, retrieval studies of TKA also found comparable findings in which 
larger UHMWPE particles were found in tissues surrounding failed mobile-bearing 
TKRs than in tissues around failed fixed-bearing TKRs [11, 29]. Design-dependent 
differences in loading and wear mechanisms may explain observed qualitative 
differences of wear particles between designs. All fixed-bearing retrievals in our 
study showed signs of scratching on UHMWPE dome regions, and the tissues with 
metal wear corresponded with implant components that had metallic and endplate 
burnishing as a result of impingement attributable to malposition and/or 
subsidence. The mobile-bearing patient tissue retrieval with UHMWPE wear 
corresponded to an implant core that had burnishing, pitting, and unidirectional 
scratching. The overall density of UHMWPE particles was relatively low in tissues 
from both cohorts, but the majority were 1 to 10 µm, which falls within a size range 
that activates macrophages [9]. Lastly, the higher number and rounder particles 
observed in the mobile-bearing patient tissue may be influenced by the increased mobility 
of the core. The mobile-bearing implant design has 5 degrees of freedom (DOF) and its 
instant axes of rotation (IAR) more consistently matches the geometrical center of the 
UHMWPE core, whereas the fixed-bearing design has only 3 DOF and the IAR is not 
always as centered [37]. The differing kinematics of bearing design likely contribute to 
the different wear mechanisms that generate distinct particle amounts and morphology. 
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However, further research and larger sample sizes are necessary to determine 
whether design-dependent differences significantly influence particle size and 
shape differences.  
 UHMWPE particles from the contemporary L-TDR cohorts were less numerous 
and rounder in comparison to the historical L-TDR group, suggesting that modern L-
TDR designs have improved wear properties. A separate study investigating 
particles > 2 µm in historical L-TDR cohorts reported a mean of 231 particles/mm2 
[33], which was roughly 10-fold higher than the amount of similar-sized particles 
from contemporary TDRs (mean, 22 particles/mm2). This comparison paralleled 
findings from a case report, which noted that the mean number of UHMWPE 
particles was two orders of magnitude lower in a different set of revised 
contemporary L-TDRs [2]. Our study also showed that mean particle circularity 
(roundness) was noticeably higher in the contemporary L-TDR cohort (mean, 0.8 
versus mean, 0.4), but aspect ratios were within the same range as those of 
historical L-TDR particles [32]. Interestingly, UHMWPE particles from conventional 
THAs fabricated with γ-inert-sterilized UHMWPE acetabular liners have been 
reported to have shapes similar to the contemporary L-TDR group [4, 12, 13, 15, 
26]. Multiple studies have reported that particles with more rounded morphologies 
trigger less robust macrophage activation compared with fibrillar-shaped particles 
[13, 35, 46]. Thus, with the samples available in this study, both the decreased 
number and increased roundness of the particles suggest that wearing of 
contemporary L-TDRs will result in a reduced inflammatory response.  
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 In summary, the amount of wear debris and subsequent tissue responses were 
greatly reduced in tissues from contemporary L-TDRs when compared to historical 
L-TDRs. We showed that periprosthetic tissues from both fixed- and mobile-bearing 
L-TDR patients contained UHMWPE particles within size ranges known to elicit a 
macrophage response. Because artificial discs are intended to last the lifetime of the 
patient, further retrieval studies are still necessary to elucidate the long-term role of 
UHMWPE wear and its association, if any, to the clinical performance of lumbar disc 
arthroplasty.  
3.6 Study Limitations 
 As any retrieval study, a few important limitations need to be noted. First, 
although the primary revision reason for all patients was pain, implant 
malpositioning and impingement were reported in three of six fixed-bearing and 
none of the mobile-bearing L-TDR patients. This complication may serve as a 
confounding variable when comparing the two designs. However, this discrepancy 
between the two cohorts may be viewed with a little skepticism given that the issue 
of impingement is not an uncommon finding for L-TDRs; it was previously reported 
for mobile-bearing L-TDR retrievals as well and contributed to wear debris 
generation and the immune responses [5]. Second, we were only able to investigate 
short-term revisions within 5 years of implantation, and of these retrievals, the 
implantation times varied between the fixed- and mobile-bearing cohorts. The times 
ranged from 1 to 6 years (mean, 4.1 years) for the fixed-bearing cohort and 2 to 3 
years (mean, 2.7 years) for the mobile-bearing cohort, although both cohorts were 
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short-term revisions. Third, the cohort sizes were small and wear particle 
characteristics of mobile-bearing devices were extrapolated from particles that 
were observed in only one of four patients who had wear debris. Nevertheless, to 
our knowledge, there are no published retrieval studies for contemporary MoP L-
TDRs. Lastly, comparisons of particle number and characteristics are provided for 
historical MoP L-TDRs; however, the previous study used ESEM and excluded wear 
particles larger than 2 µm, whereas in this study, we used polarized light 
microscopy and were able to detect particles as small as 0.34 µm. Although 
polarized light microscopy has been used in other related studies to investigate 
UHWMPE particles of particular sizes [33, 34], the different approaches make it 
difficult to make direct comparisons.  
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CHAPTER 4 
Periprosthetic Immune Response to UHMWPE Wear Particles and 
Inflammatory Factor Production in the Lumbar Spine 
4.1 Abstract 
 The pathophysiology and mechanisms driving the generation of unintended 
pain after TDR are poorly understood. It has been suggested that pain may be the 
result of UHMWPE wear debris and the resulting periprosthetic inflammation. We 
therefore asked whether inflammation could be linked to wear debris generation 
and the production of inflammatory factors that might contribute to abnormal or 
enhanced pain sensitization. Tissues were evaluated for three patient groups: 
periprosthetic tissue samples (n=30) obtained at revision of contemporary metal-
on-UHMWPE TDRs from 11 patients (implantation time 1.2-6.0 year, average 3.3 
year); painful degenerative disc disease (DDD) tissue samples (n=3) obtained from 
patients exhibiting pain at the time of initial TDR surgery; and normal disc tissue 
samples (n=4) obtained at autopsy from patients with no clinical history of back 
surgery. The wear particle number and size/shape characteristics were determined 
in tissue sections from TDR patients and immunohistochemistry was performed to 
identify CD68+ macrophages and the production of tumor necrosis factor-α (TNFα), 
interleukin-1ß (IL-1ß), vascular endothelial growth factor (VEGF), platelet-derived 
growth factor-bb (PDGFbb), nerve growth factor (NGF) and substance P, 
inflammatory factors known to play both a direct and indirect role in inflammatory-
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mediated pain sensitization. Clinical and implant factors did not show any 
correlation with the expression of these factors. However, the amounts of TNFα IL-
1ß, VEGF, NGF and substance P strongly correlated with the number of wear 
particles and also the number of CD68+ macrophages for the TDR patient group. 
Furthermore, the cytokines, TNFα and IL-1ß, and the vascularization factors, VEGF 
and PDGFbb, correlated with the presence of the neural innervation and 
hypersensitization agents, NGF and substance P, suggesting inflammation can 
contribute to pain sensitization. 
4.2 Introduction 
The pathophysiology of low back pain remains poorly understood [25], and 
even less is known about mechanism(s) involved in the generation of unintended 
pain after metal-on-UHMWPE total disc replacement (TDR). The normal human 
lumbar disc consists of an avascular/aneural nucleous pulposus, and a surrounding 
annulus fibrosis that is poorly vascularized and innervated [22]. Painful disc 
degeneration has been associated with an infiltration of inflammatory cells, as 
resident macrophages are not present, and responses leading to innervation by 
sensory nerve fibers, which follow the path of ingrowing blood vessels into disc 
tissue [6, 11]. This process is mediated by both activated fibroblasts and 
inflammatory cell infiltrates that release biological factors that may ultimately lead 
to pain sensitization. In a previous study, we reported an increase in inflammation 
and vascularization in TDR revision tissues [37]. Thus, it was hypothesized that 
biological reactions to UHMWPE wear debris in the lumbar spine result in the 
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production and interplay between key inflammatory mediators that contribute to 
the abnormal or enhanced pain sensitization in TDR patients.  
Studies have suggested that there is a functional link between the immune 
response and neurological changes that ultimately result in the generation of 
peripheral pain. Specifically, activated macrophages, derived from circulating 
monocytes, have been reported to contribute to experimental pain states by 
releasing pro-inflammatory cytokines such as TNFα and IL-1β [23, 30, 34]. In 
addition, these cells can secrete the angiogenic factors, VEGF and PDGFbb, and the 
neurotrophic factor and neuropeptide, NGF and substance P. Investigations on 
painful degenerative discs have identified a significant increase in the production of 
these factors in both the nucleus pulposus and annulus fibrosis [19, 38].  
It is important to note that TNFα and IL-1ß are not only potent stimulators of 
pro-inflammatory reactions in the disc space, but both have the potential to induce 
neural ingrowths into the disc and mediate hypersensitization by upregulating the 
expression of factors like NGF and substance P [2]. In addition, TNFα and IL-1ß can 
directly stimulate pain by acting on nociceptors, sensory neurons that respond by 
sending signals to the brain that initiate the perception of pain [33, 42]. 
Furthermore, TNFα and IL-1ß have been shown to induce angiogenesis by 
stimulating the release of factors like VEGF, PDGFbb and fibroblast growth factor 
(FGF) [6, 35]. While the underlying mechanisms of vascular ingrowth remain 
unclear, VEGF can promote blood vessel expansion into the disc space and 
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subsequently enhance innervation as the growing vessels provide a conduit for 
ingrowing neurons [26]. Thus, it is feasible that all of these cytokines play a role in 
the peripheral mediation of the unintended neuropathic pain experienced in some 
patients after disc replacement. Identifying their presence in the context of wear-
debris-induced inflammatory reactions of the lumbar spine could provide valuable 
insights into the mechanisms that contribute to the unintended pain in some TDR 
patients.  
In this study, we evaluated periprosthetic tissues collected at the time of TDR 
revision surgery using immunoshistochemistry (IHC) to quantify the levels of select 
inflammatory factors that are known to play a major role in inflammation, 
vascularization and inflammatory-mediated pain/innervation, and investigate their 
associations with wear debris and macrophages. The inclusion criteria for the 
factors focused on identifying secretory proteins that are known to be involved in 
both direct and indirect mediation of pain, and included TNFα, IL-1ß, VEGF, PDGF-
bb, NGF and substance P. Understanding the inflammatory responses and factors 
present in TDR periprosthetic tissues with and without detectable UHMWPE wear 
debris will enable us to discover mechanistic pathways that may link wear particles 
to pain sensitization. It will also provide information needed to identify therapeutic 
targets and treatment strategies to mitigate chronic pain after TDR.  
4.3 Materials & Methods 
4.3.1 Tissue Collection & Patient Information  
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 Tissues were evaluated from three patient groups: periprosthetic tissue 
samples (n = 30) from TDR patients (see Chapter 3.3.1 and Table 3-1), tissues 
samples obtained from patients with disc degenerative disease (n = 3) exhibiting 
pain at the time of initial TDR surgery, and intervertebral disc (IVD) tissue samples 
(n = 2) obtained at autopsy from normal patients with no clinical history of back 
surgery or lower back pain. Periprosthetic revision and initial TDR surgical tissues 
were collected as part of a public, multi-center retrieval research program initiated 
in 2004 [16, 17]. Normal IVD tissues samples were obtained from the Cooperative 
Human Tissue Network (CHTN) of the National Cancer Institute (NCI), the National 
Institutes of Health, Bethesda, MD (http://faculty.virginia.edu/chtn-
tma/home.html). Additional IVD tissue samples were obtained from the Life Legacy 
Foundation (Tucson, AZ). Visual analog scale (VAS) pain scores and other 
demographic data was collected when available (Table 4-1). 
4.3.2 Tissue Preparation  
   Tissues collected from revision surgeries, primary surgeries for treatment of 
DDD and autopsy were fixed in either formalin or Universal Molecular Fixative 
(UMFIX; Sakura Finetek USA, Inc, Torrance, CA, USA). One to two 4-mm punches 
from each tissue, considering variations in color, texture, and size of specimen, were 
embedded in paraffin blocks, and 6-µm serial sections were mounted onto 
ProbeOnPlus (Fischer Scientific Co, Pittsburgh, PA, USA) slides. 
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Table 4-1. Clinical Information of Patient Cohorts  
Patient ID Tissue Type Device Bearing 
design 
Sex Age  Implantation 
Time 
(years) 
VAS Score 
BHSP 022 Periprosthetic ProDisc-L Fixed Male 36 5.0 N/A 
BHSP 023 Periprosthetic ProDisc-L Fixed Male 53 3.0 N/A 
BHSP 025a 
BHSP 025b 
Periprosthetic ProDisc-L 
ProDisc-L 
Fixed 
Fixed 
Male 45 4.0 N/A 
BHSP 026 Periprosthetic ProDisc-L Fixed Female N/A N/A N/A 
BHSP 027 Periprosthetic ProDisc-L Fixed Female 28 5.0 N/A 
BHSP 0032 Periprosthetic ProDisc-L Fixed Male 40 6.0 N/A 
PDL 004 Periprosthetic ProDisc-L Fixed Female 25 1.3 N/A 
BRSP 003 Periprosthetic CHARITÉ Mobile Male 26 1.5 8 
BRSP 004 Periprosthetic CHARITÉ Mobile Female 18 3.3 7 
BRSP 006 Periprosthetic CHARITÉ Mobile N/A N/A 2.7 5 
BRSP 007 Periprosthetic CHARITÉ Mobile N/A N/A 3.3 10 
BRSP Pri 002 DDD   N/A N/A  9 
BRSP Pri 003 DDD   F 34  8 
BRSP Pri 004 DDD   F 31  7 
CHTN 38422T IVD   F 55  0 
CHTN 55035T IVD   M 42  0 
LLF I IVD   N/A N/A  0 
LLF II IVD   N/A N/A  0 
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4.3.3 Wear Particle Analysis  
For UHMWPE particle analysis, hematoxylin and eosin (H&E) (ThermoFisher 
Scientific, Waltham, MA) stained tissue sections were evaluated for wear debris (see 
Chapter 3.3.4). In brief, a 36-image (200X magnification) composite was created 
from each tissue section under polarized light that corresponded to the transmitted 
light tissue composites. In each individual image, UHMWPE wear particle number, 
size, and shape were determined by first using a customized image threshold 
operation programmed in MATLAB® (MathWorks Inc, Natick, MA, USA) followed by 
counting/measuring particles using NIH ImageJ (National Institutes of Health, 
Bethesda, MD, USA). Equivalent circular diameter (ECD), aspect ratio and circularity 
measurements were calculated to determine particle size and shape (as described in 
Chapter 3.3.4). 
4.3.4 Immunohistochemistry  
 Immunohistochemistry was performed on prepared slides to evaluate the 
expression of six secretory factors and a pan-macrophage marker: pro-
inflammatory cytokines, TNFα (Rabbit IgG, Novus Biologicals, NBP1-19532) and IL-
1ß (Rabbit IgG, Abcam, AB2105); vascularization factors, VEGF (Rabbit IgG, 
SantaCruz, sc-507) and PDGFbb (Rabbit IgG, Abcam, ); pain-related factors, NGF 
(Rabbit IgG, Abcam, AB6199) substance P (Rabbit IgG, EMD Millipore, AB1566); and 
macrophage marker, CD68 (Rabbit IgG, Abcam, AB125157). Optimal conditions for 
the inflammatory and pain-related antibodies were determined using periprosthetic 
tissues of total hip replacement patients that had severe pain and wear debris; 
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mouse kidney tissues for the vascularization factors; and human tonsil tissue for the 
macrophage marker. The antibody concentrations were: TNFα 1:100, IL-1ß 1:400, 
VEGF 1:100, PDGFbb 1:100, NGF 1:500, substance P 1:500 and CD68 1:100. Slides 
with tissues originally fixated in formalin, as opposed to UMFIX (Sakura Finetek, 
Torrance, CA), were first treated with an antigen retrieval solution (Vector Labs). All 
slides were incubated in 0.5%Triton in PBS to enhance permeability, 3% H2O2 in 
methanol to block endogenous peroxidases, and to block non-specific background in 
4% BSA, 0.1% Tween 20 in PBS. Lastly, slides were incubated at 4 °C overnight with 
the primary antibodies. For antibody visualization, samples were incubated with 
pan-specific secondary antibody, followed by horseradish peroxidase (Santa Cruz 
Biotech) and DAB solution (Vector Labs), and then counterstained with 50% 
hematoxylin.  
 In an attempt to identify macrophage phenotype subsets, M1, M2a and M2c 
cells, the monoclonal antibodies CCR7 (Rat IgG, Origene, TA320232), CD206 (Mouse 
IgG, Abcam, AB8919) and CD163 (Rabbit IgG, Labome, MBS302586) were employed. 
However, these antibodies failed to recognize their intended targets in the TDR 
revision tissues despite multiple trails with both immunofluorescent and chromgen-
based staining techniques. We believe the detection was not possible because these 
proteins are minimally expressed or not present in TDR tissues.   
4.3.5 Imaging & Analysis  
Each stained tissue section was imaged (200X objective) using an Olympus 
BX50 microscope (Olympus, Melville, NY, USA) equipped with a stepper motor-
controlled stage. DAB expression was determined by first employing a customized 
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image threshold operation programmed in MATLAB® (MathWorks Inc, Natick, MA), 
followed by measuring area via NIH ImageJ (National Institutes of Health, Bethesda, 
MD). In brief, the red, green and blue channels for the 24-bit bright field DAB-
labelled images were normalized by the sum of the three channels. Pixel values for 
8-bit images were calculated using a published formula that allows for maximal 
separation of DAB-stained pixels from the background tissue: 
255*blue/(red+green+blue) (Figure 5-1) [8]. See Appendix 1B for MATLAB script. 
   
Figure 4-1. Representative image of a tissue with DAB deposition after 
immunohistochemistry (left) followed by thresholding for DAB-stained pixels 
in MATLAB (right). 
CD68+ macrophages were quantified in each image (200x) of the stained 
tissue sections with the aid of Image-Pro Plus 6.0 (Media Cybernetics, Silver Spring, 
MD, USA). A customized macro was generated to count DAB-stained cells. A 
quantitative value of the inflammatory response was then presented as the number 
of positive cells (DAB) was normalized to total area. In brief, images were split into 
three eight-bit channels (red, green, and blue). Signal from blue channels were 
converted into masks based on a threshold value relative to the average signal 
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intensity of each image. Next, count/size operations were employed along with 
water-shed split commands in order to maximize accuracy of counts. See Appendix 
3-1 for macro.  
4.3.6 Statistical Analysis  
The normality of the data was determined using Shapiro-Wilk test (IBM SPSS 
Statistics V22 software package, IBM Corporation, Armonk, NY, USA). To statistically 
compare immunohistochemical levels between different patient groups, the Mann-
Whitney U-test was employed. Significance was based on P < 0.05. Correlations for 
wear debris, inflammatory cells and the six immunohistological markers were 
determined using Spearman Rho correlation test for non-parametric data. 
Significance was based on P < 0.05. 
4.4 Results 
4.4.1 Mean Inflammatory Factor Expression in Patient Tissues 
 The levels of six inflammatory-associated secretory factors, TNFα, IL-1ß, VEGF, 
PDGF-bb, NGF and substance P, were evaluated in TDR revision tissues and 
compared to levels in DDD patient tissue samples retrieved at the time of initial TDR 
surgery, as well as IVD tissue samples from autopsy patients with no history of back 
surgery or lower back pain (Figure 4-2). Percent area of expression for each factor 
was determined based on the amount of DAB (pixels per total tissue area (mm2) in 
each section.  
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Figure 4-2. Mean expression of inflammatory factors in tissues for TDR, DDD 
and normal IVD patients. *p<0.05 
 
Figure 4-3. Mean expression of inflammatory factors in TDR tissues with 
(n=14) and without (n=16) wear debris, DDD and normal patient tissues. 
*p<0.05 
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 We found that the mean percent area of expression for IL-1ß (p = 0.01), VEGF (p 
= 0.04), and substance P (p=0.01) were significantly higher in TDR tissues when 
compared to tissues obtained from DDD patients. TNFα (p = 0.06) and NGF (p = 0.19) 
were also increased in the TDR patient tissues. When compared to normal, IVD, 
tissues, the mean percent area for all six factors, TNFα, IL-1ß, VEGF, PDGFbb, NGF 
and substance P, were statistically increased in TDR tissues (p < 0.05). Interestingly, 
no statistical differences were observed between DDD and normal IVD tissues.  
 To further evaluate differences in the tissue cohorts, TDR tissues were separated 
into sections that had detectable (> 0.34 µm) UHMWPE wear particles (n = 14) and 
sections that did not (n = 16). The expression of all of the factors, except PDGFbb, 
was significantly higher (p < 0.05) in TDR tissues with UHMWPE wear particles 
(Figure 4-3). Overall, TDR patient tissues with detectable wear debris had the 
highest expression of each factor compared to the DDD and IVD patient cohort 
tissues. 
4.4.2 Mean Inflammatory Factor Expression in Tissues from TDR Patients and 
Associations with Patient Clinical and Implant Factors  
 As patient, clinical and implant factors may contribute to the overall biological 
response, associations with the inflammatory secreted factors were investigated. 
Five male revision patients did not express any significant differences in mean 
percent area of expression for the six inflammatory factors when compared to the 
four female patients (Figure 4-4A). Next, implant complications of malpositioning, 
subsidence, dissociation and/or migration were noted in five revision patients, but 
there  was  no relationship  with  the factors when compared to the  seven other 
TDR  patients  with  no  reported  complications  (Figure 4-4B).  Based on short-term 
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Figure 4-4. Gender (A) and implant complications (B) showed no significant 
association with inflammatory factors. 
 Figure 4-5. Implantation time showed no significant association with 
inflammatory factors. 
to mid-term TDR revision patients, ranging from 1.3 years to 6.0 years of 
implantation, increasing implantation times also failed to correlate with the percent 
area expression of these factors (Figure 4-5). Similarly, other available clinical and 
implant information on patient demographics such as age and implant design (fixed- 
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versus mobile-bearing cores) did not show any association with the expression of 
these factors (not shown). 
4.4.3 Correlations between the Amount of Wear Debris and Inflammatory 
Factors in TDR Tissues 
 
Figure 4-6. Representative tissue sections with wear debris (left, polarized 
light) and TNFα immunostaining (right). The blue arrows indicate wear 
particles and the red arrow a macrophage surrounded by TNFα expressing 
fibroblasts. 
 To determine whether UHMWPE wear particle accumulation affected the six 
inflammatory factors, particle number per tissue section was compared to the amount of 
each factor. In general, tissues that contained wear debris also showed substantially 
increased amounts of the inflammatory factors (Figure 4-6). The quantity of wear debris 
showed a significant and moderately positive correlation to the percent area of both 
TNFα and IL-1ß (p < 0.001, ρ = 0.63; P = 0.015, ρ = 0.50; Figure 4-7). Both factors 
were expressed at substantially lower levels when no particles were present, with the 
exception of highly necrotic tissues (statistical outliers). Comparisons to VEGF and 
PDGFbb expression revealed the amount of wear debris showed a significant and 
moderately  positive  correlation  with  VEGF  (p =  0.003, ρ  =  0.56,),  but  not PDGFbb  
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Figure 4-7. UHMWPE wear debris correlated with TNFα & IL-1ß 
 
Figure 4-8. UHMWPE wear debris correlated with VEGF. 
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         Figure 4-9. UHMWPE wear debris correlated with NGF and SP. 
(Figure 4-8). Nonetheless, both factors were expressed at lower levels when no particles 
were present in the tissues. Lastly, comparisons to NGF and susbstance P expression 
showed the amount of wear debris had a significant and positive correlation with both 
factors, respectively (p = 0.012, ρ = 0.46; p < 0.001, ρ = 0.59; Figure 4-9).   
4.4.4 Correlations between Wear Debris Characteristics and Inflammatory 
Factors in TDR Tissues 
 To determine whether UHMWPE wear particle size and shape affected the six 
inflammatory factors, mean measurements for particle ECD, aspect ratio and circularity, 
in each tissue section with detectable wear debris, were compared to inflammatory factor 
expression. Mean values for the wear particle size and shape showed no significant 
correlation with any of the factors, with the exception of mean particle aspect ratio to the 
percent area of TNFα (p < 0.001, ρ = 0.71, Figures 4-10 A-C). 
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Figure 4-10. Particle ECD means did not correlate with any factor expression 
(A). Particle aspect ratio means correlated with TNFα (B).  Particle circularity 
means did not correlate with any factor expression (C). 
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4.4.5 Correlations between Wear Debris, Inflammatory Factors and the 
Number of Macrophages  
Figure 4-11. Representative tissue sections with wear debris (left) and CD68+ 
macrophages (right). The blue arrows indicate wear particles and the red 
arrows macrophage. 
 To investigate the presence and influence of macrophages during the immune 
response to wear particles in TDR tissues, the number of CD68+ cells in each tissue 
section was compared to particle accumulation and inflammatory factor amounts in serial 
sections. The majority of sections that contained wear particles also showed localized 
macrophage infiltration (Figure 4-11). The number of CD68+ cells showed an expected 
significant and strong positive correlation to the number of detectable wear particles 
(Figure 4-12). In addition, the number of CD68+ cells had a significant and strong 
positive correlation to the amount of TNFα and IL-1ß in these tissues (p < 0.001, ρ = 
0.85; p = 0.001, ρ = 0.69; Figure 4-13).  The number of CD68+ cells also showed a 
significant and strong positive correlation to VEGF (p = 0.001, ρ = 0.71), however there 
was a poor relationship with PDGFbb (p = 0.090, ρ = 0.40) (Figure 4-14). Lastly, the 
number of CD68+ cells showed a significant and positive correlation to NGF and 
substance P (p = 0.003, ρ = 0.63; p = 0.002, ρ = 0.65; Figure 4-15). 
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Figure 4-12. UHMWPE wear debris strongly correlated with CD68+ 
macrophages. 
 
Figure 4-13. CD68+ cells correlated with TNFα and IL-1ß. 
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Figure 4-14. CD68+ cells correlated with VEGF, but not PDGFbb. 
 
Figure 4-15. CD68+ cells correlated with NGF and substance P. 
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4.4.6 Correlations of NGF and Substance P with Other Factors 
 
Figure 4-16. Representative inflamed tissue samples from serial sections 
immunostained for NGF and substance P (left) that matched proportionally 
with inflammatory and vascularization factors (right). The red arrows 
indicate a macrophage positive for the respective immunostain. 
The amounts of the inflammatory, neural innervation agents and pain 
mediators, NGF and substance P, were identified in TDR tissues and their 
associations with pro-inflammatory and vascularization factors were determined 
(Figure 4-16). Both NGF and substance P showed statistically significant 
correlations with the amounts of TNFα, IL-1ß, VEGF and PDGFbb (p < 0.01 for all; 
Figure 4-17). NGF had a strongly positive relationship with the TNFα and IL-1ß (ρ = 
0.77; ρ = 0.79), while substance P had a strongly positive relationship with the 
vascularization factor, VEGF (ρ = 0.77).  
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Figure 4-17. Spearman Rho correlations for NGF & SP. 
4.5 Discussion 
 To better understand the pathophysiology and mechanisms of unintended 
pain after TDR, we investigated whether inflammation could be linked to wear 
debris generation and the production of inflammatory factors that could contribute 
to abnormal or enhanced pain sensitization. Inflammatory factors that promote 
inflammation, vascularization, pain and innervation were all elevated in TDR 
periprosthetic tissues when compared to tissues from DDD patients and IVD tissues 
from normal autopsy patients with no history of lower back pain. While no 
association was found between these factors and patient clinical/implant factors, 
TNFα IL-1ß, VEGF, NGF and substance P correlated with the number of wear 
particles and also the number of CD68+ macrophages in the TDR tissue sections. 
Furthermore, the pro-inflammatory cytokines, TNFα and IL-1ß, and the 
vascularization factors, VEGF and PDGFbb, correlated with the neural innervation 
and hypersensitization agents, NGF and substance P suggesting not only the 
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presence of inflammatory reactions but also the presence of factors that can directly 
and indirectly contribute to pain at periprosthetic sites.  
Although the inflammatory pain factors showed no associations with any 
patient demographic information, clinical indications or implant factors, these 
findings may be an artifact of low sample size and power of study. Both gender and 
implant complications were expected to show at least some association with the 
inflammatory pain factors. In regards to gender differences in pain perception, 
recent studies clearly suggest men and women differ in both pain perception and 
how they respond [1, 13]. In the context of low back pain, women present with 
symptoms more frequently, undergo spine surgery more commonly [1], and  report 
higher levels of back pain than men [7, 18]. However, this was not evident in our 
study cohort, which was again limited by sample size and also the availability of VAS 
scores. Limited sample size may have also contributed to the non-associations with 
implant factors such as malpositioning that can not only lead to severe wear debris 
generation [5], but can also physically impinge upon neighboring nerve roots [41]. 
Both of these outcomes can lead to the development of pain. Unfortunately, 
malpositioning is often unreported by the surgeon [12], which may explain why 
patients with implant complications had similar inflammatory pain factor 
production compared to patients not indicated for any complication. Nonetheless, it 
is also possible the non-associations of the inflammatory factors with patient and 
clinical factors simply adds weight to the associations we observed for TDR tissue 
biological responses and wear debris. 
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While TDR tissues do not contain resident macrophages and are initially 
poorly vascularized, the generation of wear debris increased the infiltration of 
CD68+ macrophages. Past studies on hips and knees have suggested these changes 
are initiated by wear debris activation of fibroblasts. Tunyogi-Csapo and colleagues 
(2007) found that fibroblasts in periprosthetic tissues from joint replacements 
secrete pro-inflammatory cytokines in response to particulate wear as well as the 
angiogenic factors, VEGF and fibroblast growth factor [35]. Moreover, the 
production of pro-inflammatory factor-recruitment of peripheral blood monocytes 
and the production of angiogenic factors lead to extensive vascularization of 
periprosthetic hip tissue [14, 35]. While we hypothesized a similar upregulation of 
angiogenic factors, only VEGF was significantly increased and associated with the 
number of wear particles. Although increases in PDGFbb were observed when 
particle number was high. Based on the high ratio of VEGF to PDGFbb we believe the 
pro-inflammatory M1 macrophage responses predominate rather than M2 
macrophage response [29, 32]. 
It is well accepted from joint arthroplasty studies that UHMWPE particles can 
activate cells, including fibroblasts, to secrete TNFα, which can induce subsequent 
IL-1ß secretion, and together these factors can synergistically contribute to the 
recruitment and polarization of macrophages towards the M1 phenotype [21, 29]. 
Accordingly, our previous work showed an increased infiltration of macrophages in 
TDR tissues containing wear particles [37]. In support of these findings, the current 
study showed increased expression of both TNFα and IL-1ß, which correlated with 
the number of wear particles and inflammatory cells. Particle size and shape have 
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been previously reported to influence biological reactions as well [37], however 
only the aspect ratio of the particles in our study showed a significant relationship 
with TNFα. This may however be due to our limited range (> 0.34 µm) of particle 
size detection capabilities. 
While the current study is the first to identify vascularization and 
neurological factors in TDR periprosthetic tissues, a number of DDD studies have 
reported the presence of pro-inflammatory factors, blood vessel ingrowth and nerve 
ingrowth into layers of the disc, which are thought to result in chronic lower back 
pain [6, 11, 24, 27]. Specifically, NGF-expressing blood vessels have been detected 
and co-localized to sensory nerve fibers in the annulus fibrosis and even deeper into 
the nucleus pulposus of the spinal disc [11]. These nerve fibers are known to 
produce neurotransmitters, including substance P, involved in pain transmission 
[4]. Activated macrophages can further exacerbate the condition by signaling the 
release of more neurotrophins and neuropeptides by neighboring macrophages and 
neurons [2]. Purmessur et al. (2008) have shown in vitro that TNFα stimulation of 
normal cells from the IVD increases the production of susbstance P, whereas IL-1ß 
stimulation increases NGF [28]. Altogether, the current findings, combined with 
previous research, suggest a possible signaling cascade starting with fibroblast 
activation, macrophage infiltration, increased vascularization and 
innervation/nociception (pain response to inflammation and tissue damage).   
The importance of NGF and substance P production in periprosthetic tissues 
is 2-fold. First, NGF is a known mediator of sensory and nociceptive nerve function 
and substance P is a sensory pain-associated neuropeptide released at synapses; 
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thus, both contribute to hyperalgesia (increased sensitivity to pain) [3, 20, 40]. 
Second, NGF can contribute to nerve ingrowth [2, 9, 15], and without it, all sensory 
neurons will undergo apoptosis [10]; substance P is also involved in nerve ingrowth 
and is predominantly secreted at sensory nerve endings during innervation [39]. 
Both factors work in synergy and may be directly involved in mediating innervation 
and pain in the lower back [31, 36]. Taken together, the association with wear-
debris induced inflammation elucidates key mechanisms that may be involved in the 
development of pain in TDR patients. 
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CHAPTER 5 
Investigations into the Pathogenesis of Inflammatory Particle 
Disease in the Lumbar Spine based on Localized Changes in 
Vascularization & Innervation 
5.1 Abstract 
The mechanisms involved in the generation of unintended pain after metal-
on-UHMWPE total disc replacement (TDR) remain poorly understood. While wear-
debris and subsequent inflammation have been established in this dissertation as the 
biological response to UHMWPE wear particles, increased vascularization is another 
key histomorphological change that may provide the link to pathological innervation 
and ultimately pain sensitization. Our hypothesis was that ingrowth of blood vessels 
may provide a conduit for nociceptive innervation. Thus, the aim of this study was to 
explore the contributions of a neurovascular component in wear-debris-triggered 
tissue responses. We evaluated the expression of six inflammatory factors in tissue 
sections from eleven TDR patients and their association with tissue vascularity using 
immunohistochemistry. To assess the production of these factors by cells other than 
macrophages or fibroblasts, we masked blood vessels/nerves in individual images of 
tissue sections with wear-debris and varying degrees of vascularity for five TDR 
patients. Macrophages were also quantified to assess their relationship with 
angiogenesis. Our results showed the total number of blood vessels strongly 
correlated with the levels of TNFα, IL-1ß, VEGF, PDGFbb, NGF and substance P, 
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confirming that vascular changes and inflammatory-mediated responses are 
interrelated. Furthermore, the innervation/pain factors, NGF and substance P, were 
predominantly localized to vascular channels, strongly suggesting increased 
innervation of these tissues. Lastly, comparing blood vessel number with factor 
production and macrophage number in images from tissue sections with low and high 
vascularity suggested that a temporal link exists between increased inflammatory 
factors, macrophages and angiogenesis.  
5.2 Introduction 
 Angiogenesis is the growth of new blood vessels from existing vasculature that 
can play a critical role in development [6], but may also be involved in pathological 
conditions of wear-debris-induced inflammation (i.e. particle disease) after total disc 
replacement (TDR) [28]. While the term “particle disease“ was originally coined to 
describe the failure of local tissue homeostatic mechanisms for total hip replacements 
(THRs), wear particles in both the hip and spine may also indirectly lead to the 
induction of angiogenesis and other tissue functional changes [9, 28]. These changes 
are a consequence of wear particle-induced release of inflammatory factors by 
resident fibroblasts and recruited macrophages. In addition, these “activated” cells 
also proliferate and the increased cellular activity/metabolism results in higher 
oxygen consumption in the local tissue. In turn, this process induces hypoxic or 
oxygen-deficient microenvironments [26]. Subsequently, fibroblasts, macrophages 
and other hypoxic cells (even neurons) in the tissues secrete factors such as vascular 
endothelial growth factor (VEGF) to promote an increase in vascularization in an 
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attempt to alleviate hypoxia [13, 18]. Although the annulus fibrosis of the spinal disc 
regions is poorly vascularized [19], activated fibroblasts and macrophages in close 
proximity to existing blood vessels can coordinate signals with endothelial cells (ECs) 
and other stromal cells to stimulate angiogenesis [6, 12]. Specifically, activated 
macrophages, given their ability to play a trophic role in pathological angiogenesis 
and anastomosis [20, 23], can induce blood vessel ingrowth, which can consequently 
result in the infiltration of more monocytes. Thus, increased vascularization can 
ultimately lead to enhanced inflammation and more VEGF production, thereby 
creating a viscous cycle. 
 In addition to increasing oxygenation, angiogenesis can lead to increased 
innervation of the tissue by nociceptive nerve fibers. It is well established and has 
been published in anatomy textbooks for decades that peripheral nerves track 
alongside blood vessels. During development of the sympathetic nervous system, 
neural crest stem cells migrate to positions adjacent to the aorta and extend axons in 
close proximity to the peripheral vasculature [5]. Similarly, degenerative disc disease 
stimulates sympathetic nerve fibers to follow the trajectories of ingrowing blood 
vessels into the relatively avascular and aneural disc [5, 8]. Studies have shown that 
ECs from infiltrating vessels can secrete neurotrophins such as nerve growth factor 
(NGF), whereas peripheral sensory nerves can secrete VEGF, creating a complex, but 
coordinated pattern of growth between large blood vessels (typically arteries and 
veins that connect the vascular network and provide a capillary source for nutrient 
and oxygen exchange) and nerve fibers [8, 18]. In degenerative disc studies involving 
painful discogenic pain, these infiltrating nerve fibers are positive for proteins like 
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substance P, indicative of nerves originating from the dorsal root ganglion; and thus, 
these fibers are nociceptive [2, 4, 10, 21].  
 While there is already a dearth of knowledge on the mechanisms underlying 
vascular and nerve ingrowth into painful intervertebral discs, there are no reports 
regarding the contributions of a neurovascular component in the pathogenesis of 
inflammatory particle disease after TDR. We hypothesized that wear-debris-induced 
inflammatory mediators and cells noted in our previous retrieval studies of TDR 
tissues (see Chapter 4), may be intimately linked to vascularization and innervation. 
To investigate this link, we focused on localized relationships between inflammatory 
factors, CD68+ macrophages, vascularization and innervation factors in these 
periprosthetic spine tissues. We evaluated whether: (1) the total number of large 
blood vessels present in tissue sections from revised TDRs were associated with the 
inflammatory factors, TNFα, IL-1ß, VEGF, PDGFbb, NGF and substance P in the 
respective sections; (2) the innervation and pain factors, NGF and substance P, were 
localized to large blood vessels and surrounding nerve fibers; (3) the localization of 
large blood vessels, inflammatory factors and macrophages suggested temporal 
differences in tissue sections with varying levels of vascularity. 
5.3 Materials & Methods 
5.3.1 Tissue Selection & Patient Information  
 All periprosthetic revision and initial TDR surgical tissues were collected as 
part of a public, multi-center retrieval research program initiated in 2004 [15, 16]. 
For the initial analysis studying associations between the vasculature and 
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inflammatory factors in the periprosthetic spine, 30 periprosthetic tissue samples 
were evaluated from 11 TDR patients (see Chapter 3.3.1 and Table 3-1). For the 
investigations focused on the localization of blood vessels, inflammatory factors and 
macrophages, five representative tissue sections were chosen from five TDR patients 
(Table 5-1). The inclusion criteria for this selection process were: (1) the presence of 
wear debris to specifically study wear-induced tissue responses; (2) the presence of 
at least 10 blood vessels per section to match baseline levels of vascularization noted 
in intervertebral disc tissue controls; and (3) a range of low to high vascularity based 
on the Oxford scoring system (see Chapter 3.3.2 and Table 3-3) to study temporal 
differences.  
Table 5-1. Tissue Selection and Clinical Information for TDR Patients 
Patient ID Section ID 
Age at TDR 
Implantation 
(years) 
Implantation 
Time  
(years) 
UHMWPE 
Wear 
Debris 
Vascularization 
Score  
(0-3)* 
BHSP 023 Right Intradiscal 56 5.0 Yes 3 
BHSP 025 Left Posterior L5-S1 49 4.0 Yes 3 
BHSP 027 Left Discal 33 5.0 Yes 1 
BHSP 0032 L5-S1 46 6.0 Yes 3 
BRSP 003 Inferior L4-L5 28 1.5 Yes 1 
*Values based on modified Oxford scoring system developed in Chapter 4. 
5.3.2 Tissue Preparation & Immunohistochemistry  
Tissues collected from revision surgeries were fixed in either formalin or Universal 
Molecular Fixative (UMFIX; Sakura Finetek USA, Inc, Torrance, CA, USA). One to two 
4-mm punches from each tissue, considering variations in color, texture, and size of 
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specimen, were embedded in paraffin blocks, and 6-µm serial sections were mounted 
onto ProbeOnPlus (Fischer Scientific Co, Pittsburgh, PA, USA) slides. 
Immunohistochemistry was performed on prepared slides to evaluate the expression 
of six secretory factors and a pan-macrophage marker: pro-inflammatory cytokines, 
TNFα (Rabbit IgG, Novus Biologicals, NBP1-19532) and IL-1ß (Rabbit IgG, Abcam, 
AB2105); vascularization factors, VEGF (Rabbit IgG, SantaCruz, sc-507) and PDGFbb 
(Rabbit IgG, Abcam, ); pain-related factors, NGF (Rabbit IgG, Abcam, AB6199) 
substance P (Rabbit IgG, EMD Millipore, AB1566); and macrophage marker, CD68 
(Rabbit IgG, Abcam, AB125157). Optimal conditions for the inflammatory and pain-
related antibodies were determined using periprosthetic tissues of total hip 
replacement patients that had severe pain and wear debris; mouse kidney tissues for 
the vascularization factors; and human tonsil tissue for the macrophage marker. The 
antibody concentrations were: TNFα 1:100, IL-1ß 1:400, VEGF 1:100, PDGFbb 1:100, 
NGF 1:500, substance P 1:500 and CD68 1:100. Slides with tissues originally fixated 
in formalin, as opposed to UMFIX (Sakura Finetek, Torrance, CA), were first treated 
with an antigen retrieval solution (Vector Labs). All slides were incubated in 
0.5%Triton in PBS to enhance permeability, 3% H2O2 in methanol to block 
endogenous peroxidases, and to block non-specific background in 4% BSA, 0.1% 
Tween 20 in PBS. Lastly, slides were incubated at 4 °C overnight with the primary 
antibodies. For antibody visualization, samples were incubated with pan-specific 
secondary antibody, followed by horseradish peroxidase (Santa Cruz Biotech) and 
DAB solution (Vector Labs), and then counterstained with 50% hematoxylin.  
5.3.3 Imaging & Analysis  
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Each stained tissue section was imaged (200X objective) using an Olympus 
BX50 microscope (Olympus, Melville, NY, USA) equipped with a stepper motor-
controlled stage. DAB expression was determined by first employing a customized 
image threshold operation programmed in MATLAB® (MathWorks Inc, Natick, MA), 
followed by measuring area via NIH ImageJ (National Institutes of Health, Bethesda, 
MD). In brief, the red, green and blue channels for the 24-bit bright field DAB-labelled 
images were normalized by the sum of the three channels. Pixel values for 8-bit 
images were calculated using a published formula that allows for maximal separation 
of DAB-stained pixels from the background tissue: 255*blue/(red+green+blue) [3]. 
CD68+ macrophages were quantified in each image (200x) of the stained 
tissue sections with the aid of Image-Pro Plus 6.0 (Media Cybernetics, Silver Spring, 
MD, USA). A customized macro was generated to threshold and count DAB-stained 
cells, in which the algorithm allowed the non-stop analysis of up to 50 consecutive 
images. In brief, images were split into three eight-bit channels (red, green, and blue). 
Signal from blue channels were converted into masks based on a threshold value 
relative to the average signal intensity of each image. Next, count/size operations 
were employed along with water-shed split commands in order to maximize accuracy 
of counts. See Appendix 1-3 for macro.  
Lastly, automation for the quantification of blood vessels was not possible 
through conventional thresholding and edge-detection. Large blood vessels were 
quantified through manual counts conducted by at least two individuals. For 
localization analysis, the tunics of blood vessels were manually traced in each image, 
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creating regions of interest that could be masked. Note that the tunics are not visible 
at 200X magnification for smaller vessels such as capillaries, postcapillary venules or 
arterioles. However, the focus of the analysis was to determine the number of large 
vessels (i.e. arteries and veins) that theoretically provide a conduit for in-growing 
nerve fibers [8, 18]. All analysis was performed in a blinded fashion. 
5.3.4 Statistical Analysis  
The normality of the data was determined using Shapiro-Wilk test (IBM SPSS 
Statistics V22 software package, IBM Corporation, Armonk, NY, USA). To statistically 
compare immunohistochemical levels between different patient groups, the Mann-
Whitney U-test was employed. Significance was based on p < 0.05. Correlations for 
blood vessels, inflammatory factors and inflammatory cells were determined using 
Spearman Rho correlation test for non-parametric data. Significance was based on p 
< 0.05. 
5.4 Results 
5.4.1 Correlations between the Total Number of Blood Vessels and 
Inflammatory-mediated Pain Factors in TDR Tissues 
        To determine whether inflammatory-mediated pain factors correlated with 
tissue vascularity, the number of blood vessels in each tissue section was compared 
to factor expression for eleven TDR patients. The number of blood vessels, showed an 
expectedly significant and strongly positive correlation to the percent area of VEGF 
(p < 0.001, ρ = 0.70), but only a significant and weakly positive correlation to PDGFbb 
(p = 0.022, ρ = 0.46) (Figure 5-1). In the majority of cases, PDGFbb was only expressed 
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in high amounts when the tissue sections were highly vascularized (>45 blood vessels). For 
the pro-inflammatory cytokines, the number of blood vessels also showed a significant 
and strongly positive correlation to the percent area of TNFα (p = 0.001, ρ = 0.70), 
and a significant and moderately positive correlation to IL-1ß (p = 0.002, ρ = 0.57) (Figure 
5-2). However, high TNFα levels were predominantly observed only when the tissue 
sections were highly vascularized (>45 blood vessels). Lastly, comparisons to the 
innervating/pain factors revealed the number of blood vessels also showed a significant 
and strongly positive correlation to the percent area of NGF (p < 0.001, ρ = 0.70), and 
a   significant   and   moderately   positive   correlation to substance P (p = 0.003, ρ = 0.57)  
 
Figure 5-1. Blood vessel number correlated with VEGF and PDGFbb. 
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Figure 5-2. Blood vessel number correlated with TNFα and IL-1ß. 
 
Figure 5-3. Blood vessel number correlated with NGF and substance P. 
126 
 
(Figure 5-3). While both factors showed a correlative relationship with blood vessel 
number, variations in expression levels were noted in both tissues sections with moderate 
and high vascularity.  
5.4.2 Co-localization of Factors with Blood Vessels 
 
Figure 5-4. Representative images of TDR tissues immunostained for PDGFbb 
(left), NGF (middle) and substance P (right) illustrating co-localization of all 
three factors to blood vessels (black arrows).  
Five vascularized tissue sections with wear debris from five TDR patients were 
selected to determine whether the inflammatory factors and particularly, innervation 
factors were co-localized to ingrown blood vessels in the periprosthetic spine tissues; 
each DAB-stained image was individually analyzed at 200X magnification and factor 
expression was averaged for each of the selectedtissues. All six factors, VEGF, 
PDGFbb, TNFα, IL-1ß, NGF and substance P, were expressed in some blood vessels to 
a certain degree (Figure 5-4), however only three factors appeared to be specifically 
localized to blood vessels.  
Masking blood vessels in images from the five tissue sections showed a 
decrease in amounts for all six factors at varying levels. Quantifying the percentage 
decrease of the factors when blood vessels were masked showed that PDGFbb and 
the innervation/pain factors NGF and substance P were reduced by more than 25%, 
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inferring that they were largely localized to blood vessels, and being produced by ECs, 
vascular smooth muscle cells and/or peripheral nerves (Figure 5-5). Furthermore, 
NGF was significantly higher in blood vessels compared to TNFα (p = 0.016), and 
PDGFbb was significantly higher in blood vessels compared to VEGF, TNFα, IL-1ß and 
substance P, respectively (p = 0.008; P = 0.008; p = 0.016; p = 0.016).  
  
Figure 5-5. Percentage decrease of all six factors in periprosthetic tissues 
when blood vessels were masked. 
5.4.3 Correlations for Blood Vessel Number with Inflammatory-mediated Pain 
Factor Expression and Macrophages in Tissues with Varying Levels of 
Vascularity 
To assess how vasculature is related to local production of these factors, 
representative tissue sections (selected for wear debris and varying levels of vascu-  
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Figure 5-6. Blood vessel number and factor amounts per image in (A) low and 
(B) highly vascularized patient tissues. 
larity) from five TDR patients were chosen in which blood vessels and inflammatory-
mediated pain factors were quantified in individual images (at 200X magnification). 
These results were then separated based on low and highly vascularized tissue 
sections (Figure 5-6A & B). In less vascularized tissue sections, the number of blood 
vessels weakly correlated with only TNFα (p = 0.007; ρ = 0.33) and substance P (p = 
0.039, ρ = 0.27). In highly vascularized tissue sections, the number of blood vessels 
correlated significantly with decreasing strength to TNFα (p < 0.001, ρ = 0.58), 
PDGFbb (p < 0.001, ρ = 0.55) and VEGF (p = 0.004, ρ = 0.35). Contrary to results from 
less vascularized tissue sections, substance P, although not statistically significant, 
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showed a negative association (p = 0.115, ρ = -0.24). NGF and IL-1ß showed no 
significant correlation in either case, but maintained a weakly positive association in both 
low and highly vascular tissues. A larger sample size may be necessary to identify the 
production of NGF and IL-1ß by ECs, vascular smooth muscle cells and/or peripheral 
nerves. Nonetheless, taken together, this data suggests a differential expression of factors 
depending on vascularity. 
 
Figure 5-7. Blood vessel number and macrophage number per image in low 
(A) and highly vascularized (B) patient tissues. 
To determine how vessel number is related to the local presence of 
macrophages, blood vessel and CD68+ macrophage number were quantified in 
individual images (at 200X magnification) and then collectively compared for low and 
highly vascularized tissue sections (Figure 5-7A & B). In less vascularized tissue 
sections, the number of blood vessels correlated significantly, but very weakly, to the 
number of CD68+ macrophages (p = 0.001, ρ = 0.55). In contrast, in highly 
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vascularized tissue sections, the number of blood vessels correlated significantly and 
very strongly to the number of CD68+ macrophages (p < 0.001, ρ = 0.92).  
Although no significant correlations were originally found for implantation 
time (see Chapter 4), the mean implantation time for the low and high vascularity 
groups was 3.25 years and 4.3 years, respectively. 
5.5 Discussion 
Wear-debris and subsequent inflammation have been established in TDR 
revision tissues (see Chapters 4 & 5). In this study, increased vascularization has been 
identified as a consistent histomorphological change in response to wear debris. As 
such, the ingrowth of blood vessels may be providing a conduit for nociceptive 
innervation. Thus the aim of this study was to explore the contributions of a 
neurovascular component in wear-debris-mediated tissue responses. By determining 
the production of six inflammatory-mediated pain factors in tissue sections for all 
eleven patients making up the original TDR cohort, we found the total number of 
blood vessels was significantly associated with TNFα, IL-1ß, VEGF, PDGFbb, NGF and 
substance P, confirming that vascular changes and inflammatory-mediated responses 
are interrelated. Based on individual images of tissue sections with wear-debris from 
five TDR patients (a new approach), we found that in addition to PDGFbb, the 
innervation/pain factors, NGF and substance P, were predominantly localized to 
vascular channels. Lastly, correlations for blood vessel number with factor expression 
and macrophage number in images from tissue sections with low and high vascularity 
revealed a temporal link between TNFα, macrophages and angiogenesis. 
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The significant localization of NGF and substance P with vascular channels 
supported our hypothesis that innervation is intertwined with the trajectories of in-
growing blood vessels. Although this study does not provide evidence for the 
presence of actual nerves or pain, it is well established that these factors are involved 
in nerve ingrowth and predominantly secreted at sensory nerve endings resulting in 
nonciception or pain [1, 7, 14, 29]. Furthermore, both factors work in synergy and 
may be directly involved in mediating innervation and pain of the lower back [24, 27]. 
Taken together, the association of NGF and substance P with wear-debris induced 
inflammation and vascularization elucidates key mechanisms that may be involved in 
the development of pain in TDR patients.  
Tissue sections with low and high vascularity (and noted for the presence of 
wear debris) were selected with the idea that the latter group contains more in-grown 
blood vessels and thus, systematic analysis of individual images in the two sets may 
provide insight into the temporal component of particle-induced pathogenesis. 
Substance P was the only factor that showed a strong association to low, but not 
highly vascular tissues, suggesting that it may be one of the initiating factors for the 
coordinated in-growth of blood vessels and nerves. Whereas, TNFα, VEGF and 
PDGFbb showed stronger associations with blood vessel number in highly vascular 
tissue sections, suggesting they may be playing a more prominent role during 
relatively late stages of particle-induced tissue response.  
Interestingly, TNFα showed a progressive correlation to low and high 
vascularity, suggesting that even though this factor is not co-localized to blood 
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vessels, it may be playing an essential role in regulating angiogenetic progression. 
Although the role of TNFα in angiogenesis is the subject of some controversy, the 
duration of TNFα signaling can differentially regulate EC cell responses [25]. For 
example, in vitro studies have shown the initial secretion of TNFα can block signaling 
of VEGF receptor-2 and delay the VEGF-driven angiogenic response by inhibiting EC 
cell proliferation and migration [11, 22]. On the other hand, depending on the 
duration of TNFα signaling, it can also prime EC cells for sprouting by inducing tip cell 
phenotype via macrophage nuclear factor-κB (NF-κB) activation [25]. Since 
macrophages are a major source of TNFα, and their numbers also increased in highly 
vascularized tissues this strengthens a synergistic association of inflammation and 
TNFα with angiogenesis. Supporting this synergistic hypothesis, animal studies in 
mice and chicks indicate inflammatory factors like TNFα are essential for 
macrophage-induced angiogenesis [17]. Furthermore, a reduced number of 
macrophages can result in a significant delay in the onset of the angiogenic switch, 
suggesting inflammatory factors, which includes all six factors in this study, may be 
required for increased vascularization of periprothetic TDR tissues. In conclusion, 
while the current results reveal some temporal differences and potential stages in 
wear-debris-induced vascularization, more research with a larger sample size is 
necessary to better understand the systematic progression of particle disease.  
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CHAPTER 6 
Rare and Abnormal Biological Complications of Osteolysis after 
Total Disc Replacement: A Case Series† 
6.1 Abstract 
While this dissertation has focused on elucidating the clinical relevance of 
wear debris in the spine with an emphasis on pain, which is the primary reason for 
revision, osteolysis is a rare complication that should not be entirely discounted. 
Although few such complications have been reported for lumbar total disc 
replacement (TDR) and hybrid TDR fixations, our retrieval center identified and 
evaluated retrieved implants and periprosthetic tissue reactions for two cases of 
osteolysis following disc arthroplasty with ProDisc-L prostheses. Implants were 
examined for wear and surface damage, and tissues for inflammation, polyethylene 
wear debris by polarized light microscopy and metal debris by energy-dispersive X-
ray spectroscopy. Despite initial good surgical outcomes, osteolytic cysts were noted 
in both patients at vertebrae adjacent to the implants. For the hybrid TDR case, 
heterotopic ossification and tissue necrosis due to wear-induced inflammation were 
observed. In contrast, the non-hybrid implant showed signs of abrasion and 
impingement, and inflammation was observed in tissue regions with metal and 
polyethylene wear debris. In both cases, wear debris and inflammation may have 
contributed to osteolysis. Surgeons using ProDisc prostheses should be aware of 
these rare complications.  
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6.2 Introduction 
 Total disc replacement (TDR) is an established alternative to lumbar fusion for 
the treatment of back and leg pain that is associated with degenerative disc disease 
(DDD). In cases of 2-level DDD, hybrid fixation is a new approach that involves 
combining the advantages of TDR with spinal fusion at the adjacent (typically 
inferior) level. This approach preserves motion at one level and maintains stiffness in 
the lower segment to prevent adjacent segment degeneration. Aunoble and 
colleagues have shown that the clinical outcomes for patients that received hybrid 
surgery may be superior to 2-level TDRs or fusion in certain cases as there was a mean 
reduction of 24.9 in the owestry disability index (ODI) and a 64.6% improvement in 
the visual analog scale (VAS)[2]. Nevertheless, this does not mean every patient will 
benefit from hybrid fixation; for instance, the condition of the facet joints also serves 
as a central factor when determining the type of construct that is appropriate for a 
particular patient. 
  Although the majority of patients attain clinically significant pain reduction 
after 1-level TDR or hybrid fixation, foreign-body response to wear debris and rare 
instances of osteolysis have been noted for other devices. Historical generations of 
polyethylene-core devices such as the Charité Disc [originally Waldemar Link, 
Hamburg, Germany, later fabricated by DePuy Spine, Raynham, MA and currently 
discontinued] prostheses have shown evidence of polyethylene wear debris in 
periprosthetic tissues, accompanied by histological changes, the presence of 
histiocytes and multinuclear giant cells [9, 18]. Polyethylene wear particles are 
released from the implant as a consequence of abrasive and adhesive wear 
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mechanisms and are then ingested by resident macrophages initiating a chronic 
immune response that can lead to osteolysis[4]. Evidence of lumbar periprosthetic 
osteolysis appeared in 1 of 21 implant revisions from 18 patients who received a 
Charité Disc in our previously reported study, but little is known about osteolysis 
around ProDisc-L implants [9]. 
Interestingly, the one osteolysis case reported in our previous study occurred 
in a patient that underwent hybrid fixation. This raises the question of whether the 
combination of TDR and fusion may create a loading and kinematic environment 
conducive to potential osteolysis. Another potential factor that may contribute to 
osteolysis in the spine is the use of bone morphogenic protein (BMP) during fusion. 
McKay et al. noted that resorption rates around the implant increase with the use of 
BMP-2, presumably due to BMP-induced enhancement of osteoclast activity, which 
results in vertebral osteolysis [6, 14].  
 The purpose of this study was to report two unusual cases of osteolysis with a 
ProDisc-L lumbar disc replacement—one in which the patient underwent TDR at the 
level superior to BMP-induced interbody fusion at L5-L6 and another who had similar 
osteolytic lesions after 1-level TDR without any exposure to BMP-2. Both patients 
underwent TDR with ProDisc-L [Synthes, West Chester, PA] prosthesis, which 
consists of an ultra-high molecular weight polyethylene (UHMWPE) core and two 
metallic endplates made of a cobalt-chromium (CoCr) alloy and plasma-coated on the 
outside with titanium, similar to the Charité [10]. However, unlike the Charité, the 
UHMWPE core of ProDisc-L is locked into the inferior endplate, thus allowing relative 
motion only between the UHMWPE core and the superior endplate. To our 
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knowledge, there have been no previous reports on complications associated with 
osteolysis with the use of ProDisc-L.    
6.3 Materials & Methods 
6.3.1 Patients and Clinical Information 
Two patients who suffered from lumbar disc herniation and radiculopathy 
underwent surgery. One patient required multi-level treatment and opted for hybrid 
fixation with ProDisc-L TDR and fusion, while the other received 1-level ProDisc-L 
TDR. Both TDRs were extracted during revision surgery and periprosthetic tissue 
specimens selected from regions adjacent to the implant were obtained. Retrievals, 
operative notes and radiographs were de-identified and collected in accordance with 
an IRB-approved protocol. 
6.3.2 Implant Retrieval Analysis 
The two sets of retrieved components were cleaned in 10 % bleach and 
examined under a stereomicroscope equipped with a digital camera (Leica DFC490) 
to assess for surface damage and gross fracture. All components were inspected to 
identify surface damage mechanisms (plastic deformation, scratching, burnishing, 
pitting, and embedded debris). Damaged regions of the implants were analyzed using 
scanning electron microscopy (SEM; Supra 50 VP, Zeiss Peabody, MA, USA), energy-
dispersive X-ray spectroscopy (EDS) and x-ray fluorescence (XRF). 
6.3.3 Tissue Preparation and Histological Analysis 
140 
 
 
 
Tissues collected from revision surgeries were fixed in Universal Tissue 
Fixative (Sakura Finetek USA, Inc., Torrance, CA, USA), and decalcified based on the 
presence of heterotopic ossification determined by microCT (μCT 80, Scanco Medical, 
Bru¨ttisellen, Switzerland). One to two 4-mm punches from each tissue, considering 
variations in color, texture, and size of specimen, were embedded in paraffin blocks 
for 6-lm serial sectioning and staining with Alcian blue (Electron Microscopy 
Sciences, Hatfield, PA, USA), hematoxylin, and eosin (H&E) (ThermoFisher Scientific, 
Waltham, MA, USA). Entire tissue sections were imaged under transmitted light 
microscopy using a Motic BA300POL microscope (Motic, Richmond, British Columbia, 
Canada), equipped with an elliptically polarized light imaging system and ProgRes 
SpeedXT core 5 (Jenoptik, Jena, Germany) microscope camera. Inflammatory cells 
were confirmed using the Wright-Giemsa stain (Electron Microscopy Sciences, 
Hatfield, PA, USA). Tissues with notable chronic inflammation were examined using 
environmental scanning electron microscopy (ESEM; XL-30 ESEM-FEG, FEI Company, 
Hillsboro, OR, USA) with backscatter and were analyzed with EDS. 
6.4 Case 1 
 A 40-year-old male suffering from discogenic collapse with lower back pain and 
radiculopathy at L5-S1 underwent anterior discectomy at L5-S1 and interbody 
arthrodesis with 17x24mm titanium-threaded fusion cages filled with BMP-2. The 
cages were inserted on each side of the vertebrae. A few months later, a posteriorly 
displaced cage, along with osteophyte formation and foraminal stenosis, required the  
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Figure 6-1. Sagittal (A) and axial (B) CT scans from case 1 illustrating 
discogenic herniation and osteolytic cysts at inferior L4 and superior L5. The 
axial scan also shows that there may be facet osteophytes and nerve root 
compression at the foramen 
patient to undergo revision of the cage. Segmental pedicle screws were used to 
stabilize the cage on the right side; 6.5mm Xia (Stryker Spine, Allendale, NJ) pedicle 
screws were inserted at L5 and S1. Once the cages were locked, posterior interbody 
arthrodesis was then implemented at L5-S1 with the use of BMP-2 in two small 
sponges placed between each cage. One year later, with continued back pain and disc 
herniation at L4-L5, the patient opted for hybrid fixation and underwent anterior 
interbody placement of 12mm-large and 6-degree ProDisc-L (Synthes, West Chester, 
PA) prosthesis at L4-L5. The following year, the patient had removal of pedicle screw 
instrumentation at L5-S1 and there was solid fusion at the level. It may be important 
to note that the patient also required mass resection of osteophytes, other bony spurs 
and scar tissue.  
 Three years after fusion, persistent pain was experienced by the patient and 
severe arthropathy and degeneration was noted at right L4-L5. As the patient refused 
142 
 
 
 
to undergo disc removal and anterior fusion, posterior fusion was undertaken; 6.5mm 
screws were inserted and a PEEK rod was implemented at L4-L5, followed by 
posterolateral arthrodesis using local bone autograft, BMP-2, and DBX Demineralized 
Bone Matrix Allograft (Musculoskeletal Transplant Foundation, Edison, NJ). However, 
computed tomographic (CT) scans in the following year revealed osteolytic cysts at 
L4-L5 (Figure 6-1). The patient now consented to artificial disc removal. The PEEK 
rod stabilization system (2 PEEK rods and 4 pedicle screws) was removed and sent 
for retrieval analysis, along with the explanted artificial disc. Preoperative work up 
and intraoperative cultures ruled out infection. Tissue samples adjacent to the disc 
were also removed for histological analysis. After explantation of disc, the patient 
underwent spinal fusion with vertebral corpectomy. The area was filled and sealed 
with allograft bone and BMP-2. In the same year, pedicle screws were placed with 
rods for stabilization and posterior lateral arthrodesis was conducted with more local 
bone autograft and BMP-2. An overview of clinical information is provided in Table 
6-1. 
Table 6-1. Clinical information for the hybrid case 1 & non-hybrid case 2. 
Implant Level Sex 
Age at 
Implantation 
Age at 
Revision 
Primary 
Diagnosis 
Revision 
Reason 
Previous 
Surgeries 
Implantation 
Time 
Case 1 L4-L5 M 41 46 
Lumbar disc 
herniation, 
radiculopathy 
Pain, 
osteolysis 11 5 years 
Case 2 L4-L5 M 56 59 
Lumbar disc 
herniation,  
radiculopathy 
Pain, 
subsidenc
e, 
osteolysis 4 3 years 
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6.4.1 Device Retrieval Analysis 
 
Figure 6-2. Retrieved ProDisc-L TDR, 5 years after insertion.  The device was 
damaged during explantation. While it is unclear as to whether the 
polyethylene core was damaged in-vivo, there is no evidence of wear 
mechanisms on the end-plates. 
 The ProDisc-L prosthesis was retrieved five years after implantation. The 
polyethylene core was damaged during explantation, particularly the dome of the 
core (Figure 6-2). Due to iatrogenic damage, we could not determine if the rims of the 
polyethylene core experienced impingement with the superior endplate. While the 
backside surface also experienced iatrogenic damage, there was evidence of 
burnishing and scratching that occurred in vivo. There were no obvious signs of 
impingement on the metallic endplates, and the abrasive scratches were not 
patterned in any physiological manner, suggesting they were formed by surgical tools 
during device removal. Analysis using environmental scanning electron microscopy 
(ESEM) (XL-30 ESEM-FEG, FEI Company, Hillsboro, Oregon) and energy X-ray 
dispersive spectroscopy (EDS) revealed no abnormal surface deposits on the metallic 
endplates. As expected, x-ray fluorescence (XRF) scans consistently detected cobalt-
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chromium ratios matching ASTM F-75 cobalt alloy weight-standards in the interior of 
the endplates, and the exterior plasma-coated elements consisted of alloy 
compositions seen in commercially pure titanium.   
6.4.2 Tissue Analysis 
 
Figure 6-3. Bony tissue from case 1 stained with H&E (100X) showed necrotic 
bone with empty osteocyte lacunae (arrow) and necrotic marrow. 
 Periprosthetic tissues from this patient were obtained from two unclassified 
regions around the implant. Two tissue samples from one region were identified to 
be fibrocartilage, the other two samples from the second region were mature 
trabecular bone. One isolated region in the fibrocartilage tissue contained 
hemosiderin deposits and macrophages; consistent with an innate response to 
hemorrhage prior to explantation. There was no evidence of metal wear debris in any 
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tissues and only minor polyethylene debris was detected in isolated regions of the 
trabecular bone at a mean density of 1.13 particles/mm2.  In bony tissue samples, the 
fatty marrow in the intertrabecular spaces contained only a small number of viable 
cells; isolated regions of these samples consisted of necrotic bone marrow along with 
necrotic bone with empty osteocyte lacunae (Figure 6-3). An overview of tissue 
morphology is provided in Table 6-2. 
6.5 Case 2 
 
Figure 6-4. Sagittal (A) and axial (B) CT scans from case 2 showing L4 
subsidence on the right side of the vertebra and one large osteolytic cyst in L5. 
Smaller osteolytic formations are also evident at superior L5. 
A 56-year old male with a herniated disc and radiculopathy at L4-L5 underwent 
anterior TDR with a 10mm-large and 6-degree ProDisc-L. Three years after, 
subsidence of disc was noted at L4 on the right side, along with the formation of 
osteolytic cysts in CT scans at L5 that appear similar to the lesions seen in case 1 
(Figure 6-4). Progressive back pain led to removal of ProDisc-L, followed by 
placement of 22mm PEEK interbody graft filled with BMP-2  for interbody  fusion  at 
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*Exact tissue region of extraction is unknown. 
Table 6-2. An overview of tissue morphology for the two cases. 
Implant 
Tissue 
Location 
Degeneration Bone/Cartilage Hemosiderin 
Innate/ 
Adaptive 
Inflammation 
PE Wear 
Debris 
(particles
/mm2) 
Metal 
Wear 
Debris 
Case 1 *Region 1 No No/Yes Minor Minor/No None No 
 *Region 2 Yes Yes/None None No/No 1.13 No 
Case 2 
Lateral 
Annulus I No No/Isolated None No/No None No 
 
Lateral 
Annulus II Yes Isolated/Yes None No/No None No 
 Left Lateral Yes No/Yes 
Moderate; 
Isolated Moderate/No None No 
 
Lateral 
Spur I Yes Yes/Isolated None No/No None No 
 
Lateral 
Spur II Yes Yes/No None No/No None No 
 
Posterior 
Lateral Yes Yes/No Mild Moderate/Yes 2.74 No 
 
Superior 
End Plate No Yes/No None No/No None No 
 Left Cyst No Isolated/No Mild Severe/Yes 2.96 Yes 
 Right Cyst Isolated Isolated/No Moderate Severe/Yes 2.88 Yes 
 Inner Cyst Yes No/No Moderate Severe/Yes 2.90 Yes 
 Intradiscal Isolated 
Isolated/ 
Isolated 
Moderate; 
Isolated Severe/Yes None Yes 
 
Right 
Intradiscal No No/No Severe Moderate/Yes None Yes 
 
Posterior 
Intradiscal Yes No/No Mild; Isolated Moderate/Yes 1.01 Yes 
 
Anterior 
Intradiscal Yes Yes/Yes None No/No 1.25 No 
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L4-L5. Preoperative workup and intraoperative cultures were negative for infection. 
6.5.1 Device Retrieval Analysis 
Figure 6-5. Retrieved ProDisc-L TDR, 3 years after insertion. Note the signs of 
impingement on both endplates (arrows). The impinged region on the 
metallic plate (lower right) has a smooth surface compared to the unimpinged 
region (upper right). 
 The ProDisc-L prosthesis was retrieved three years after implantation. There 
was clear evidence of chronic impingement between the endplates and burnishing at 
the core’s edge; microscopic scratches of fan-shaped pattern were found on the 
interior of the metallic plates and a glossy appearance on the polyethylene core, 
respectively (Figure 6-5). SEM images of the impinged regions showed a polished 
appearance in comparison to the as-manufactured texture seen in non-impinged 
regions of the metallic plate. The unidirectional and circumferential wear patterns 
seen on the endplates suggest the wear may have occurred during axial rotation 
and/or lateral bending of the articulating surfaces. The impingement was most likely 
due to implant subsidence which was observed by the surgeon during surgery. The 
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dome of the core also had evidence of multi-directional scratches and burnishing. 
There were no indications of fatigue wear or fracture of the polyethylene core. No 
abnormal surface deposits were observed by SEM/EDS analysis. XRF scans showed 
the metallic surface-constituents on the interior of the endplates consistently 
matched CoCr ratios seen in ASTM F-75 cobalt alloy standards, and the exterior of 
plates consisted of weight compositions seen in commercially pure titanium. 
6.5.2 Tissue Analysis 
Figure 6-6. Histology of inner-cyst tissue with H/E stain showing mixed 
inflammation throughout. Inset A shows presence of macrophage-ingested 
metallic debris (H/E, 400X). Inset B shows presence of lymphocytes in the 
tissue (Wright-Giemsa, 400X). 
 The periprosthetic tissues in this patient showed several abnormalities such as 
progressive degeneration, varied inflammation levels, and metal and polyethylene 
wear debris (Table 6-2). While degeneration was observed in tissues from various 
regions, inflammation was predominantly in the intradiscal and  cyst   tissue;   there 
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Figure 6-7. Titanium alloy and cobalt-chrome particles (arrows) were 
confirmed by use of backscatter scanning electron microscopy with elemental 
dispersive spectroscopy. Analysis of a region of interest (square) evidenced 
cobalt as the most abundant metal visualized by scanning electron microscopy. 
Wt = weight; At = atomic weight 
were no signs of inflammation in tissues from the lateral annulus, left lateral, lateral 
spur, superior end plate and anterior intradiscal regions. Cyst tissue from L5 regions 
showed signs of both innate and adaptive immune response; macrophage ingested 
metal-wear-debris was present throughout the tissue and isolated areas of 
lymphocytes were also present (Figure 6-6). Cyst and intradiscal tissues also 
contained hemosiderin deposits (not shown), suggesting a prior hemorrhage that 
may have contributed to or exacerbated the chronic inflammation.  To confirm 
metallic wear debris, tissues with notable inflammation were examined by ESEM 
using backscatter and were analyzed with EDS. The particles from cyst and intradiscal 
tissues were predominantly cobalt and chromium, however titanium was also 
detected (Figure 6-7). Polyethylene wear debris was present in relatively low 
numbers in all cyst, posterior-intradiscal, anterior-intradiscal and posterior-lateral 
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tissues. The mean polyethylene particles in these tissues was 2.08 particles/mm2. 
These particles varied from oval to amorphous in shape and were localized to regions 
of chronic inflammation (Figure 6-8).  
 
Figure 6-8. An H/E stained region of left-cyst tissue was stained with Wright-
Giemsa (A, 1000X) and observed under polarized light (B, 1000X), showing 
evidence of mixed inflammation and polyethylene particles, respectively. 
6.6 Discussion 
 This study reported two unusual cases of osteolysis in TDR patients with a 
ProDisc-L. The first patient suffered from multi-level DDD and opted for hybrid 
fixation, while the second had a 1-level TDR. Both patients developed osteolyic lesions 
in vertebrae adjacent to the prostheses. Infection was ruled out in both cases. 
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Retrieval and histological analysis of the hybrid case showed minor amounts of wear, 
however tissue responses included fibrocartilage generation, heterotopic 
ossification, and necrosis due to inflammation.  The second case showed signs of 
endplate impingement and adverse local tissue reactions (ALTRs) in intradiscal and 
cystic tissues. In this second, impingement case, the amount of polyethylene wear 
debris was relatively low, but there was CoCr wear debris and associated 
inflammation. In both cases, inflammatory tissue responses may have contributed to 
the osteolytic lesions.  
 One difference between the hybrid and non-hybrid case was the use of BMP-2. 
The hybrid patient was exposed to BMP-2 on five occasions, in comparison to the 
patient that had a 1-level TDR who received none. Although osteolysis was a late 
observation after BMP-2 application, the hybrid patient only sought medical attention 
due to pain. A number of tissue responses to BMP-2 have been noted after spine 
surgery including heterotopic ossification observed in the hybrid patient’s retrieved 
tissue [1, 7, 12]. Although previously believed to be asymptomatic, heterotopic 
ossification can lead to delayed neural compression and pain [7]. Furthermore, recent 
studies reported increased resorption rates with the use of BMP-2 around implants, 
raising the question whether BMP-2 contributes to osteolysis in regions adjacent to 
the fused segment [6, 14]. Authors have reported asymptomatic osteolysis after 
interbody fusion and attributed bone loss to endplate violation during disc space 
preparation and/or to overdosing of BMP-2 [11, 13, 17]. Whether BMP-2 has a dose-
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responsive effect on the activation of osteolytic pathways remains unclear, since an 
optimal BMP-2 dose for fusions is still not agreed upon.  
 Osteolysis, along with tissue reactions involving mixed immune responses have 
been previously reported in a CHARITÉ by Kurtz et al. [9], but these devices consisted 
of polyethylene cores that were gamma-air-sterilized. ProDisc devices utilize 
conventional gamma-inert-sterilized polyethylene that has been previously reported 
in total joint replacements to significantly lower oxidation, wear debris generation 
and inflammation [5, 8]. ProDisc TDRs have been approved by the Food and Drug 
Administration, and only a limited number of complications have been documented 
with the use of either ProDisc-L or ProDisc-C. While hybrid fixation with ProDisc-L 
and fusion remains under clinical evaluation, there have been no previous reports of 
osteolysis with the use of ProDisc-L.  However, with use of ProDisc-C for cervical TDR, 
one exceptional case of progressive osteolysis was reported and attributed to a 
possible immune-mediated metal sensitivity reaction [16].  
 In contrast to the minimal immune reaction in the hybrid case, there were 
substantial ALTRs in the intradiscal and cyst tissue of the non-hybrid case. Wear 
debris-induced inflammation is known to mediate osteolysis; thus, impingement and 
subsequent pro-inflammatory processes may explain the clinical symptoms and 
radiographic progression seen in the non-hybrid case [15]. All samples of cyst tissue 
showed signs of chronic inflammation and lymphocytic infiltration which were 
similar to ALTRs to metal ions from implant corrosion of metal-on-metal total hip 
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replacements (THRs) [3]. These findings suggest that ALTRs from THRs share some 
characteristics with the cyst tissue from the non-hybrid case.  
 The present study reported two rare osteolysis cases following implantation of 
the Prodisc-L. In one case, wear-debris induced inflammation; in the second case, 
inflammation induced heterotopic ossification. As surgeons incorporate ProDisc 
technology into their clinical practice, the rare complication of osteolysis and its 
occurrence should be taken into account when defining contraindications for spinal 
arthroplasty.  
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CHAPTER 7 
Conclusions & Future Directions 
7.1 Conclusions 
 This research was conducted to evaluate the present efficacy of TDR 
technology by performing retrieval analyses of revised implants and periprosthetic 
tissues. Much of what is known about conventional or gamma-inert-sterilized metal-
on-UHMWPE TDRs was originally derived from in vitro simulations. However, given 
the extensive complexity of the musculoskeletal system, there is no in vitro testing, 
simulation or analytical modeling that can truly and fully predict the performance of 
these implants. Furthermore, in vivo testing of spinal implants in animal models to 
assess the interactions of the living tissue environment provide limited and 
subjective information on implant performance, tissue-implant interface and 
biocompatibility due to varied anatomy, healing rates and biomechanical 
environments. For this reason, it is hard to overstate the importance of implant 
retrieval analyses of implants and tissues, as they provide unique and crucial 
insights of in situ performance, along with vital information on mechanisms of both 
failure and success.  
 Implants and their corresponding tissue retrievals from eleven patients 
revised for TDRs were extensively studied and documented in this body of work. 
Despite the small sample size, this is presently the only research (to the author’s 
knowledge) on contemporary TDR implant and corresponding tissue retrievals. This 
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study has uncovered several unknown issues related to UHMWPE wear generation 
and subsequent biological responses in the lumbar spine. Specifically, this 
dissertation addressed the following broad questions: (1) Are wear particles and 
associated biological reactions present in tissues from patients revised for painful 
gamma-inert sterilized TDRs and how do design and/or biomaterials of these newer 
TDRs compare to each other and previous devices? (2) Are UHMWPE wear debris 
and particle-induced inflammation linked to implant and/or clinical factors and are 
both associated with the production of inflammatory factors that can potentially 
contribute to the development of pain in TDR patients? (3) Is there a relationship 
between inflammation, vascularization and innervation in the periprosthetic lumbar 
spine and how do these wear-debris-induced morphological changes contribute to 
the pathogenesis of particle disease?  
 To answer the first question, fixed- and mobile-bearing implant retrievals 
and their corresponding tissues were evaluated. Not only was this investigation 
itself novel, but this was the first study to identify and quantify wear debris and 
corresponding biological reactions in periprosthetic tissues from contemporary 
gamma-inert-sterilized TDRs. UHMWPE wear particles were characterized and the 
number, size and shape were found to affect tissue inflammatory responses. 
Interestingly, no association was shown between wear debris generation and the 
TDR designs when comparing fixed- versus mobile-bearing devices. Overall, the 
current generation of contemporary TDRs were found to result in reduced wear 
debris generation and inflammatory reactions compared to historical or gamma-air-
sterilized TDRs.   
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 Investigating the immune response to UHMWPE wear particles by evaluating 
immunohistochemical markers of inflammatory pain resulted in some intriguing 
and unexpected results. First, given that malpositioning was a concern in a couple of 
revision patients, implant complications such as impingement and clinical factors 
such as implantation time were expected to affect the extent of biological responses; 
however, there was no indication of this based on correlation studies with the 
inflammatory pain factors. Interestingly, all six inflammatory factors were 
expressed to a greater extent in TDR patient tissues compared to IVD tissues from 
patients with no history of back pain. Factors were also more highly expressed in 
TDR patient tissues compared to DDD patients (with non-implant related pain). 
Further investigation revealed the interesting finding that separating TDR tissues 
with and without wear debris provided distinct differences in inflammatory factor 
expressions. Based on this finding, TDR patient tissues were pooled and wear 
particle number was found to be correlated with TNFα, IL-1ß, VEGF, NGF and 
Substance P, but not PDGFbb. Given that macrophages have the potential to secrete 
all of the above factors, their numbers were quantified and also found to be 
correlated with the expression of these five factors. Taken together, this report was 
the first to show that UHWMPE wear debris and subsequent inflammation in the 
periprosthetic spine may lead to the production of factors that are directly 
associated with inflammatory pain and nociception.  
 These results led us to identify the potential missing links that can connect 
wear-debris induced inflammation to pain: vascularization and innervation. 
Building on the hypothesis that in-growing blood vessels are providing a conduit for 
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nerve fibers, it was found that all of the aforementioned inflammatory pain factors 
correlated with increasing numbers of blood vessels. Additionally, the innervating 
factors NGF and SP (which are primarily be secreted by neurons) were localized to 
the vascular channels. Lastly, comparing blood vessel number with factor 
expression and macrophage number in images from tissue sections with low and 
high vascularity suggested the possibility of a temporal link between increased 
inflammatory factors, macrophages and angiogenesis. Even though this study does 
not provide evidence for the presence of actual nerves or pain in the discal regions, 
unveiling and linking wear-induced inflammation and innervation factors with 
associated morphological changes of increased vascularization provides an 
important insight in the pathology that may directly contribute to pain sensitization.  
The data generated from this study provide crucial insight into the spectrum 
of neuroimmunological responses to UHMWPE wear debris, and help to identify 
biological pathways associated with pain that can be targeted to potentially prevent 
the need for TDR revision surgery. It is worth noting that the TDR hardware from all 
of the patients in this study were relatively uncompromised from a mechanical 
standpoint, and thus, finding ways to either minimize wear-debris generation even 
further and/or inhibiting wear-induced inflammatory cascades will be invaluable to 
the field of total disc arthroplasty to improve clinical outcomes. 
7.2 Implications & Future Directions 
7.2.1 Therapeutic Strategies for Treatment 
159 
 
 A better understanding of the pathogenesis of inflammatory particle disease 
in the spine, provided the TDR hardware remains mechanically uncompromised, 
allows the potential to develop novel therapeutic strategies to inhibit and/or 
mitigate pain sensitization. The importance of alleviating wear-debris associated 
pain in TDR patients is to improve the overall longevity of TDR implants and avoid 
complex and high-risk revision surgical procedures. Based on the findings embodied 
in this dissertation, these strategies include: (1) modulation of macrophage 
phenotype; (2) local inhibition of TNFα; and (3) local inhibition of VEGF.  
Macrophages, like other immune cells, have various phenotypes or 
polarization states. As such, macrophages are involved in not only innate 
inflammation and adaptive immunity, but also tissue repair/regeneration. Thus, 
modulation of the macrophage polarization state could provide a target for 
therapeutic intervention of particle-disease-induced pain. In our study, the 
significant amounts of TNFα and IL-1ß, in conjunction with a high ratio of VEGF to 
PDGBbb in TDR periprosthetic tissues, suggested that M1 macrophage pro-
inflammatory responses predominated over anti-inflammatory/healing responses 
driven by M2 macrophages (see Chapter 4). A number of joint replacement studies 
have also reported similar findings suggesting an M1 rather than an M2 response in 
periprosthetic tissues [1, 3, 5-7, 14, 16, 20, 21]. Furthermore, preliminary in vitro 
and in vivo prospective investigations on the modulation of macrophage 
polarization from an M1 to an M2 response have reported favorable outcomes. 
Specifically, the addition of interleukin-4 (IL-4) to cultured human peripheral blood 
monocytes, which had been activated by wear particles, promoted macrophage 
160 
 
polarization from M1 to M2 and reduced the production of pro-inflammatory factors 
TNFα, IL-1ß and interleukin-6 (IL-6) [4, 15]. In a separate in vitro study, the addition 
of IL-4 to cultured monocytes reduced TNF-α production as the macrophage 
phenotype was sequentially converted from a neutral M0 phenotype to M1 and then 
to an M2 phenotype [10], suggesting IL-4 treatment is effective on infiltrating or 
activated macrophages rather than modulating resident macrophages that are 
neutral [13]. Consistent with in vitro findings, recent in vivo studies using rodent 
models to investigate particle-induced inflammation and osteolysis also showed IL-
4 treatment suppressed TNFα production and attenuated bone resorption [11, 17]. 
While more research is certainly necessary (especially in the spine) to clearly 
understand macrophage polarization in regards to implant wear debris, early IL-4 
studies provide evidence that it may be possible to suppress or attenuate wear-
debris-induced inflammation and thus down-stream responses that lead to pain.  
  While the above studies showed that modulating macrophage polarization 
also suppresses TNFα production, this potent pro-inflammatory cytokine can serve 
as an attractive therapeutic target by itself in the spine. In our study, TNFα 
production in TDR periprosthetic tissues was integrally associated with wear-
induced inflammatory pain, as it was strongly correlated with the number of wear 
particles, CD68+ macrophages, blood vessels and the presence of the neural 
innervation and hypersensitization agents, NGF and substance P (see Chapter 4 & 5).  
Furthermore, TNFα showed a progressive correlation with low and high vascularity, 
suggesting that it may be playing an essential role in regulating the angiogenetic 
progression/innervation that can contribute to pain sensitization. Hence, TNFα 
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inhibitors or blockers may be effective in inhibiting or suppressing wear-induced 
inflammatory reactions that lead to pain. A number of TNFα blockers have already 
been cleared by the FDA and deemed effective for the treatment of rheumatoid 
arthritis (RA), a disease characterized by inflammation and pain. Some of the 
commonly used drugs that block TNFα binding to its receptor include infliximab, 
etanercept and adalimumab, all of which have been shown to successfully reduce 
inflammation in randomized double-blind placebo-controlled studies [2, 8, 18, 19]. 
More recently, these inhibitors have been used to decrease inflammation in a 
number of autoimmune diseases besides RA [12]. Given the relatively low and 
infrequent side effects of these drugs (compared to other immunosuppressive and 
cytotoxic agents) [12], future research investigating their therapeutic potential in 
the periprosthetic spine may be warranted.     
 Although inflammation is the driving force of wear-induced adverse 
reactions, this body of work showed vascularization is arguably the most important 
link that is specific to the pain-associated pathogenesis of particle disease in the 
lumbar spine; and thus can serve as a relatively new avenue of research for 
therapeutic intervention. In this regard, the angiogenic factor VEGF, like TNFα, was 
strongly correlated with the number of wear particles, CD68+ macrophages, blood 
vessels and with the presence of the neural innervation and hypersensitization 
agents, NGF and substance P (see Chapter 4 & 5). Furthermore, VEGF was not only 
produced by inflammatory cells including fibroblasts and macrophages, but it was 
also produced by endothelial cells. Hence, it can be hypothesized that VEGF 
inhibitors would reduce blood vessel ingrowth and presumably innervation in 
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periprosthetic spine tissues. Although FDA-approved VEGF inhibitors like 
bevacizumab have been well-established to inhibit angiogenesis in ovarian cancer 
[9], there is a dearth of knowledge on their use in the context of inflammatory-
mediated pain, and therefore warrants future attention.     
7.2.2 Cervical Total Disc Replacement  
 The systematic review presented in Chapter 2 showcased current cervical 
retrieval studies of metal-on-polymer TDRs with fixed-bearing designs reporting 
similar outcomes of wear debris generation and tissue responses to lumbar TDRs. 
However, this was only based on five studies with very limited sample sizes and 
study designs; there still exists a scarcity of data to clearly understand implant wear 
debris generation and biological responses that are specific to the cervical spine.  
Interestingly, as of the time of this writing, only one lumbar, but five cervical disc 
artificial disc designs have been approved by the Food and Drug Administration 
(FDA). This raises the question of whether artificial disc replacements fare better in 
cervical regions. Cervical segments and discs are anatomically smaller and 
biomechanically experience less stresses and movements than lumbar regions [22]. 
Whereas, the vertebral bodies of the lumbar spine are much larger and transversely 
wider in order to withstand and transmit discal loads that are substantially greater 
than the cervical regions. For this reason, it can be hypothesized that the clinical 
wear performance of cervical TDRs may possibly be superior to lumbar devices. 
Considering that chronic neck pain can be just as debilitating as lower back pain, 
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extrapolating both the pitfalls and successes of lumbar TDR technology to the 
cervical regions could prove very valuable.  
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Appendix 
1. Relevant MATLAB Scripts 
1-1. Polarized Light Input File 
%polyprocess.m 
 
%% Automated Selection of DAB-labeled Tissue 
% By SYV 
 
%script to segment polyethylene from background 
%read the fully polarized and brightfield images 
iorig = imread('filename.jpg'); 
ibf = imread('filename.jpg'); 
  
%part1: polarized particle masking 
%select the 'blue' channel 
p1 = iorig(:,:,3); 
  
%threshold the blue channel 
%note: the .2 is image dependent, seems to work ok.  Range is from 0 to 
1 
pth = im2bw(p1,1.0); 
  
%remove 'small objects' that are camera noise 
%NOTE, 'nthresh' is camera/imaging dependent! 
%When you correctly perform Black/White References, this value can be 
set 
%to 0. 
nthresh = 00; 
apth = bwareaopen(pth,nthresh); 
  
%build new RGB image for displaying only poly particles 
for i=1:3, nap(:,:,i) = uint8(apth).*iorig(:,:,i);end 
  
  
%display poly segmented image 
%here is your chance to change nthresh accordingly 
%imshow(nap); inactivate this line to get rid of the first image 
  
%count poly pixels (area of poly)  
inap = rgb2gray(nap); 
ppix = sum(sum(apth)); 
  
%part2: brightfield masking 
gibf = rgb2gray(ibf); 
  
%threshold, note: must select value, 0.75 seems to work 
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%the ~ inverts the image to make tissue white 
gibfth = ~im2bw(gibf,.8); 
  
%count 'tissue' pixels 
tpix = sum(sum(gibfth)); 
  
%easy to compute poly vs. tissue region ratio and display result 
ratiopoly = ppix / tpix; 
  
%display poly and tissue maps 
%figure,imshow(apth*29 + gibfth*61,colorcube); 
  
[L,num] = bwlabel(apth,8); 
  
pnum = num; 
  
%Enable these two command lines if you want to look at original 
polarizied 
%light an brightfield. 
%figure,imshow(L); 
%figure,imshow(iorig); 
  
imwrite(L, 'filename.jpg'); 
imwrite(apth*29 + gibfth*61,colorcube, 'filename.jpg'); 
  
subplot(2,2,1), subimage(iorig) 
subplot(2,2,2), subimage(L) 
%subplot(2,2,3), subimage(ibf) 
%subplot(2,2,4), subimage(apth*29 + gibfth*61,colorcube) 
  
  
 
1-2. DAB Quantification Input File 
% DAB.m 
 
%% Automated Selection of DAB-labeled Tissue 
% By SYV 
  
close all 
  
%% Load in images and process 
files = dir('filename.jpg'); 
for k = 1:(numel(files)) 
    OrigImg=imread(files(k).name); 
    % Splitting the image into R, G, and B matrices 
    R=OrigImg(:,:,1); % The first page is red 
    G=OrigImg(:,:,2); % The second page is green 
    B=OrigImg(:,:,3); % The third page is blue 
    BN=(255*((B)./(0.9*(R+G+B)))); % Normalizing (see Ref. Brey et 
al.,2003); Use 80-90% RGB if tissue is over-stained; Use 90-99% B if 
tissue is under-stained, but stay consistent between stains  
    %BNinv=sum(255-BN,3); % Inverted image to highlight DAB-labeling  
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    %Save processed image 
    imwrite(BN,[ 'filename.jpg' files(k).name]); 
end 
  
%% To view a processed image 
  
%ProcImg = imread('filename.jpg'); 
%figure,hold on 
%imshow(ProcImg); 
%hold off 
 
2. Relevant ImageJ Macros 
2-1. Macro for Area Analysis of Transmitted Light Images 
run("8-bit"); 
 
run("Set Scale...", "distance=3.887 known=1 pixel=1 unit=µm"); 
 
setThreshold(100, 200); 
 
//run("Threshold..."); 
 
run("Measure"); 
 
2-2. Macro for Particle Analysis of Processed Polarized Light Images 
//Run only on 20X Polarized Light Images post-Matlab. 
run("8-bit"); 
   
//run("Threshold..."); 
setAutoThreshold("Default"); 
//run("Threshold..."); 
run("Convert to Mask");  
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//The following commands set the appropriate scales of pixels/µm.  The 
default distance=3.887 for 20X images.  Then a second threshold is 
performed to prepare for the particle analysis. 
 
run("Set Scale...", "distance=3.887 known=1 pixel=1 unit=µm"); 
//run("Threshold..."); 
setAutoThreshold("Default dark"); 
  
run("Set Measurements...", "area centroid standard perimeter fit shape 
area_fraction display redirect=None decimal=3"); 
 
//To use the right analysis, remove the “//” from the beginning of the 
“run” command. 
 
//Line for All Particles (ECD) 
run("Analyze Particles...", "size=0.2298-Infinity circularity=0.00-1.00 
show=Outlines display exclude summarize"); 
 
//Line for particles less than 1 µm (ECD) 
//run("Analyze Particles...", "size=0.2298-0.785 circularity=0.00-1.00 
show=Outlines display exclude summarize"); 
 
//Line for particles less between 1 and 10 µm (ECD) 
//run("Analyze Particles...", "size=0.785-78.53 circularity=0.00-1.00 
show=Outlines display exclude summarize"); 
 
//Line for particles greater than 10 µm (ECD) 
//run("Analyze Particles...", "size=78.53-Infinity circularity=0.00-
1.00 show=Outlines display exclude summarize"); 
 
III. Relevant Image-Pro Plus Macro 
3-1. Macro for Automated CD68+ DAB-Stained Cells 
Sub macrophage() 
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Dim x As Integer 
Dim DocId As Integer 
For x = 1 To 50 
ret = IpDocGet(GETACTDOC, 0, DocId) 
 ret = IpCmChannelExtract(CM_RGB, CM_RGB, 2) 
 ret = IpBlbShow(1) 
 ret = IpSegSetRange(0, 0, 100) 
 ret = IpSegPreview(CURRENT_C_T) 
 ret = IpBlbEnableMeas(BLBM_ROUNDNESS, 1) 
 ret = IpBlbSetFilterRange(BLBM_ROUNDNESS, 0.1, 7.0) 
 ret = IpBlbSetFilterRange(BLBM_AREA, 50.0, 200000.0) 
 ret = IpBlbCount() 
 ret = IpBlbUpdate(0) 
 ret = IpBlbSplitObjects(1) 
 ret = IpDcShow(1) 
 ret = IpDcShow(3) 
 ret = IpDcSelect("Image", "Name", 0) 
 ret = IpDcSelect("Count_Size", "Count", 0) 
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 ret = IpDcShow(1) 
 ret = IpDcSet(DC_AUTO, 0) 
 ret = IpDcUpdate(DC_FETCH) 
 ret = IpDocClose() 
 ret = IpDocCloseEx(DocId) 
 Next x 
End Sub 
